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The transient capacity to autonomously form and organize all of the embryonic and extra-
embryonic tissues involved in the development of a complete organism is termed totipotency. In 
mammals, totipotency is a feature restricted to the earliest cells of the pre-implantation embryo, 
which harbor this unique capacity during the first 1-3 cell cycles, depending on the species. 
However, our understanding of the regulatory mechanisms responsible for the establishment, 
maintenance and termination of such a highly plastic regulatory state remains limited. Mammalian 
totipotency occurs concomitantly to a set of highly-intermingled biological processes such as 
global chromatin remodeling, an unusual set of metabolic characteristics and the de-repression 
of the vast majority of transposable elements, and it is unclear whether these processes act to 
sustain it. Following a general overview of these processes, in this dissertation I present my 
contributions to a body of work on an in vitro model system for mammalian totipotency, which 
exhibits certain molecular features of the in vivo totipotent state. Afterwards, in the second part 
of this thesis, I present the transcriptional analyses that I have conducted with the aim of 
understanding the role of transposable element transcription during pre-implantation 
development. Overall, this work describes a set of phenomena that arise in totipotent cells in vivo 
and in totipotent-like cells in vitro and explores how recapitulating certain molecular features of 





































Part 1. The molecular basis of totipotent-like cells in culture 
§ Generate a roadmap for the spontaneous emergence of 2-cell-like cells in mouse 
embryonic stem cell cultures. 
§ Identify the molecular drivers that underlie the exit of the embryonic stem cell state 
towards the 2-cell-like state and their mode of action. 
§ Determine whether 2-cell-like cells recapitulate other features of the totipotent 2-
cell embryo beyond gene expression changes. 
 
Part 2. The molecular basis of mammalian totipotency in vivo 
§ Develop an approach to jointly assess gene expression changes and transcription 
initiation sites from single cell or single embryo samples. 
§ Systematically generate transcriptional profiles using this method at different 
timepoints of pre-implantation development across 5 mammalian species. 
§ Identify a conserved totipotency-associated transcriptional program. 
§ Determine the degree of evolutionary conservation of transposable element 
























































Mammalian pre-implantation development 
 
A brief history of mammals 
About 210 million years ago – shortly after the giant supercontinent Pangea began to break up, 
but prior to the advent of the unresolved cataclysm that marked the end of the Triassic (Figure 1)  
– a set of little insectivorous carnivores emerged as the first group of mammals (Kemp, 2005). 
Armed with big brains, highly differentiated dentition, active thermal homeostasis and a rather 
avant-garde jaw, these tiny – yet sturdy – mammals had already procured the near entirety of 
modern mammalian features. Although the precise timing is yet to be determined (Vaughan et al., 
2013), two main lineages would emerge shortly after the appearance of these first mammals: i) 
the Monotreme lineage, which has survived up to our days in the oviparous forms of the platypus 
and of four species of echidnas; and ii) the Therian lineage, that would go on to give rise to all 
viviparous mammals, including marsupials and eutherians. Notably, all of these pioneering 
mammals most likely still relied on egg-laying for reproduction, despite at this point already 
possessing the vast majority of morphological and physiological features that are typically 
associated with modern mammals.  
 
Over the course of the first two thirds of mammalian history – some 140 million years during which 
dinosaurs dominated the world’s terrestrial ecosystems – mammals would diversify and give rise 
to the cladistic diversity with which we are now acquainted. Mesozoic mammals would turn out 
to be tremendously inventive, proliferating and branching out into numerous lineages despite the 
fact that none of them seem to have grown past the size of an average cat (Kemp, 2005; Vaughan 
et al., 2013). In particular, one of the most extraordinary innovations that would arise during this 
period would be the advent of embryonic implantation and its associated viviparity within the 
Figure 1. Timeline of mammalian evolution. 
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Therian lineage (Figure 2), at some point before their split into the Marsupial and Eutherian 
lineages 170-190 million years ago (Williamson et al., 2014). By adhering to the mother’s uterus 
in order to obtain additional nutrients, an implanted therian embryo would be able to develop for 
an extended period of time within the mother without entirely relying on an egg’s yolk. While 
marsupials would device rather short-lived placentas to achieve this task and would give birth to 
comparatively undeveloped young, eutherians would further advance these mechanisms and 
would undertake the vast majority of their developmental program upon implantation (Roberts et 
al., 2016). As I will discuss further below, implantation would turn out to be one key novelty with 
deep implications for the landscape of cellular potency itself. 
 
Finally, the last chapter of mammalian history commenced approximately 65 million years ago, 
following the mass extinction event that brought the end of the dinosaurs (Kemp, 2005). With the 
dinosaurs gone, this episode of mammalian evolution would see the emergence of the first large 
bodied eutherians and marsupials, which would quickly fill the ecological niches left behind by the 
dinosaurs. Despite initially possessing a virtually identical set of morphological features, the better-
implanting eutherian mammals would eventually outcompete their marsupial counterparts and 
today represent the vast majority of mammalian species. Overall, mammalian evolution can be 
partially understood as the development of a series of increasingly sophisticated sustenance 
mechanisms that arose to nourish the developing embryo. 
 
Embryonic implantation in mammals 
Implantation conferred early mammals the capacity to develop for an extended period of time 
within the mother, in the absence of a large provision of yolk in the egg. Already in the last 
common ancestor of monotremes and therians (Figure 2), a specialized tissue called the 
trophoblast had arisen which would permit the absorption of vital nutrients from the mother 
(Frankenberg, 2018). For reasons that are not entirely understood, monotremes – and probably 
their last common ancestor with therians – had dispensed of a substantial fraction of yolk content 
in favor of absorbing nutrients from the uterine medium through a very primitive placenta 
(Frankenberg, 2018; Selwood and Johnson, 2006). These nutrients are essential for development 
and will sustain the monotreme embryo in utero until it reaches the 19-20 somite stage and is 





While the monotreme trophoblast never lies in direct contact with the uterine endometrium, 
therian embryos would eventually evolve the capacity to break the outer coating of the egg and 
enter in direct contact with the uterus in order to exchange nutrients (Frankenberg, 2018). 
Towards the last third of the marsupial pregnancy, the trophoblast will implant into the uterine 
endometrium with a varying degree of invasiveness depending on the marsupial species (Hughes, 
1974), and a rather rudimentary placenta will be formed. After a very brief period of 
organogenesis, an extremely altricial neonate will be born and will conclude the greater part of 
morphogenesis attached to the mother’s teat (Smith, 2001). Eutherians, on the other hand, 
implant considerably earlier and complete a significantly greater fraction of their development 
inside the womb. In contrast to the two thirds of in-womb development that marsupials complete 
before implantation, eutherian mice embryos implant already at the 4th day of their ~19 day 
developmental program (Wang and Dey, 2006). 
 
Despite its crucial character, it remains unclear how exactly did the trophoblast cell lineage that 
gives rise to the placenta arise over the course of mammalian evolution (Roberts et al., 2016). 
Although functionally comparable yolk-associated tissues are known to exists in birds and reptiles 
(Frankenberg, 2018; Selwood and Johnson, 2006), it is unclear whether they are actually 
homologous to the mammalian trophoblast in terms of cellular and molecular identity. Across all 
three Monotreme, Marsupial and Eutherian mammalian lineages, the very first cell fate decision in 
the embryo involves a choice between the trophoblast and the pluriblast fates, and occurs during 
Figure 2. Evolution of mammalian implantation. 
 18 
the very first 4 - 7 cell cycles, depending on the species (Selwood and Johnson, 2006). Indeed, 
no obviously homologous cellular lineage is known to exist in any other amniote in terms of timing 
and function, suggesting that the trophoblast is either a mammalian novelty or radical 
transposition of the developmental timing of an existing cellular lineage. Thus, the emergence of 
implantation was only possible because of the appearance of a novel cellular lineage at the 
beginning of development, and the remodeling of the cell potency landscape to make room for a 
cellular state with the expanded cellular potency required to produce it. 
 
Cellular potency during pre-implantation development 
Pre-implantation development refers to the window of mammalian development that initiates 
following fertilization of the oocyte by the sperm, and that ends several days later at the time of 
implantation (Figure 3). Fertilization produces a rather peculiar cell called the zygote, which 
harbors both of the parental genomes inherited from the gametes in two physically segregated 
nuclei. One cell division later, both of the parental genomes will be incorporated into the single 
nuclei of the two daughter cells, although certain epigenetic asymmetries inherent to their parental 
origin will remain. In the case of the mouse embryo, several cell divisions later during the 8-cell 
stage, the embryo initiates a process called compaction – through which cells become polarized; 
upon their next division to the morula stage, outer and inner cells are formed for the first time, and 
the former become preferentially specified to the trophoblast lineage. Another morphological 
change, called cavitation, starts to take place at this point and results in the generation of a fluid-
filled cavity called the blastocoel. From this point on, the embryo will be termed a blastocyst and 
will consist of a laminar sphere of trophoblast cells and a cumulus of pluripotent cells – termed 
the inner cell mass or pluriblast – on the inner side of one of the poles of this sphere.  
Figure 3. Overview of eutherian pre-implantation development. During this period, the developmental 
stage is referred to according to the number of cells present in the embryo and individual cells are 
termed blastomeres. 
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In terms of cellular potency, the various cells that arise over this window of development can be 
classified into four main categories: totipotent, plenipotent, pluripotent and trophoblast cells 
(Condic, 2014). In mouse, the totipotent window (Figure 3) includes the zygote and 2-cell stage 
embryo, since individual blastomeres of each of these two stages can produce an entire organism 
on their own (Casser et al., 2017; Tarkowski, 1959). In contrast, cells from the 4-cell and 8-cell 
stages are plenipotent because they have yet to be allocated to any of the two lineages of the 
early blastocyst: the pluripotent inner cell mass – which will give rise to the embryo proper and 
some extra-embryonic tissues – and the trophoblast – which will give rise to the placenta (Kelly, 
1975; Tabansky et al., 2013). While at the morula stage these two lineages have already started 
to be specified, these cells are actually still bipotent and will not commit to either fate until the 
formation of the blastocyst (Rossant and Vijh, 1980). Although in the early blastocyst outer cells 
have already committed irreversibly to their trophoblast fate, inner cells will not commit to the 
pluripotent fate for another cell division and can be directed to contribute towards the trophoblast 
if physically transplanted (Posfai et al., 2017). 
 
The totipotent embryo 
How exactly does a single cell give rise to an entire multicellular organism is one of the longest-
running and most fascinating questions in biology. This transient capacity to autonomously form 
and organize all of the embryonic and extra-embryonic tissues involved in the development of a 
new organism is termed totipotency. In mammals, totipotency is a feature restricted to the 
earliest cells of the pre-implantation embryo. Although its definition entails different interpretations 
(Condic, 2014) – and is used loosely in some instances (Macfarlan et al., 2012; Morgani et al., 
2013) – in this work I will refer to totipotency as the capacity of a single cell to autonomously and 
successfully form and organize all of the embryonic and extra-embryonic tissues that emerge 
during the development of a new organism (Ishiuchi and Torres-Padilla, 2013). For example, over 
the course of mouse development, only the zygote and each of its two daughter cells are strictly 
totipotent since only they can produce an entire organism on their own. In this case, it is said that 
the last twinning-stage over the course of mouse development is the 2-cell stage, since only up 
to this stage can genetically-identical twin offspring be derived by physically separating each of 
the individual blastomeres. 
 
Totipotency across mammals 
Interestingly, the developmental window during which totipotency manifests is not fixed and varies 
among mammalian species (Figure 3). In bovine and sheep embryos, all four of the 4-cell stage 
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blastomeres are capable of developing into an entire calve or lamb when transferred individually 
into surrogate mothers (Johnson et al., 1995; Willadsen, 1981). Similarly, in Rhesus monkeys, 
embryos composed of only two 8-cell stage blastomeres are occasionally capable of developing 
to term, further providing evidence of the surprising fact that in some species, a quarter-embryo 
– although in this particular case, not a single cell – is sufficient to form an entire organism (Chan, 
2000). Even more remarkable, however, are the reports that individual 8-cell stage pig, sheep 
and rabbit blastomeres are potentially totipotent and can occasionally give rise to a live piglet, 
lamb or kitten on their own (Moore et al., 1968; Saito and Niemann, 1991; Willadsen, 1981). 
Although these experiments have also been attempted in mouse embryos – the best studied 
model system for early mammalian development – no live mouse pup has been reported to arise 
from a single 4-cell stage or 8-cell stage blastomere. Notably, single blastomeres of the 4-cell 
stage do produce a small pseudo blastocyst, but this blastocyst frequently lacks derivatives of 
the pluripotent ICM and is mostly composed of trophoblast cells (Rossant, 1976). Remarkably, it 
appears that compaction and cavitation seem to initiate at the same time in mouse embryos 
derived from a single blastomere and in intact embryos (Tarkowski and Wróblewska, 1967), 
suggesting the existence of a regulative, time-sensing mechanism that actively limits totipotency. 
However, considering that it is well established that mouse 4-cell stage blastomeres have the 
capacity to contribute to both the ICM and the trophoblast (Kelly, 1975; Tabansky et al., 2013), 
it follows that the apparent loss of totipotency in these 4-cell stage blastomeres might actually 
result from a premature restriction in cellular potency occurring at a later time, before the 
specification  of sufficient cells of each lineage is achieved. 
 
The molecular basis of mammalian totipotency 
Nevertheless, our understanding of the molecular mechanisms that regulate totipotency in 
mammals is still very limited. In addition to the technical difficulties inherent to working with the 
pre-implantation embryo, our limited understanding is also a consequence of the complexity of 
biological processes spanning the totipotent window. In mouse, the totipotent zygote and 2-cell 
stage embryos are characterized by an unusual metabolism (Kaneko, 2016), the absence of 
conventional heterochromatin (Eid et al., 2016; Fadloun et al., 2013a), an atypical chromatin 
organization (Burton and Torres-Padilla, 2014), and a rather unique transcriptional landscape 
characterized by the expression of usually silent genetic elements such as retrotransposons, 
tandem repeats and totipotency-specific genes that are only active during this period (Evsikov et 
al., 2006; Fadloun et al., 2013b; Göke et al., 2015; Peaston et al., 2004; Rodriguez-Terrones and 
Torres-Padilla, 2018). Below, I will summarize three of the unusual biological processes that occur 
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at the onset of mammalian development that might underlie – either jointly or individually – the 
exceptional plasticity of totipotent cells. 
 
Metabolic features of totipotent cells 
In terms of cellular metabolism, the mouse pre-implantation embryo exhibits a set of rather 
unusual properties that most likely reflect its disconnection from the mother’s blood supply, its 
exposure to the oviduct and uterine medium – which might possess an evolutionary conserved 
role dating back to the monotreme means of embryo nutrition (see above) – and the need to 
produce sufficient amounts of certain critical metabolites to aid in the chromatin remodeling 
process (Nagaraj et al., 2017). While glucose is known to be present in the oviduct (Gardner and 
Leese, 1990), mouse pre-implantation embryos are unable to use this metabolite for energy 
production prior to the morula stage (Brinster, 1965). Intriguingly, while glucose is not able to fuel 
energy metabolism between the zygote and 8-cell stage, its presence is essential for the embryo’s 
developmental progression past the 2-cell stage and a brief exposure to glucose as short as 1 
minute is sufficient to prevent these embryos from undergoing developmental arrest (Chatot et 
al., 1994). Indeed, it appears that the earliest stages of pre-implantation development rely instead 
on monocarboxylates such as pyruvate and lactate (Brinster, 1965) to satisfy their energetic 
demands through oxidative phosphorylation (Houghton et al., 1996), and to generate sufficient 
amounts of critical metabolites such as acetyl-CoA and α-ketoglutarate (Nagaraj et al., 2017). 
These metabolites might be necessary to fuel the chromatin remodeling process that occurs after 
fertilization, and in agreement with this, transposition of the Pyruvate Dehydrogenase enzyme 
complex from the mitochondria to the nucleus at the 2-cell stage has been shown to be essential 
for the embryonic genome to be successfully activated (Nagaraj et al., 2017). Because it’s 
possible – and even likely – that the unique metabolic features of the early pre-implantation 
embryo contribute to its exceptional plasticity, during my PhD I have explored whether 
reproducing these metabolic conditions aids in the reprogramming process to a 
totipotent-like state which will be described further below. Because of its ongoing nature, 
however, this work has not been included in this cumulative thesis. 
 
Totipotent cells undergo an extensive process of chromatin remodeling 
Following fertilization, parental genomes are subject to an intense process of chromatin 
remodeling that is thought to underlie the reprogramming of the highly differentiated gametes 
into totipotent cells. In particular, the paternal genome is enwrapped in protamines rather than 
histones and is thus the subject of an intense wave of histone deposition (Santenard et al., 2010). 
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Globally, the earliest cells of the mouse embryo possess a completely atypical chromatin 
organization, that is evident even in a DAPI staining of genomic DNA. In contrast to the punctual 
organization of pericentromeric heterochromatin into chromocentres that is present from 
the 4-cell stage on, oocytes and 2-cell stage embryos instead organize these same genomic 
regions into a set of ring-like structure called nucleolar-like-bodies (Burton and Torres-Padilla, 
2014; Kopečný et al., 1989). In terms of chromatin modifications, mouse pre-implantation 
embryos exhibit further unique characteristics, such as global DNA demethylation (Eckersley-
Maslin et al., 2018) and the apparent lack of conventional constitutive heterochromatin (Fadloun 
et al., 2013a). Overall, because of the reprogramming process that occurs at the onset of 
mammalian development, chromatin in totipotent cells is particularly open (Wu et al., 2016) and 
rather devoid of repressive histone modifications. It remains an open question how exactly this 
unique chromatin context underlies the totipotent capacity of these cells. In this dissertation, 
Eid et al. describe the developmental arrest of mouse pre-implantation embryos upon 
induction of the H4K20me3 constitutive heterochromatin mark. By analyzing gene 
expression data in manipulated and control embryos, I contributed to the determination of 
the molecular mechanisms underlying this developmental arrest. Overall, the 
downregulation of constitutive heterochromatin at the beginning of mammalian 
development appears to be essential for normal developmental progression and, perhaps, 
totipotency. 
 
 Totipotency window (range of twinning stages) 
ZGA timing 
(major wave) 
Earliest transcription detected 
(start of minor wave) 
Mouse Zygote – 2-cell stage 2-cell stage (Woodland and Graham, 1969) 
Zygote 
(Mintz, 1964) 
Cow Zygote – 4-cell stage 8-cell – 16-cell stages (Camous et al., 1986) 
Zygote 
(Memili and First, 1999) 
Rhesus Zygote – 4-cell stage 4-cell – 8-cell stages (Schramm and Bavister, 1999) 
2-cell stage 
(Schramm and Bavister, 1999) 
Rabbit Zygote – 8-cell stage 8-cell – 16-cell stages (Christians et al., 1994) 
Zygote 
(Christians et al., 1994) 
Pig Zygote – 8-cell stage 4-cell stage (Arrell et al., 1991) 
4-cell stage 
(Tománek et al., 1989) 
Table 1. Timing of the totipotency window and of zygotic genome activation across several eutherian 
species. In Rhesus monkeys and Pigs, it’s possible that technical factors might underlie the failure to detect 
transcription at the Zygote stage. 
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Transcriptional features of totipotent cells 
Shortly after fertilization, the mammalian genome will be transcriptionally activated for the first time 
in an event called Zygotic Genome Activation (ZGA) (Table 1). In mouse, this transcriptional 
event can be subdivided because of its timing into two parts: the minor wave of zygotic genome 
activation that occurs at the zygote stage (Mintz, 1964), and the larger major wave of zygotic 
genome activation that occurs later in the 2-cell stage (Woodland and Graham, 1969). While 
numerous developmentally-critical genes that are specific to the genome activation event are 
transcribed at this time and might underlie the totipotent capacity of the early embryo, it is most 
tempting to speculate on the contribution of the other major substrate of these transcriptional 
waves: transposable elements. Across both humans and mice, specific families of transposable 
elements are activated during genome activation (Fadloun et al., 2013b; Göke et al., 2015; 
Hendrickson et al., 2017; Peaston et al., 2004), in many cases enabling the transcription of 
chimeric genes that can only be transcribed downstream of the promoters of these repetitive 
elements. During my PhD, I have characterized the transcriptional landscapes of pre-
implantation development across five different mammalian species in an effort to assess 
the evolutionary conservation of the totipotent transcriptional program and of 
transposable element expression, among other questions. Although at the time of 
submission of this dissertation these analyses are still ongoing, the methodological 
advances that enabled the generation of these datasets as well as some preliminary 




A supplementary introductory section on transposable elements and their regulatory roles during 
mammalian pre-implantation development has been included in Appendix I. Copyright to include this 
publication in this dissertation has been retained and can be consulted in Appendix III.  
The reference is: 
Rodriguez-Terrones D. & Torres-Padilla M.E. (2018). Nimble and ready to mingle: transposon outbursts 





In vitro model systems for the study of mammalian 
pluripotency and totipotency 
 
Mouse embryonic stem cells are an in vitro model system of pluripotency 
Mouse embryonic stem cells (ESCs) are an in vitro model system for the study of the pluripotent 
cells from the mouse embryo. Although these cells are derived from the inner cell mass of the 
mouse pre-implantation blastocyst, in vitro they actually correspond to a heterogeneous mixture 
of at least two different developmental stages (Wray et al., 2010). Depending on culture 
conditions, these cells can transition back and forth between a state reminiscent of the pre-
implantation epiblast – termed naïve pluripotency and defined by high expression of the 
transcription factor Rex1 – and another one reminiscent of the post-implantation epiblast – 
termed primed pluripotency, defined by low Rex1 expression and more prone to differentiate. 
As is evident from these heterogeneities, mouse ESCs recapitulate developmental features of 
their in vivo counterparts to a great extent and are even capable of resuming their developmental 
roles when transplanted back into the embryo. 
 
In terms of their molecular identity, ESCs are characterized by the activity of a conserved gene 
regulatory network involving the transcription factors OCT4 (Nichols et al., 1998), SOX2 (Masui et 
al., 2007) and NANOG (Chambers et al., 2003), among several others (Kim et al., 2008). Indeed, 
this regulatory network not only modulates the pluripotent state of the cell but is even capable of 
inducing pluripotency in differentiated cell types (Takahashi and Yamanaka, 2006). With regards 
to epigenetic marks, naïve pluripotent stem cells are characterized by low levels of DNA 
methylation that become upregulated upon entry to the primed state, a situation that is also 
observed to occur in the mouse embryo (Leitch et al., 2013). Intriguingly, mouse ESCs also 
recapitulate several of the metabolic features observed in the early embryo, such as a mixed 
reliance on glycolysis and oxidative phosphorylation in the naïve state that shifts to an almost 
absolute use of glycolysis in the primed state (Zhou et al., 2012). Overall, in addition to 
reproducing the developmental characteristics present in the pluripotent cells of the mouse 
embryo, mouse embryonic stem cells also recapitulate many of the molecular features observed 
in their in vivo counterparts. 
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Mouse 2-cell-like cells are an in vitro model system of totipotency 
In addition to the aforementioned heterogeneities, a small subpopulation of cells resembling the 
mouse 2-cell stage embryo spontaneously arises in mouse embryonic stem cell cultures and 
constitutes approximately 0.5% of the culture at any given time. This totipotent-like 2-cell-like 
population of mouse ESCs was originally identified on the basis of its expression of the 2-cell-
stage specific MERV-L family of retrotransposons (Macfarlan et al., 2012) and later found to 
exhibit a series of chromatin features in common with the 2-cell stage embryo such as higher 
histone mobility (Bošković et al., 2014). The ERV-L family of retrotransposons stands out for 
having been co-opted as promoters and other regulatory sequences for a wide range of genes 
activated at zygotic genome activation in both mouse and human, and its activation is suggestive 
of a reversion to a regulatory state reminiscent of the 2-cell stage embryo. In addition, given that 
these cells arise in pluripotent cultures, it is very surprising to note that these cells have been 
reported to downregulate protein levels of OCT4 (Macfarlan et al., 2012), calling into question 
whether they are even pluripotent.  
 
Further adding to the list of mouse ESC heterogeneities, an altogether different subpopulation 
expressing the 2-cell stage specific gene Zscan4 has been described to occur in approximately 
5% of the cells in a mouse ESC culture (Falco et al., 2007; Zalzman et al., 2010). By periodically 
entering into this Zscan4+ state every ~10 passages, mouse ESCs elongate their telomeres 
through not completely resolved molecular mechanisms. What exactly is the relationship 
between the 2-cell-like subpopulation and Zscan4+ population is a question that I aim to 
address in the first part of this thesis. Beyond the actual cellular potency of these 
subpopulations, understanding how pluripotent cells rewind back to a molecular state 
reminiscent of the totipotent embryo could greatly aid us in understanding the molecular 
dynamics underlying totipotency in vivo. To this end, we also describe our search for 















































































Early embryonic-like cells are induced by downregulating 
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The amazing capacity of the early embryo to generate all cells of an 
organism is transient. This feature, referred to as totipotency, implies 
that a full organism can be derived from a single cell and contrasts 
with pluripotency, which refers to the ability of a cell to contribute 
to all three germ layers of the embryo but not to the extraembryonic 
lineages1–4. Thus, totipotent cells have greater cellular plasticity. In mice, 
only the zygote and 2-cell-stage blastomeres are fully totipotent because 
they can generate an organism on their own without the need of carrier 
cells3. Totipotent-like 2C-like cells have been shown to arise spontane-
ously in ES-cell cultures, but only in the extremely low proportion of 
around 0.5% (ref. 1). Similarly to 2-cell-stage embryos, 2C-like cells 
also reactivate transcription of endogenous retroviruses (ERVs), in par-
ticular MERVL. Although most somatic cells can be readily induced to 
pluripotency2,5, it is unknown whether totipotent cells can be induced 
in vitro. Moreover, the molecular and epigenetic features of totipotent 
cells are poorly characterized. Here, we set out to identify molecular play-
ers associated with transitions between pluripotent and totipotent states. 
We show that depletion of either the p150 or the p60 subunits of chro-
matin assembly factor-1 (CAF-1) in ES cells increases the population of 
2C-like-cells. CAF-1 depletion leads to increased accessibility at MERVL 
and to upregulation of neighboring genes, thus generating a transcrip-
tional profile similar to that of 2-cell-stage embryos. Induced 2C-like 
cells after CAF-1 loss share the molecular characteristics of endogenous 
2C-like cells and exhibit molecular features of 2-cell-stage embryos.
RESULTS
To obtain insights into the molecular mechanisms underlying the 
transition toward the 2-cell-like state, we sought to identify common 
features between early embryos and 2C-like cells that differ from those 
of pluripotent cells. We generated stable ES-cell lines containing an 
EGFP reporter under control of the MERVL long terminal repeat 
(2CøEGFP) (Fig. 1a). Examination of several clones revealed that 2C-
like cells, identified by EGFP expression and the absence of OCT4 pro-
tein1, lack chromocenters (Fig. 1b), similarly to zygotes and 2-cell-stage 
embryos6, thus suggesting that, compared to pluripotent and somatic 
cells, they display major global differences in nuclear organization. 
Instead of the well-defined 4′,6-diamidino-2-phenylindole (DAPI)-
stained foci indicative of pericentromeric clustering into chromocent-
ers in ES cells, the DAPI-rich regions in 2C-like cells appeared spread 
and were strongly enriched in acetylated histones, results suggesting 
accelerated histone turnover (Fig. 1b and Supplementary Fig. 1a). 
Absence of chromocenters was accompanied by a robust transcriptional 
activation of the major satellite (MajSat) repeats of the pericentromeric 
chromatin (Fig. 1c), a feature of zygotes and 2-cell-stage embryos7–9. 
Thus, both early embryos and 2C-like cells lack chromocenters and 
reactivate transcription of major satellites and MERVL (Fig. 1d).
Depletion	of	CAF-1	induces	2C-like	cells
To identify molecular pathways that regulate features of 2-cell-stage 
embryos and 2C-like cells, we searched for candidate proteins known 
to regulate chromocenter integrity and/or histone turnover. CAF-1 is 
a trimeric complex responsible for deposition of histones H3 and H4 
during DNA synthesis10,11, and depletion of the p150 subunit of CAF-1 
results in chromocenter loss in pluripotent ES cells and in pericentric 
heterochromatin instability in Drosophila12,13. We thus performed 
RNA interference (RNAi) for the two major CAF-1 subunits, p150 
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and p60, in ES cells containing the 2CøEGFP reporter. We confirmed 
depletion of CAF-1 subunits by western blotting and immunofluores-
cence (Fig. 1e,f). As previously reported12, RNAi for p150 abolished 
detectable chromocenters (Fig. 1f) and led to a dramatic upregulation 
of EGFP-positive cells (Fig. 1g,h). Reverse-transcription quantitative 
PCR (RT-qPCR) and RNA fluorescence in situ hybridization (RNA-
FISH) revealed that activation of the 2CøEGFP reporter reflected 
transcriptional reactivation of endogenous MERVL (Fig. 1i and 
Supplementary Fig. 1b). Moreover, p150 depletion resulted in strong 
upregulation of major-satellite transcription (Fig. 1i). We obtained 
similar results upon p60 knockdown (KD) (Supplementary Fig. 2). 
Remarkably, the overall number of cells expressing the 2CøEGFP 
reporter increased by 10- to 30-fold in the absence of p60 or p150 
(Fig. 1g,h), thus suggesting that depletion of CAF-1 can dramatically 
induce the emergence of 2C-like cells.
Members of the ERVL family of retrotransposons act as alterna-
tive promoters of mouse genes and generate chimeric transcripts in 
2-cell-stage embryos14 and in 2C-like cells1. We therefore asked 
whether CAF-1 depletion leads to upregulation of 2-cell-specific 
genes, including chimeric transcripts. p150 depletion resulted 
in strong upregulation of the 2-cell-specific transcripts Eif1a-
like and Zscan4 as well as Gm6763, which generates a chimeric 
transcript linked to the MERVL long terminal repeat (LTR) (Fig. 2a 
and Supplementary Fig. 2). Although major satellites and MERVL 
transcripts were strongly upregulated, other active retrotransposons 
such as IAP and LINE1 were largely unaffected, thus suggesting 
that p150 depletion does not affect global transcription of all repeti-
tive elements (Fig. 2a). Similarly to spontaneous 2C-like cells1, 
EGFP-positive cells induced by p150 depletion were also devoid of 
OCT4 protein (Fig. 2b). Thus, we conclude that CAF-1 controls the 
stability of stem-cell states and that the cells induced upon CAF-1 
depletion are similar to 2C-like cells that emerge spontaneously.
Chromocenter	disruption	does	not	induce	2C-like	cells
We next investigated the mechanism through which depletion of 
CAF-1 induces cells with totipotent-like features. Because the lack of 
chromocenters and reactivation of major-satellite transcription are 
commonly found in 2-cell embryos, we first asked whether conferring 
these features to ES cells would be sufficient to induce 2C-like cells, by 
using a transcription activator–like effector (TALE) that specifically 
binds major satellites15, fused to the VP64 transactivator (Fig. 2c). 
Targeting VP64 to major satellites in ES cells led to decondensation of 
chromocenters, as visualized with DAPI, and to accumulation of H4 
K16 acetylation therein (Fig. 2d). Expression of TALE-MajSat-VP64 
robustly increased major-satellite transcription (Fig. 2e). However, 
TALE-MajSat-VP64 expression did not result in increased MERVL 
transcription or in loss of OCT4 protein (Fig. 2e,f), and the number 
of ES cells expressing the 2CøEGFP reporter remained unchanged 
(Supplementary Fig. 2). Thus, although chromocenters and major-
satellite transcription appear to be characteristic features of totipotent 
cells, loss of chromocenters and reactivation of major satellites are not 
sufficient to induce 2C-like cells.
Second, we asked whether the passage through replication was nec-
essary for induction of the 2CøEGFP reporter upon p150 depletion. 
After confirming that thymidine treatment efficiently arrested ES cells 
at G1-S phase (Supplementary Fig. 3), we performed RNAi for p150, 
blocked cells at G1-S and analyzed ES cells by immunostaining and 
RT-qPCR (Fig. 3a). Thymidine treatment suppressed the phenotype 
caused by p150 depletion, thus leading to a strong reduction in the 





















































































































































































































































Figure 1 Depletion of CAF-1 induces 2C-like cells. (a) Representation  
of the 2CøEGFP reporter. (b) OCT4 and GFP immunostaining in the  
2CøEGFP reporter–expressing ES-cell line. Representative images from  
>60 cells analyzed in three independent cell cultures are shown. (c) RNA-FISH for MERVL and  
major satellites in the 2CøEGFP reporter–expressing ES-cell line. 2C-like cells are indicated by an arrow. Scale bars,  
5 µm (b,c). Representative images from three independent cell cultures are shown. (d) Common features between 2C-like cells and 2-cell-stage  
embryos. (e) KD with different siRNAs for p150 and p60 and analysis of whole cell extracts with the indicated antibodies. Results are representative of  
two independent experiments. GAPDH is a loading control. (f) Loss of chromocenters and reactivation of the 2CøEGFP reporter in cells lacking p150 
protein, after p150 KD. Representative images from three independent cell cultures are shown, with >50 cells analyzed for each experiment. Scale bar,  
10 µm. (g) Immunostaining of the 2CøEGFP line with antibodies to GFP and p150 after p150 KD. Scale bar, 100 µm. n, number of independent 
experiments with independent cell cultures. (h) Quantification of GFP-positive cells by FACS 2 d and 3 d after transfection of control, p150 or p60 siRNA. 
Bars show the mean, and raw values from two independent cell cultures are also shown. (i) RT-qPCR for MERVL and MajSat in 2CøEGFP reporter–expressing 
ES-cell line after KD of p60 and p150. Shown are the mean ± s.d. of two technical replicates for three cell cultures in experiments performed on different 
days. **P < 0.01; ***P < 0.001 (two-tailed Student’s t test, compared to control siRNA).
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control (Fig. 3b). G1-S arrest also rescued the loss of chromocenters, 
which were instead readily detectable by DAPI staining in spite of the 
absence of p150 (Fig. 3c). Finally, induction of MERVL and major-
satellite transcription was also diminished in p150-KD ES cells after 
treatment with thymidine, whereas the abundance of LINE1 and IAP 
transcripts was unaffected (Fig. 3d). Thus, inhibition of cell-cycle 
progression through S phase suppresses induction of 2C-like cells 
after p150 depletion, a result suggesting that induction occurs 
concomitantly with or after replication.
Loss	of	chromatin-assembly	activity	induces	2C-like	cells
We performed a complementation assay to determine how p150 is 
involved in suppressing the emergence of 2C-like cells. To discern 
whether the phenotype induced by p150 depletion reflects a deficiency 
in DNA synthesis and/or in chromatin assembly, we focused on four 
domains within p150: two noncanonical PIP domains that interact 
with PCNA, the HP1-interaction motif and the ED domain (Fig. 3e). 
The N-terminal PIP1 is dispensable for chromatin assembly and does 
not contribute significantly to p150 targeting to replication sites, 
whereas ablation of PIP2 impairs chromatin assembly without inhibit-
ing DNA synthesis16. Likewise, the p150 HP1-interaction domain is 
required for CAF-1 localization to heterochromatin outside of S phase 
but is dispensable for de novo chromatin assembly and for CAF-1 
targeting to replication foci17. In contrast, the ED domain, composed 
of clusters of glutamate and aspartate residues, is essential for assembly 
activity18. We generated ES cells expressing either full-length p150 or 
each of four Flag-tagged p150 mutants lacking these domains, and we 
confirmed that all five constructs were homogeneously and efficiently 
expressed, although the p150 ∆PIP1 and ∆ED deletions displayed 
slightly lower protein levels (Fig. 3f and Supplementary Fig. 3). 
We then depleted endogenous p150 with a short interfering RNA 
(siRNA) (p150 siRNA #1) that does not target the transgenes used for 
complementation (Fig. 3e). Expression of exogenous full-length p150 
and of the ∆PIP1 and ∆HP1 mutants suppressed the increase of 2C-like 
cells induced by depletion of endogenous p150 (Supplementary Fig. 3). 
RT-qPCR revealed that expression of the ∆PIP1 and ∆HP1 mutants, 
compared to the full-length p150, led to similar transcript levels for 
MERVL, Zscan4, Gm6763 and major satellites (Fig. 3g). Likewise, 
chromocenters were readily visible after expression of exogenous 
full-length p150 or the ∆PIP1 and ∆HP1 mutants (Fig. 3h). Strikingly, 
however, the ∆ED and the ∆PIP2 constructs, which each lack domains 
required for the chromatin-assembly activity of CAF1, were unable 
to rescue p150 deficiency, and cells instead exhibited significant 


































































































































































































































































































































































DAPI GFPFlag H4K16ac DAPI Oct4Flag Merge
n = 3
fFigure 2 Loss of chromocenters and forced  
transcriptional activation of major satellites  
are not sufficient to induce 2C-like cells.  
(a) RT-qPCR of the indicated genes upon  
p150 KD. Shown are the mean ± s.d. of  
three independent cell cultures, performed in  
two technical replicates. *P < 0.01 (two-sided  
Student’s t test, compared to control siRNA).  
(b) Scoring of endogenous (siRNA control)  
and p150 KD–induced 2C-like cells  
immunostained with an antibody to OCT4,  
according to the presence or absence of OCT4 and chromocenters. n, number of cells analyzed for each combination. (c) Schematic representation  
of the TALE constructs used in d. NLS, nuclear localization signal. (d) Immunostaining of 2CøEGFP-reporter ES cells for Flag, GFP and acetylated  
H4 K16 after transfection of two different TALE constructs as indicated. Cells expressing TALE-Maj-VP64 are indicated by arrowheads. Scale bar, 10 µm.  
Shown are representative images of >20 cells analyzed in each of three independent cultures. (e) RT-qPCR analysis for major satellites (MajSat) and 
MERVL after transfection of two different TALE constructs (left) and for expression levels for each of the constructs (right). Data are mean ± s.d. of three 
independent cell cultures. ***P < 0.001 (two-sided Student’s t test, compared to mock transfection (mock)). (f) Flag and OCT4 immunostaining of cells 
transfected as in d. Cells expressing TALE-Maj-VP64 are indicated by arrowheads. Scale bar, 10 µm. Representative images of >20 cells analyzed in  
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and failed to maintain chromocenter integrity (Fig. 3g,h). Moreover, 
whereas expression of the full length, ∆PIP1 or ∆HP1 constructs 
suppressed the emergence of 2C-like cells, the ∆PIP2 or the ∆ED 
mutants failed to do so (Supplementary Fig. 3). Because RNAi for 
p60 in human cells leads to loss of chromatin assembly during DNA 
synthesis19, these data are in agreement with the observation that 
depletion of p60 alone also increases the number of cells express-
ing the 2CøEGFP reporter. Importantly, a second siRNA (p150 
siRNA #2) targeting both endogenous p150 and the exogenously 
expressed p150 mutants recapitulated the emergence of 2C-like cells 
(Supplementary Fig. 3). Thus, CAF-1 can regulate the stem-cell state 
through its chromatin-assembly activity, but p150’s functional inter-
action with HP1 and with PCNA through the PIP1 is dispensable. 
Moreover, the data point to a role for the chromatin-assembly activity 
of CAF-1 in orchestrating the emergence of 2C-like cells. Importantly, 
ablation of another histone-deposition pathway through downregula-
tion of the HIRA chaperone did not affect chromocenter integrity or 
2CøEGFP expression (Supplementary Fig. 4), thus suggesting that 
the induction of totipotent-like features upon CAF-1 KD is not a 
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DAPI Flag DAPI Flag
p150 siRNA #1h
Figure 3 Induction of 2C-like cells is triggered by the loss of the chromatin  
assembly activity of CAF-1. (a) Schematic representation of the experimental  
procedure used for b–d. (b,c) Immunostaining for GFP and p150 of 2CøEGFP  
reporter ES cells transfected with p150 siRNA and treated with either vehicle  
(water) or thymidine. The population of GFP+ cells is indicated in b, and the  
chromocenters are visualized by DAPI in c. Scale bars, 10 µm (b) and 100 µm (c).  
Representative images from three independent cell cultures are shown. (d) RT-qPCR  
analysis for MERVL, MajSat, LINE1 and IAP in the four different conditions used  
in b and c. Data are mean ± s.d. of three cell cultures in experiments performed on  
different days in technical duplicates. *P < 0.05; **P < 0.01; ***P < 0.001  
(Tukey’s honest significant difference (HSD) test). (e) Schematic representation of  
full-length p150 with the functional domains and the mutants used in the  
complementation assay indicated. Red asterisks indicate the position of four point  
mutations at the p150 siRNA #1 target sequence, which render the exogenous  
transgene resistant to p150 siRNA #1 but not to p150 siRNA #2. (f) Expression  
level of p150 full-length or mutants analyzed by western blotting. GAPDH, loading  
control. (g,h) Analysis by RT-qPCR for MERVL, Zscan4, Gm6763 and MajSat (g) or  
by immunostaining for Flag (h). Samples are cells stably expressing p150 full-length  
or mutants and transfected with p150 siRNA #1 to deplete endogenous p150. Scale bar, 10 µm. Representative data of three independent cell cultures 
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Transcriptome	upon	CAF-1	depletion	resembles	2-cell	stage
Next, we asked whether CAF-1 depletion results in a global transcrip-
tional profile similar to that of 2-cell-stage embryos, paying particular 
attention to retrotransposon activation. We performed RNA sequenc-
ing (RNA-seq) in ES cells after KD of either of the two CAF-1 subunits, 
p150 and p60. Analysis of differentially expressed transcripts with appli-
cation of a false discovery rate (FDR)-adjusted P-value cutoff revealed 
2,517 and 1,676 upregulated genes with more than two-fold change in 
gene expression after treatment with p150 or p60 siRNA, respectively, 
and only 96 and 31 downregulated genes (Fig. 4a and Supplementary 
Tables 1 and 2). The greater number of upregulated than downregu-
lated genes suggests a general openness of the chromatin upon CAF-1 
depletion, in agreement with a hypothesis of general repressor func-
tion for CAF-1 (ref. 13). Comparison of differentially expressed genes 
in p150- and p60-depleted ES cells revealed a high similarity between 
the two data sets (Supplementary Fig. 5), results in agreement with 
the observations that p150 and p60 are interdependent in mediating 
chromatin assembly. Among the upregulated genes upon CAF-1 KD, we 
identified Eif1a-like genes (which include Gm5662, Gm2022, Gm4027, 
BB287469, Gm2016, Gm21319, Gm8300 and Gm10264), Zscan4 
genes (Zscan4b–Zscan4f  ), Zfp352 and Tdpoz genes (Tdpoz1–Tdpoz5) 
expressed in 2-cell embryos20. Pluripotency-associated genes such as 
Nanog and Pou5f1 (Oct4) were unaffected (Fig. 4a and Supplementary 
Tables 1 and 2), in line with the observation that endogenous 2C-like 
cells maintain pluripotency-associated gene transcription but have 
downregulated protein levels1. We also performed a comprehensive 
analysis of the expression of repetitive elements by aligning reads to 
the genome, applying as annotation the coordinates of repeat elements 
obtained with RepeatMasker (v4.0.3; http://www.repeatmasker.org/). 
Remarkably, only a subset of retrotransposons were highly upregulated 
upon treatment with p150 or p60 siRNA compared to control siRNA 
(Fig. 4b and Supplementary Tables 3 and 4). In particular, gsat_mm 
(major satellite repeat) and the MERVL families of retrotransposons 
mt2_mm, mervl-int and mt2b1—which are specifically activated in 
2-cell embryos—were the highest-upregulated elements after either p60 
or p150 KD (Fig. 4b and Supplementary Tables 3 and 4). Consistently 
with the RT-qPCR results, the upregulation of repetitive elements 
upon CAF-1 depletion was not global but displayed specificity: LTR 
retrotransposons of the MERVL family were very highly upregulated 
after KD of either p150 or p60, but IAPEz, LINE1 and other types of 
active retrotransposons were unaffected (Fig. 4b).
To establish the extent of similarity between induced 2C-like 
cells and 2-cell-stage embryos, we compared the list of differentially 
expressed genes with those extracted from a comparison between 
oocyte and 2-cell embryos and therefore deemed to be specifically 
activated in 2-cell-stage embryos1. A statistically significant subset 
of genes were commonly upregulated (Supplementary Fig. 5; 
P = 5.93 × 10−14 and 1.56 × 10−14 for p150 and p60 RNAi, respectively, 
by two-sided Fisher’s exact test), thus suggesting that 2-cell embryos 
and CAF-1–KD cells share overlapping gene-expression patterns. 
To further assess the identity of 2C-like cells induced upon CAF-1 
KD, we performed a systematic comparison of the expression pro-
files of endogenous 2C-like cells, p60 KD–induced 2C-like cells and 
p150 KD–induced 2C-like cells against all stages of preimplantation 
development. We first generated RNA-seq data derived from the GFP-
positive sorted population of cells for each condition (Supplementary 
Tables 5 and 6), which further revealed that induced 2C-like cells upon 
CAF-1 KD have highly similar transcriptional profiles to endogenous 
2C-like cells (P < 2.2 × 10−16 and P < 2.2 10−16, by FDR-adjusted 
two-sided Fisher’s exact test, for KD of p150 and p60, respectively) 
(Online Methods). We then extracted the genes specifically expressed 
in zygote, 2-cell, 4-cell, 8-cell and 16-cell stages, and early blastocyst 
from ref. 21 (Online Methods) and compared them with the sets of 
genes upregulated in endogenous 2C-like, p60 KD–induced 2C-like 
and p150 KD–induced 2C-like cells. This analysis revealed that the 
gene subset specific to 2-cell-stage embryos is overrepresented in the 
set of upregulated genes in 2C-like cells induced after KD of p60 or 
p150, in comparison with any of the other stages analyzed and simi-
larly to endogenous 2C-like cells (P = 4.44 × 10−15 and 2.09 × 10−13  
for KD of p150 and p60, respectively, and P = 2.90 × 10−16 for endog-
enous 2C-like, by Bonferroni-adjusted two-sided Fisher’s exact test) 
(Supplementary Fig. 6). This implies that a substantial proportion 
of the transcriptional network specific to 2-cell-stage embryos is 
activated after CAF-1 depletion in ES cells. Chimeric transcripts 
such as Esp24, Gm8994, Gm7102 and Gm12114, which derive from 
MERVLs, are overrepresented within the commonly upregulated 
genes in 2-cell-stage embryos1 and in p150- or p60-depleted cells 
(Supplementary Tables 7 and 8). Moreover, we observed readthrough 
transcription from endogenous retrovirus into genes located in prox-
imity to MERVL-related elements after KD of p150 and p60 (data 
not shown). These observations prompted us to ask whether CAF-1 
regulates expression of genes associated with or located close to 
retrotransposons, thereby generating a transcriptional profile similar 
to that of early embryos14. We determined the percentage of upregu-
lated genes out of the total number of genes located within a fixed 
distance of a repeat (Supplementary Fig. 5). Strikingly, this analysis 
revealed that a large proportion of genes proximal to the MERVL LTR 
(mt2_mm, mt2b and mt2c) were upregulated upon CAF-1 KD 
(Fig. 4c and Supplementary Fig. 7). Interestingly, we did not find 
significant proximal distance association between upregulated genes 
and repeat elements unrelated to the MERVL family, such as LINE1 
(Fig. 4c). These results suggest that the overlap of upregulated genes 
in both 2-cell embryo and CAF-1–depleted ES cells can be largely 
ascribed to the activation of genes proximal to retrotransposon 
elements normally activated in 2-cell-stage embryos, in particular the 
MERVL family of retrotransposons. Indeed, a global distance analysis 
indicated that genes that were commonly upregulated in CAF-1 
depleted cells and expressed in 2-cell-stage embryos are significantly 
closer to MERVL family of retrotransposons (mt2_mm, mt2b1 or 
mt2c_mm) compared to nonoverlapping genes and are also signifi-
cantly closer when compared to the rest of the genes in the genome 
(Fig. 4d; P < 2 × 10−16 for both p150 and p60, by two-sided Wilcoxon 
rank-sum test). Altogether, these results imply that CAF-1 might 
regulate a subset of 2-cell stage–specific genes that are dependent on 
the presence of retrotransposon elements.
To address how CAF-1 depletion mediates changes in retrotrans-
poson expression in these induced 2C-like cells, we asked whether 
CAF-1 modulates chromatin accessibility as it does in HeLa cells19 
by using micrococcal nuclease (MNase) digestion. We isolated 
nuclei from control siRNA-treated ES cells and from fluorescence- 
activated cell sorting (FACS)-sorted GFP-positive 2C-like cells after p60 
siRNA transfection and performed a time course of MNase digestion. 
Analysis of the digested DNA revealed a higher global accessibility 
to MNase in EGFP-positive 2C-like cells induced after p60 depletion 
(Supplementary Fig. 7). To specifically address whether MERVL 
elements are in a more open chromatin configuration in these cells, 
we performed Southern blot hybridization after MNase digestion, 
using a MERVL LTR probe, which revealed that MERVL LTRs are 
indeed more accessible in EGFP-positive 2C-like cells induced after 
p60 depletion compared to control ES cells (Fig. 4e). These results 
suggest that CAF-1 knockdown promotes expression of MERVL 
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Chromatin	features	similar	to	those	of	2-cell	embryos	upon	
CAF-1	loss
We recently reported that high chromatin mobility is a hallmark of 
totipotent cells and that 2-cell-stage nuclei display unusually high 
core-histone mobility22. To address whether CAF-1 KD–induced 
2C-like cells share similar chromatin features with 2-cell-stage 
embryos, we asked whether CAF-1 depletion results in changes in 
histone mobility comparable to those observed in both 2-cell-stage 
embryos and endogenous 2C-like cells. We performed fluores-
cence recovery after photobleaching (FRAP) analyses of H3.1-GFP 
in ES cells containing a MERVL LTR-driven tdTomato reporter 
(2CøtdTomato)22 after p60 and p150 KD. Remarkably, tdTomato-
positive cells induced upon p60 and p150 KD displayed a very high 
H3.1-GFP mobility (Fig. 5a), and the H3.1-GFP mobile fractions were 
highly similar to those in 2-cell-stage embryos and in spontaneously 
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Figure 4 CAF-1 depletion induces expression of genes located in proximity to repetitive elements. (a) MA plots displaying differentially expressed genes 
in p150- and p60-depleted ES cells. n = 2 cell cultures in experiments performed on different days (Spearman’s rho ≥ 0.97 for each pair of replicates; 
Supplementary Note). Arrows represent data points outside of the plotting area. DE, differentially expressed. (b) MA plots showing differentially expressed 
repeats in p150- and p60-depleted ES cells. n = 2 cell cultures in experiments performed on different days (Spearman’s rho ≥ 0.99 for each pair of 
replicates; Supplementary Note). (c) Proportion of differentially expressed genes in p150- or p60-KD samples located in the vicinity of specific repeat 
types. Colored lines represent the percentage of upregulated genes among all overlapping genes up to a distance of 200 kb surrounding each repeat  
type. At left: blue, mt2_mm; green, mt2b1; purple, mt2c_mm. At right: green, lx3_mus; pink, lx5 orange, b2_mm1a; black, l1md_a; purple, l1md_f.  
(d) Distribution of distances (log2) between differentially expressed genes upon p150 or p60 KD and/or genes upregulated in 2-cell embryos to the  
2-cell-specific repeats. The absolute distance between the transcription start site of a gene and the end of the closest 2-cell-specific MERVL family of 
repeats (either mt2_mm, mt2b1 or mt2c_mm) was measured for each gene. Box plots indicate the median log2 base-pair distance distribution, and 
notches indicate confidence interval. The box covers the interquartile range. Whiskers extend to 1.5 times the interquartile range, and the center lines 
indicate medians. Dots indicate outliers. P values were calculated by two-sided Wilcoxon rank-sum tests with Bonferroni correction for multiple testing. 
RE, repetitive element. (e) MNase analysis with a MERVL probe after p60 KD. Images are representative of two Southern blots from two independent 
experiments. The positions of the DNA corresponding to mono-, di- and trinucleosomes are indicated. Quantification of the signal intensity over the region 
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Figure 5 CAF-1 depletion generates cells  
with similar chromatin features to 2-cell-stage 
embryos and higher reprogrammability upon 
SCNT. (a) FRAP recovery curves of H3.1-GFP 
in tdTomato-positive and tdTomato-negative 
cells after KD of p60 or p150. Recovery was 
quantified in the bleached area over a 60-s 
period, and the curves were normalized to zero 
to account for differences in bleach depth 
between experiments. Individual points are 
mean ± s.e.m., and mean values were fit into 
an exponential curve. The number of nuclei 
analyzed for each condition is indicated.  
(b) Estimated mobile fractions (± s.e.m.) of 
H3.1-GFP in induced 2C-like cells upon CAF-1 
KD (p150 KD and p60 KD) compared to H3.1-
GFP mobile fraction in spontaneously arising 
2C-like cells (Endo.tdTomato+), 2-cell-stage 
embryos and ES cells (ES tdTomato−). NS, not 
significant; *P < 0.05 by two-sided unpaired 
t test. n, number of nuclei analyzed for each 
condition, derived from experiments performed 
on least three different days: n = 20 for 2C and 
Endo.tdTomato+; n = 16 for ES tdTomato− and 
p60 tdTomato+; n = 22 for p150tdTomato+.  
(c) Schematic representation of the nuclear 
transfer (NT) experiments performed in this study. (d) Development of NT embryos to 2-cell stage and to morula or blastocyst. The percentage of NT 
embryos developed to 2-cell (left) and morula or blastocyst (right) is shown. *P < 0.05, ***P < 0.001, compared to GFP− cells (two-sided Student’s t test) 
(raw data in Supplementary Fig. 7). Data are mean ± s.e.m. from independent nuclear transfer experiments performed four times on different days.  
(e) Differential transcription from RRRs in CAF-1 KD–induced and endogenous 2C-like cells. RNA-seq data from sip150 (sorted GFP+), sip60  
(sorted GFP+) and endogenous 2C-like cells (sorted GFP+) were compared to that from GFP− ES cells. The percentage of RRRs with upregulated (up), 
downregulated (down) and unchanged transcription is shown. P = 1 ×10−4 by one-sided permutation test; n = 10,000 permutations.
mobility in CAF-1 depletion–induced 2C-like cells is similar to that in 
2-cell-stage embryos and that induced 2C-like cells share molecular 
features of totipotent cells.
Induced	2C-like	cells	have	higher	reprogrammability	on	SCNT
The above data indicate that induced 2C-like cells after CAF-1 deple-
tion display a transcriptional program and the chromatin features of 
2-cell-stage embryos. Cells can be tested for their bipotential capacity 
to give rise to inner cell mass and trophectoderm derivatives through 
physical aggregation with morula-stage embryos or through injec-
tion into blastocysts. However, we reasoned that because 2C-like 
cells correspond to a different, much earlier, developmental timing 
than that of the recipient embryos used to test bipotentiality, a more 
appropriate approach should be used to test functional relevance. 
Therefore, to address the impact on embryonic development of the 
chromatin and transcriptional features of 2C-like cells induced upon 
CAF-1 KD, we performed somatic-cell nuclear transfer (SCNT) into 
enucleated mouse oocytes. We reasoned that if nuclei of 2C-like cells 
regain totipotent features of 2-cell-stage embryos, their success rate 
upon SCNT should be greatly improved compared to ES cells because 
early, totipotent embryos are substantially better donors for SCNT23. 
Indeed, the capacity to reprogram the donor nucleus also depends on 
the potency state of the donor nucleus itself23. For donors, we used 
FACS-sorted GFP-negative cells, GFP-positive endogenous 2C-like 
cells and GFP-positive 2C-like cells induced after p60 KD (Fig. 5c). 
We also controlled for the effects of FACS on SCNT success rate 
(Supplementary Fig. 7). The number of embryos that cleaved 
to the 2-cell stage was greatly increased when 2C-like (GFP-posi-
tive) cells were used as donors compared to ES cells (GFP− cells) 
(68% compared to 28%, n = 210 and 200, respectively). Importantly, 
p60-KD GFP-positive cells showed a similar 2-cell-stage cleavage rate to 
endogenous 2C-like cells (61%, n = 197) (Fig. 5d and Supplementary 
Fig. 7). The rate of development to the morula or blastocyst stage 
for SCNT embryos derived from endogenous 2C-like and p60 KD–
induced 2C-like cells was 4- and 2.5-fold higher, respectively, than 
those derived from ES cells, thus indicating that endogenous 2C-like 
cells as well as 2C-like cells induced upon p60 KD have a greater 
reprogrammability than ES cells (Fig. 5d). These results prompted 
us to investigate whether reprogramming-resistant regions (RRRs) 
normally transcribed in 2-cell-embryos24 are differentially expressed 
in 2C-like cells compared to ES cells. RRRs are transcribed in normal 
2-cell and successful SCNT embryos but not in SCNT embryos that 
fail to undergo complete reprogramming24. Analysis of RRRs in 
endogenous 2C-like, p60-KD and p150-KD induced 2C-like cells 
revealed that a large proportion of RRRs are significantly upregu-
lated in endogenous and induced 2C-like cells compared to ES cells 
(Fig. 5e; P = 1 × 10−4 by one-sided permutation test, n = 10,000 per-
mutations), thus indicating that high transcriptional activity at RRRs 
is common between 2C-like cells and 2-cell embryos. These data 
indicate that, similarly to 2-cell-stage embryos, endogenous and 
induced 2C-like cells have higher reprogrammability than ES cells, 
suggesting a broader developmental capacity.
p60	levels	anticorrelate	with	MERVL	expression
Finally, we asked whether changes in CAF-1 levels correlate with 
spontaneously arising endogenous 2C-like cells. For this, we used 
a 2C reporter that drives the expression of a destabilized turboGFP 
(2Cø3XturboGFP-PEST) that reflects the dynamics of MERVL acti-
vation and repression, and therefore the emergence of 2C-like cells. 
Immunostaining with antibody to p60 revealed that spontaneously 
arising 2C-like cells tend to display virtually undetectable levels of 
p60 (Fig. 6a,b), thus suggesting that endogenous levels of p60 might 
fluctuate in a small proportion of ES cells largely corresponding to 
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analyzed p60 in 2-cell-stage embryos at replication sites throughout 
S phase, using 5-ethynyl-2′-deoxyuridine (EdU) and subsequent 
immunostaining for PCNA and p60. Remarkably, we found that p60 
was undetectable on embryonic chromatin during a short time window 
in early S phase, in spite of robust EdU and PCNA staining (Fig. 6c), 
thus suggesting a transient uncoupling between DNA synthesis and 
chromatin assembly in the early embryo. Importantly, RNA-FISH 
with the MERVL probe revealed that this time window in the early 
2-cell-stage embryo corresponds to the time when MERVL elements 
are transcriptionally activated (Fig. 6d).
DISCUSSION
The molecular features of totipotent cells include absence of 
OCT4, robust reactivation of retrotransposons and major satellite 
repeats, lack of chromocenters and higher chromatin mobility. 
The chromatin of totipotent cells thus has very distinctive features 
from that of pluripotent cells. Molecularly and developmentally, 
totipotent cells must be regarded as being in a unique cellular state 
that supports a high level of cellular plasticity. Our results indicate 
that the modulation of histone deposition, and not a DNA-synthesis 
defect, is the basis for the emergence of 2C-like cells induced after 
CAF-1 depletion. Importantly, our results showing that a large 
proportion of 2C-like cells have undetectable levels of p60 suggest 
that changes in chromatin assembly are indeed a key mechanism 
underlying the emergence of 2C-like cells. CAF-1 performs the 
first step of the chromatin-assembly process, which consists in 
bringing H3 and H4 to the daughter DNA strands25. Rapid nucleo-
some assembly is retarded in the absence of functional CAF-1 (ref. 26). 
We propose that less efficient and/or delayed chromatin assembly 
generates a chromatin state that promotes totipotency (Fig. 7). This is 
in agreement with our observations documenting a lack of detectable 
p60 on embryonic chromatin during early S phase in early 2-cell-
stage embryos, coincident with the time of transcriptional activation 
of MERVL elements.
It remains to be addressed whether the bipotentiality to contribute 
to inner cell mass and trophectoderm documented for endogenous 
2C-like cells1 is a genuine indicator as an assay for totipotency and 
whether chimera experiments would show a higher bipotentiality for 
induced 2C-like cells than for ES cells. Indeed, it should be noted 
that ES cells also show a degree of contribution to the trophectoderm 
when aggregated in morulas or injected into blastocysts27–29. In the 
two cases in which bipotentiality has been addressed conclusively 
with markers of trophoblast derivatives in the post-implantation 
placenta28,30, bipotential cells, unlike 2C-like cells, expressed pluri-
potency markers and a number of genes expressed at the morula stage. 
Thus, in these cases, bipotential cells share transcriptional features 
with morulas and therefore represent a different developmental time 
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Figure 6 Endogenous p60 levels in ES cells and  
embryos anticorrelate with the expression of  
MERVL. (a) 2Cø3XturboGFP-PEST ES cells were  
fixed and processed for immunostaining with  
antibodies to turboGFP, p60 or p150. 2C-like  
cells are indicated by arrowheads. The images are  
representative examples of the quantification shown  
in b. Scale bar, 10 µm. (b) Left, number of 2C-like  
cells, identified by the presence of turboGFP, that  
express p60 or p150. Right, turboGFP-negative  
ES cells, analyzed in parallel as controls.  
Data are from two independent cell cultures;  
n, total number of cells analyzed for each  
condition. (c) Analysis of p60 at replication  
sites throughout S phase in 2-cell-stage embryos.  
Embryos were subjected to EdU pulses in S phase  
and subsequently fixed, analyzed by the Click-iT  
reaction to reveal EdU33 and immunostained for  
PCNA or p60. Triton-X100 preextraction was  
performed to observe the accumulation of PCNA  
and p60 to replication sites. Shown are maximal  
projections of confocal Z series of representative  
embryos according to the indicated number of total  
embryos analyzed (n). Scale bar, 2 µm. (d) RNA-FISH analysis using  
a MERVL probe in freshly collected zygotes (27 h), early 2-cell-stage (35 h), mid 2-cell-stage (42 h) and late 2-cell-stage embryos (48 h) showing 
transcriptional activation of MERVL exclusively in early 2-cell-stage embryos. Right, negative control embryos treated with RNase A. Representatives of 





























670	 VOLUME 22 NUMBER 9 SEPTEMBER 2015 nAture structurAl & moleculAr biology
A r t i c l e s
We argue that SCNT provides an alternative and complementary 
approach to test for the plasticity status of the donor nucleus. Indeed, 
early embryos are much better donors than ES cells23,31 and can there-
fore be used to test for differences in the plasticity status of donor 
nuclei. Most importantly, enucleated zygotes efficiently develop to the 
blastocyst stage only when an early 2-cell donor nucleus is transferred 
but very rarely if the donor nucleus is derived from a late 2-cell, early 
4-cell or mid 8-cell embryo32. Interestingly, there is a drastic differ-
ence in reprogramming ability upon SCNT when early 2-cell embryos 
are used as donors, as compared to late 2-cell embryos. Importantly, 
whereas early 2-cell embryos activate MERVL, have no detectable p60 
at replication sites and have no chromocenters, late 2-cell embryos 
possess none of these three characteristics. Thus, although the recip-
ient oocyte or zygote used for SCNT is potentially totipotent, the 
capacity to reprogram a donor nucleus also depends on the potency 
state of the donor nucleus itself. Therefore using SCNT to address 
the state of the donor nucleus would be one valid approach. However, 
interpretation of these results should be complemented with a careful 
and comprehensive molecular analysis. Our SCNT data demonstrate 
that the rate of development for embryos derived upon transfer from 
endogenous 2C-like and CAF-1-induced 2C-like cells is 4- and 2.5-fold 
higher, respectively, than for ES cells, thus indicating that endogenous 
and induced 2C-like cells have higher reprogrammability than ES cells 
and pointing toward a broader developmental capacity.
Until now, resetting to totipotency has been possible only through 
SCNT. Although transcriptional reprogramming effectively reverts 
differentiated cells to the pluripotent state, it appears that chromatin 
reprogramming may be a key process in acquisition of totipotency. 
Indeed, ES cells acquire higher reprogrammability upon CAF-1 deple-
tion. Understanding the molecular mechanisms that drive and can 
induce totipotent features in vitro is essential to understanding of 
how a maximum degree of cellular plasticity can be achieved and 
maintained, thereby providing more options for efficient reprogram-
ming and potential therapeutic avenues. Our results suggest that an 
atypical chromatin-assembly pathway that results in global changes 
in chromatin accessibility and histone mobility lies at the nuclear and 
molecular foundations of totipotency.
METhODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. RNA-seq data have been deposited in the 
ArrayExpress database under accession code E-MTAB-2684.
Note: Any Supplementary Information and Source Data files are available in the online 
version of the paper.
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downregulation of CAF-1 in ES cells generates cells with molecular 
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and in vitro in 2C-like cells but are absent in pluripotent cells. These 
features include (i) a highly mobile chromatin, (ii) lack of chromocenters, 
(iii) activation of pericentromeric heterochromatin, (iv) reduced levels of 
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ONLINE	METhODS
Cell culture and transfection. E14 mouse ES cells were cultured in DMEM 
containing GlutaMAX, 15% FCS, LIF, 0.1 mM 2-mercaptoethanol, nonessential 
amino acid and penicillin/streptomycin in gelatin-coated plates. All the experi-
ments were performed with this medium unless otherwise indicated. Medium 
containing 2i (3 µM CHIR99021 and 1 µM PD0325901) was used during the drug 
selection to generate stable cell lines and during subsequent maintenance of the 
cells. Lipofectamine 2000 and Lipofectamine RNAi MAX (Life Technologies) 
were used to transfect plasmids and siRNA, respectively. The effect of RNAi was 
examined 2 d after transfection unless otherwise indicated. To examine the effect 
of RNAi 3 d after transfection, a second transfection was carried out 1 d after 
the first transfection to maintain the RNAi activity over 3d. We used Silencer 
Negative Control No. 1 siRNA (Life Technologies) as a negative control for siRNA 
treatment. We used Silencer select siRNA (Life Technologies) consisting of the 
following sequences for targeted gene knockdown:
Mouse p150 #1: CAGACUGUAUGAUCAUAGAtt (sense)
Mouse p150 #2: CGAGUGUGGUCAUUAUCGAtt (sense)
Mouse p60 #1: CAACGAGCAUAAAAGUUAUtt (sense)
Mouse p60 #3: CACCAAAGCUGUCAAUGUUtt (sense)
Mouse HIRA #1: GCAUACUGCUUUAAUCCAUtt (sense)
Mouse HIRA #2: GAUCGAAGUUUGAAGGUAUtt (sense)
Plasmid construction and generation of stable cell lines. To construct the plas-
mid that contains 2CøEGFP, a fragment of the MERVL element containing the 
5′ LTR and a partial gag-coding fragment of 729 bp in length (designated the 2C 
promoter) was amplified from genomic DNA from mouse embryonic fibroblasts 
according to ref. 1. This fragment was used then to replace the CMV promoter 
sequence in the pEGFP N2 vector (Clontech) so that EGFP is expressed by the 
promoter activity of MERVL LTR. Several stable cell lines carrying this reporter 
element were generated by G418 selection and subsequent clonal selection in ES 
medium containing 2i. The 2-cell-like cells were identified in ES-cell cultures by 
the presence of EGFP-positive cells that lack OCT4 protein as described before1. 
We verified the karyotype in two different clones, and these clones were used for 
the experiments in this manuscript. To generate a reporter with a destabilized 
fluorescent protein, we further modified this 2CøEGFP vector to construct 
2Cø3XturboGFP-PEST. The 3XturboGFP-PEST sequence was cloned by PCR 
from a previously described vector34, and the GFP sequence in 2CøEGFP was 
replaced with the sequence of 3XturboGFP-PEST. We also used 2CøtdTomato 
plasmid obtained from Addgene (plasmid 40281) to generate stable cell 
lines with hygromycin selection so that 2-cell-like cells could be identified by 
tdTomato expression. For the TAL effector (TALE) plasmids, the expression 
plasmid containing a TALE that recognizes major satellite sequences generated 
in our laboratory (pTALYM11-B15)15 was modified so that the TALE had a 
Flag tag and the VP64 activator domain at the C terminus.
For the p150 expression vectors, full-length p150 cDNA was amplified 
and cloned by PCR from a cDNA library from E14 mES cells. Subsequently, 
point mutations (silent mutations) were introduced on four nucleotides at the 
sequences targeted by siRNA p150 #1, and a Flag tag was added at the C-terminus 
to generate an RNAi-resistant form of p150 mRNA. This mutant template was 
subsequently used to generate the PIP1, HP1-binding, PIP2 or ED deletions by 
conventional PCR-based mutagenesis. All these mutants were cloned into the 
pCAG-IRES-Hygro vector (a kind gift from M. Takeichi), and the plasmids were 
transfected into the 2CøEGFP-reporter ES cells. ES-cell clones homogenously 
expressing full-length or mutant p150 were selected by immunofluorescence with 
an antibody to Flag after the hygromycin selection.
Immunofluorescence. Cells were cultured on coverslips coated with gelatin and 
fixed with 2% or 4% paraformaldehyde in PBS for 10 min at room temperature. 
After the fixation, cells were permeabilized with 0.2% Triton X-100 in PBS for 
10 min at room temperature and incubated in blocking buffer (3% BSA in PBS) 
for 30 min at room temperature. Cells were incubated with primary antibodies 
diluted in the blocking buffer for 1–1.5 h at room temperature and washed with 
PBS-T (PBS containing 0.02% Triton-X100) three times. Cells were then incu-
bated with Alexa-conjugated secondary antibodies (Life Technologies) diluted 
in the blocking buffer for 1–1.5 h at room temperature, washed with PBS-T 
three times and mounted in Vectashield solution (Vector Labs). Images were 
collected on an inverted TCS SP5 confocal microscope (Leica). Antibodies to the 
following proteins were used: Oct4 (BD Laboratories 611203), Zscan4 (Millipore 
AB4340), Gapdh (Millipore MAB374-clone 6C5), turboGFP (Origene TA150042-
clone 2H8), turboGFP (Thermo PA5-22688), Hira (Millipore 04-1488-clone 
WC119), RFP (MBL M155-3 and MBL PM005), PCNA (Santa Cruz sc-56), GFP 
(Abcam ab13970), Flag (Wako 018-22381 and Sigma F7425), and p60 and p150 
(refs. 35,36). Secondary antibodies were Alexa 488 goat anti-mouse, A-11001; 
Alexa 488 goat anti-rabbit A-11008; Alexa 555 goat anti-rabbit A-21428; and 
Alexa 555 goat anti-mouse A-21422 (Life Technologies). For all commercial anti-
bodies, validation and characterization can be found in the technical data sheets 
provided by the manufacturer. 
Antibodies. Antibodies to the following proteins were used in this work: 
Rabbit p150 and p60 (refs. 35,36) (kind gifts from G. Almouzni and J.-P. Quivy), 
mouse Oct4 (611203, BD Pharmingen), rabbit and mouse RFP (PM005 and 
M155-3, MBL), rabbit GFP (598, MBL), chicken GFP (ab13970, Abcam), mouse 
turboGFP (2H8, Origene), rabbit turboGFP (PA5-22688, Thermo Scientific), 
mouse Flag (1E6, Wako), rabbit Flag (F7425, Sigma), mouse HIRA (WC119, 
Millipore), rabbit Zscan4 (AB4340, Millipore) and mouse GAPDH (MAB374, 
Millipore).  Original images of gels and blots used in this study can be found in 
Supplementary Data Set 1.
RNA-FISH. RNA-FISH was carried out as described elsewhere34. Cells were 
cultured on coverslips coated with laminin-511 (BioLamina). Cot1 DNA was 
omitted in the hybridization buffer. Probes for MERVL corresponding to the 
250-bp fragment in the gag-coding region and probes for major satellite repeats 
were prepared by PCR with Alexa488- or TAMRA-labeled dATP, respectively. 
RNase A (1 mg/mL in PBS) treatment was performed at 37 °C for 30 min after the 
permeabilization step, as a negative control. To confirm the correlation between 
endogenous MERVL activation and EGFP-reporter expression, RNA-FISH for 
MERVL was carried out in wild-type E14 mES cells after transfection with control 
or p150 siRNA.
MNase Southern blotting. 2 × 105 to 5 × 105 FACS-sorted GFP-positive cells 
after p60 knockdown or unsorted control knockdown cells (which were also 
passed through the cell sorter) were pelleted at 1,000 r.p.m. at 4 °C. The cell pellet 
was resuspended in ice-cold NP-40 lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM 
NaCl, 0.5% NP-40, 0.15 mM spermine and 0.5 mM spermidine) and incubated 
on ice for 5 min. The samples were centrifuged at 1,000 r.p.m. for 3 min at 4 °C, 
and then washed in a wash buffer (10 mM Tris-HCl, pH 7.4,15 mM NaCl, 
60 mM KCl, 0.15 mM spermine and 0.5 mM spermidine) and centrifuged 
again at 1,000 r.p.m. for 3 min at 4 °C. Pellets were then resuspended in 800 
µL of ice-cold MNase digestion buffer (10 mM Tris-HCl, pH 7.4, 15 mM NaCl, 
60 mM KCl, 0.15 mM spermine, 0.5 mM spermidine and 1 mM CaCl2). A 
200-µL aliquot of each nuclei sample was digested with 1 U (5 U/mL) MNase 
(Roche) at 25 °C for 1 min, 5 min, 10 min and 20 min. The reaction was stopped 
by the addition of an equal volume of stop buffer (0.1 M Tris-HCl, pH 8.5, 
20 mM EDTA and 2% SDS). The samples were treated with 0.5 mg/ml 
proteinase K at 37 °C overnight. DNA was extracted with phenol/chloroform 
and treated with RNase A (0.1 mg/mL) for 2 h at 37 °C. DNA was purified again 
with phenol/chloroform and concentrated by ethanol precipitation. The amount 
of DNA was quantified with Qubit 2.0 (Life Technologies), and an equal amount 
of DNA was used for subsequent Southern blotting assay. DNA fragment size 
was analyzed with a Bioanalyzer (Agilent Technologies) with a high-sensitivity 
DNA analysis kit. DNA templates to prepare the probes for Southern blotting 
for the MERVL LTR were generated by amplification of 200-bp MERVL LTR 
fragment from the 2CøEGFP reporter plasmid by PCR and subsequent DNA 
fragment purification. The probes were prepared by PCR with [32P]dCTP, by a 
random-primer protocol.
Fluorescence-activated cell sorting. FACS Calibur (BD Biosciences) was 
used to quantify the population of GFP-positive cells. We used FACSAria II 
(BD Biosciences) to collect GFP-positive cells for MNase Southern blotting assays.
Fluorescence recovery after photobleaching (FRAP). Control, p150 or p60 
siRNA was transfected into the 2CøtdTomato E14 stable ES-cell line in glass-
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expression vector was transfected into the cells. FRAP experiments were 
performed 1 d after the plasmid transfection, as described before22.
Real-time PCR. Total RNA was extracted from ES cells with a GenElute total 
RNA miniprep kit (Sigma) and treated with turbo DNase (Life Technologies) to 
remove genomic DNA. Reverse transcription was performed with SuperScript III 
(Life Technologies) with random hexamers. Real-time PCR was performed 
with Lightcycler 480 SYBR Green I Master Mix (Roche) on a LightCycler 480 
Real-time PCR System (Roche). The relative expression level of each gene was 
normalized to Gapdh expression level. The primers used in this study30,37–40 are as 
follows (forward and reverse): MERVL (5-CTCTACCACTTGGACCATATGAC 
and 5′-GAGGCTCCAAACAGCATCTCTA); IAP (IAPEZI) (5′-AAGCAGCA 
ATCACCCACTTTGG and 5′-CAATCATTAGATGCGGCTGCCAAG); LINE1 
(orf1) (5′-GGACCAGAAAAGAAATTCCTCCCG and 5′-CTCTTCTGGCTT 
TCATAGTCTCTGG); Zscan4 (5′-GAGATTCATGGAGAGTCTGACTGAT 
GAGTG and 5′-GCTGTTGTTTCAAAAGCTTGATGACTTC); Eif1a(-like) 
(5′-AACAGGCGCAGAGGTAAAAA and 5-CTTATATGGCACAGCCTCCT); 
Cdx2 (5′-AGGCTGAGCCATGAGGAGTA and 5′-TGAGGTCCATAATTC 
CACTCA); Gm6763 (5′-CTGGTGGGAAGCTCTTCTTG and 5′-TCAACG 
TTCCAAATTCAGCA); TALE (5′-CATGGATGCAGTGAAAAAGG and 
5′-ACGTGCGTTCGCCAATAC); major satellite (5′-GCACACTGAAGGAC 
CTGGAATATG and 5′-GATTTCGTCATTTTTCAAGTCGTC);  GAPDH (5′-CA 
TGGCCTTCCGTGTTCCTA and 5′-GCCTGCTTCACCACCTTCTT). 
RNA sequencing. 2 d after transfection of siRNA control, p150 #2 and p60 #1, 
total RNA was extracted from wild-type E14 mES cells with a GenElute total 
RNA miniprep kit (Sigma) and treated with turbo DNase (Life Technologies). 
DNase-treated total RNA was purified with an RNeasy MinElute Cleanup kit 
(Qiagen). Two biological replicates were prepared for each sample. Libraries for 
strand-specific sequencing were created with a TruSeq Stranded Total RNA with 
Ribo-Zero Gold Prep Kit (Illumina). Briefly, starting with 0.3 µg of total RNA, 
the first step involved the removal of cytoplasmic and mitochondrial ribosomal 
RNA (rRNA) with biotinylated, target-specific oligonucleotides combined with 
Ribo-Zero rRNA-removal beads. The purified RNA was fragmented into small 
pieces with divalent cations under elevated temperature. The cleaved RNA frag-
ments were used to generate first-strand cDNA with reverse transcriptase and 
random primers, and this was followed by second-strand cDNA synthesis with 
DNA polymerase I and RNase H. The double-stranded cDNA fragments were 
blunted with T4 DNA polymerase, Klenow DNA polymerase and T4 PNK. 
A single A nucleotide was added to the 3′ ends of the blunt DNA fragments with 
a Klenow fragment (3′ to 5′ exo minus) enzyme. The cDNA fragments were 
ligated to double-stranded adaptors with T4 DNA ligase. The ligated products 
were enriched by PCR amplification (30 s at 98 °C; 12 cycles of 10 s at 98 °C, 30 s 
at 60 °C and 30 s at 72 °C; 5 min at 72 °C). Excess primers were then removed by 
purification with AMPure XP beads (Agencourt Biosciences Corporation). Final 
cDNA libraries were checked for quality and quantified with a 2100 Bioanalyzer 
(Agilent). The libraries were loaded in the flow cell at 8-pM concentration, and 
clusters were generated in the Cbot. Sequencing was carried out on an Illumina 
HiSeq 2500 (Illumina) with a 50-bp paired-end protocol, according to Illumina’s 
instructions. Image analysis and base calling were performed with RTA 1.17.21.3 
and CASAVA 75.
RNA-sequencing analysis. Two biological replicates for p150, p60 and scrambled 
RNAi controls were sequenced on the Illumina HiSeq 2500 platform as paired-
end 50-base reads, according to the manufacturer’s standard protocols. Image 
analysis and base calling were performed with RTA 1.17.21.3 and CASAVA 75.
Read prepreprocessing. Reads were trimmed with Sickle (https://github.com/
najoshi/sickle/). Stretches of bases with Phred scores below 20 were trimmed from 
both ends to a minimum length of 30 bp. Read pairs in which at least one read 
failed to pass the quality filters were discarded from further analysis.
Alignment to reference sequence. Reference sequence and annotation for 
the mouse genome (v GRCm38) were downloaded from the Illumina iGenome 
portal (http://support.illumina.com/sequencing/sequencing_software/igenome.
ilmn). Reads were aligned to the reference genome with TopHat2 (ref. 41), 
taking into consideration the minimum and maximum intron size of the 
mouse genome. The total number of sequenced reads can be found in 
Supplementary Table 9.
Differential gene-expression analysis. Differential gene-expression analysis was 
performed with DeSeq2 (ref. 42). Both knockdown samples were compared to 
scrambled RNAi controls. Data from Macfarlan et al.1 were analyzed in the same 
way. The HTSeq framework43 was used for read counting against gene annotation 
with the reverse strand. This resulted in a within-replicate correlation ≥0.97 for 
all pairs (Spearman’s rho) (Supplementary Note). Genes with an FDR-adjusted 
P value ≤0.05 and a log2 fold change of at least 1 were considered to be differ-
entially expressed. This resulted in a total of 2,517 and 1,676 upregulated genes 
and 96 and 31 downregulated genes in samples treated with p150 siRNA and 
p60 siRNA, respectively.
Differential repeat-expression analysis. The annotation for repeat elements in 
the mouse genome was obtained with RepeatMasker (http://www.repeatmasker.
org/) with RMBlast as the search engine. For differential repeat expression, reads 
were separated into uniquely mapping and nonuniquely mapping. Nonuniquely 
mapping reads were used for mapping against all occurrences of a given repeat 
element, with an added padding of 25 bp to both repeat-sequence ends in order 
to increase the likelihood of mapping reads uniquely; this was done for all repeat 
elements found in the mouse genome. Nonuniquely mapping reads that mapped 
to more than one type of repeat were excluded from further analysis. The total 
number of reads used for this analysis can be found in Supplementary Table 9. 
Read counts for each element, including uniquely mapping reads and reads 
mapping to a single element, were used as input for DeSeq2. Individual repeat 
elements with an FDR-adjusted P value ≤0.05 and a log2 fold change in read 
counts ≥1 were considered to be differentially expressed.
Distance analysis. In order to calculate the distance between genes and repeat 
elements, the repeat annotation from RepeatMasker was used for comparison 
against gene annotation. Custom-made scripts were used to count the total 
number of genes found in 500-bp bins located at increasing distances from each 
repeat occurrence or directly overlapping them. Whole-gene annotation was 
retrieved from Biomart (GRCm38.p2). Overall, 513 genes from Biomart did not 
match the iGenomes annotation used to map reads and were therefore discarded 
from further analysis. Custom-made scripts were used to obtain the distance 
from each gene to the closest repeat occurrence for either of the MERVL LTR 
repeats mt2, mt2b1 or mt2c. The distance was calculated as the number of base 
pairs between the annotated transcription start site of a gene to the closest end 
of a repeat without taking into account the orientation of the repeat element. 
The distance distributions to repeats for genes that had previously been identi-
fied as being upregulated in either p150 or p60 siRNA samples or 2-cell embryo 
samples from data from Macfarlan et al. or both (subsets described in Fig. 4c 
and Supplementary Fig. 5d) were compared in a pairwise fashion with two-
sided Wilcoxon rank-sum tests with Bonferroni correction for multiple testing. 
Individual gene subsets were further compared to the distance distribution of 
their respective gene-group complement with two-sided Wilcoxon rank-sum 
tests with Bonferroni correction.
EdU labeling for 2-cell embryos. 2-cell-stage embryos were collected at 
33–34 hphCG, and embryos were cultured in KSOM medium for at least 1 h before 
being transferred to KSOM medium containing 50 µM EdU (Life Technologies). 
After embryos were incubated for 45 min with EdU (which are at 34.5–36 
hphCG), embryos were washed in PBS, pre-extracted with 0.1% Triton X-100 in 
PBS for 4 min and fixed with 4% PFA in PBS for 15 min. After that, embryos were 
permeabilized with 0.5% TritonX-100 in PBS for 15 min and blocked with 3% 
BSA in PBS. After the blocking, click-it reaction was performed for 1 h, and 
this was followed by washing with blocking buffer and immunostaining with 
antibodies to PCNA and p60 . Because the cell cycle was not synchronized by 
hCG injection, different stages of replication was classified according to the EdU 
staining patterns. All experiments with mouse embryos were approved by the 
Ethics Committee of the Université de Strasbourg (Cometh’) and performed 
under the authorization of French legislation. Size, age and strain information 
are included in ref. 34. For these experiments, no statistical method was used to 
predetermine sample size. The experiments were not randomized and were not 
performed with blinding to the conditions of the experiments.
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Supplementary Figure 1 
Global histone acetylation in 2C-like cells and RNA-FISH for endogenous MERVL and major satellites after p150 depletion. 
a. 2C::EGFP ES cells were immunostained for GFP and pan-acetylated H4, H4K16ac,H4K12ac, H4K5/12ac, H4K8/12ac or H3K9ac as 
indicated. The antibody for pan-acetylated H4 recognizes acetylated H4 K5, K8, K12 or K16. More than 50 cells were analysed in 3 
biological replicates. Scale bar, 10 µm. 
b. RNA-FISH for MERVL and MajSat was performed in wild type E14 ES cells after transfection of siRNA for control or p150. Scale bar, 50 
µm. 




Supplementary Figure 2 
Effect of p60 KD, Zscan4 activation by CAF-1 KD and use of targeted TALEs to activate major satellite transcription. 
a. ES cells transfected with control siRNA or p60 siRNA were immunostained for p60. Scale bar, 10 µm. Note the absence of 
chromocentrer after p60 loss as revealed by DAPI staining. 
b. As in a, but showing several 2C::EGFP ES cell colonies at a lower magnification after p60 RNAi using two different siRNAs. 
c. Growth curves of control or p150- or p60-depleted ES cells. Cell growth was analyzed after transfection of siRNA for control, p150 or 
p60 at the indicated days after transfection. The same number of cells was plated for each condition and cell numbers were counted in 
parallel. Shown are the mean ± s.d. of two biological replicates. 
d. RT-qPCR analysis for Zscan4 expression after control, p150 or p60 RNAi in ES cells. **p<0.01 (Student’s t-test, compared to si control). 
e. 2C::EGFP ES cells transfected with control, p150 or p60 siRNA as above and were immunostained for GFP and Zscan4. Scale bar, 100 
µm. 
f. Upregulation of ZSCAN4 protein levels was assessed by western blot after the transfection of control, p150 or p60 siRNA in ES cells. 
GAPDH was used as a loading control. 
g. 2C::EGFP ES cells were transfected with TALE-Maj-Flag or TALE-Maj-VP64 or mock-transfected and subsequently processed for 
immunostaining using an antibody for GFP and Flag. Scale bar, 100 µm. 




Supplementary Figure 3 
G1-S cell-cycle arrest prevents the emergence of 2C-like cells after p150 RNAi and complementation assay for p150.  
a. The cell cycle distribution of 2C::EGFP ES cells was analyzed by propidium iodide staining after 24 h treatment of water control or 5mM 
thymidine. 
b. 2C::EGFP ES cells stably expressing full-length p150 or p150 mutants, as indicated on the left of each row, were immunostained for 
Flag and GFP after the transfection of siRNA control, si p150 #1 or si p150#2. Note that while sip150#2 targets both the endogenous p150 
and the exogenous mRNAs, sip150#1 targets exclusively the endogenous p150. Scale bar, 100 µm. 




Supplementary Figure 4 
RNAi for HIRA in ES cells does not elicit a chromocenter defect or a dramatic upregulation of the 2C::EGFP reporter. 
a. Knockdown efficiency for HIRA in 2C::EGFP ES cells was confirmed by western blot. Two different siRNAs were used. GAPDH was 
used as a loading control.  
b. 2C::EGFP ES cells transfected with control siRNA or two different siRNA for HIRA were immunostained for GFP and HIRA. Scale bar, 
100 µm. Shown are representative images of two independent biological replicates.  
c. Quantification of the percentage of EGFP-positive 2C-like cells by FACS following transfection of siRNA control or two different siRNA 
for HIRA. Shown are the mean ± s.e.m. of two independent biological replicates. The numbers above the columns indicate the fold change 
of EGFP-positive cells compared to si control.  
d. ES cells transfected with control or HIRA siRNA were immunostained for HIRA. The DNA was stained with DAPI. Scale bar, 10 µm. 




Supplementary Figure 5 
Analysis of differentially expressed genes and repeats after RNAi for CAF-1 subunits p150 or p60. 
a. Volcano plots of differentially expressed genes (left panels) and repetitive elements (right panels) in p150- (upper panels) and p60- (lower panels) 
depleted ES cells are shown. The data analysed derive from two independent biological replicates for all three conditions (within replicate correlation >= 
0.97 for each replicate pair; Spearman’s rho). An MA representation of the same data is depicted in Figure 4a.  
b. Venn diagram comparing up- and down-regulated genes in p150- or p60-depleted ES cells. 
c. Venn diagram showing the comparison between differentially expressed genes in p150- or p60-depleted ES cells and those in 2-cell embryo. The 
differentially expressed genes in 2-cell stage embryo were obtained employing the same differential gene expression analysis as for the p150- and p60-
depleted cells, comparing RNA-seq data from oocyte and 2-cell embryos from Macfarlan and colleagues (Macfarlan, A. et al., Nature. 487, 57-63, 2012). 
d. Diagram showing the strategy for the distance analysis performed for Figure 4c. The genomic coordinates of a specific repeat type (Repeat X) were 
determined genome-wide, and windows of 500 bp upstream and downstream of each occurrence of the repeat X were used to record the genes located up 
to a +/- 200 kb distance from each repeat occurrence (different instances of Repeat X are depicted with subscripts). We then calculated the percentage of 
upregulated genes (green boxes) in p150- or p60-depleted cells among the total number of genes in a given interval. 
e. Schematic representation for the distance analysis performed in Figure 4d. The genomic coordinates for the transcription start site of each set of 
upregulated genes were determined, and the distance to the closest end of either mt2_mm, mt2b1 or mt2c repeat was determined. Note that, in comparison 
to d, in which the analysis is ‘repeat centric’, the diagram depicted in e is ‘gene centric’. 




Supplementary Figure 6 
RNA-seq analyses on FACS-sorted cells. 
a. MA plots displaying differentially expressed genes in untreated GFP-positive cells, GFP-positive cells after p150 KD and GFP-positive cells after p60 KD 
compared to untreated GFP-negative ES cells. Data is from 2 biological replicates (Spearman’s rho >= 0.95 for each pair of replicates; Supp. Tables 5 - 6). 
b. Comparison of fold-change differential gene expression levels between endogenous 2C-like cells (untreated GFP-positive) and p150KD 2C-like cells 
(left) or p60KD 2C-like cells (right). To allow a direct comparison between the samples, all differential gene expression analyses in this figure are done 
against a common reference of FACS sorted untreated GFP-negative cells. 
c. Venn diagram showing the comparison between differentially expressed genes in untreated GFP-positive cells, GFP-positive cells after p150 KD or GFP-
positive cells after p60 KD and those in 2-cell embryo. Differentially expressed genes in 2-cell embryo obtained as in Supp. Fig.7c. 
d. Distribution of distances (log2) between differentially expressed genes in untreated GFP-positive cells, GFP-positive cells after p150/p60 KD and/or 
genes upregulated in 2-cell embryos to 2-cell specific repeats. The absolute distance between the TSS of a gene and the end of the closest 2-cell specific 
MERVL family of repeat (either mt2_mm, mt2b1 or mt2c_mm) was measured for each gene within the dataset analysed. Box plots indicate the median log2 
bp distance distribution and a confidence interval around it (notches). p-values calculated with Wilcoxon tests with Bonferroni correction for multiple testing.  
e. Proportion of genes specific to each embryonic stage upregulated in endogenous 2-cell like, p60 KD induced 2-cell like and p150 KD induced 2-cell like 
cells. Genes specific to each stage were determined by comparison of datasets in Deng et al.,Science 343, 193-196 (2014). A gene was considered 
expressed when it showed an RPKM value higher than 10 in at least 20% of the cells analyzed for its respective stage (similar results were obtained for 
RKPM values of 1 and 5, and cell proportions between 10-50%). A gene was considered exclusive to a stage when it was found to be expressed in only a 
single stage out of: Zygote, mid-2-cell, 4-cell, 8-cell, 16-cell or early blastocyst. Sets of upregulated genes in endogenous 2-cell like, p60 KD induced 2-cell 
like and p150 KD induced 2-cell like cells were selected as in Supp. Fig. 6c. Because the number of genes specific to each stage is different, we calculated 
the percentage of genes upregulated in each of the three 2C-like cells in relation to the number of gene subsets specific for each developmental stage. 
Statistical significance was assessed through Fisher’s exact tests with Bonferroni correction for multiple testing. p-values are as follows: in the comparison 
of endogenous 2C-like cells: with zygote p=0.724; with 2-cell p=2.901e-16; with 4-cell p=0.730; with 8-cell p=1; with 16-cell p=1; with early blastocyst 
p=0.373. In the comparison of p60KD-induced 2C–like cells: with zygote p=1; with 2-cell p=2.092e-13; with 4-cell p=0.051; with 8-cell p=1; with 16-cell p=1; 
with early blastocyst p=1. In the comparison of p150KD-induced 2C-like cells: with zygote p=1; with 2-cell p=4.448e-15; with 4-cell p=0.003; with 8-cell p=1; 
with 16-cell p=1; with early blastocyst p=1. 




Supplementary Figure 7 
Repeat analysis randomized, global chromatin accessibility in p60-induced 2C-like cells and SCNT raw data. 
a. These data correspond to the same analysis strategy as in Figure 4d but with a random assignment of differentially expressed genes 
the same size as in the original groups; p150 KD (left), p60 KD (right). Coloured lines represent the percentage of randomly selected 
differentially expressed genes among all overlapping genes up to a distance of 200kb surrounding each repeat type, mt2_mm (blue), 
mt2b1 (green) and mt2c_mm (purple). 
b. DNA fragment distribution after MNase digestion over increasing incubation timings in control, unsorted cells and EGFP-positive cells 
after p60 RNAi. After purification, the DNA was analyzed using a bioanalyzer. The purple and green lines indicate the position of the 
molecular weight marker in the chip. The DNA size corresponding to mono-, di- or tri-nucleosome is indicated on the right of each panel. 
c. Raw data from nuclear transfer experiments with untreated GFP-negative (GFP-), untreated GFP-positive (GFP+) and GFP-positive 
cells after p60 KD (sip60 GFP+) are summarized in the table. 
d. Comparison of SCNT efficiency using unsorted ES cells (no FACS) and GFP- negative ES cells. The results of nuclear transfer 
experiment with FACS-sorted GFP-negative cells (GFP-) and unsorted cells (No FACS) are summarized in the table. Given that the 
population of GFP-negative cells is ~99% in ES cells, the difference between these two groups is due to the effect of FACS procedure 
itself. For c and d: PN, number of NT-embryos with pronuclear formation; 1&ab, number of NT-embryos arrested at 1-cell or showing 
abnormal morphology; 2C, number of NT-embryos developed to 2-cell stage; 4/8C, number of NT-embryos developed to 4- or 8-cell 
stage; M/B, number of NT-embryos developed to morula or blastocyst. The percent of the development to 2-cell (2cell%), 4- or 8-cell 
(4/8C%), and morula or blastocyst (M/B%) was calculated using the number of NT-embryos that formed visible pronuclei. 
	  




The Supplementary Note contains the controls and explanations corresponding to 
all the RNAseq datasets generated in this work and is distributed as follows: 
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Cellular plasticity, the ability to give rise to different cellular fates, is essential for multicellularity. Multicellular organisms derive from a single cell, the 1-cell embryo, which forms at 
fertilization and has the capacity to generate a full organism. This 
capacity is referred to as totipotency1–3. Pluripotency emerges later 
in development and relates to the ability to form all germ layers of 
the embryo proper, but not the extra-embryonic annexes4. In the 
mouse, only the zygote and individual 2-cell-stage blastomeres are, 
strictly speaking, totipotent, as they can generate a full organism on 
their own5–7.
Pluripotent ES cells derived from the inner cell mass of the blas-
tocyst8,9 recapitulate some molecular features of the preimplanta-
tion epiblast, including expression of transcription factors such as 
NANOG and OCT4 (also known as POU5F1)10–12. ES cell cultures 
are heterogeneous, with subpopulations of cells differing in gene 
expression in a dynamic equilibrium13–18. Much of this heterogene-
ity results from changes in expression of pluripotency-associated 
transcription factors (TFs), which are part of the core regulatory 
network of ES cells19. In addition, the developmental potentials of 
ES cells grown under different conditions are not equivalent20–23.
Unlike pluripotency, the molecular features of totipotency 
remain largely unknown. Cells resembling 2-cell-stage embryos 
arise spontaneously in ES cell cultures, constituting less than 1% 
of the culture24. These 2-cell-like cells display a transcriptome that 
is highly similar to that of 2-cell-stage embryos, including expres-
sion of genes like members of the Zscan4 family and the MERVL 
retrotransposon24,25, and they have molecular features that are dis-
tinct from those of ES cells, including downregulation of the OCT4 
protein24, greater histone mobility26 and dispersed chromocenters27. 
Two-cell-like cells seem to have greater developmental plasticity 
and greater nuclear reprogrammability than ES cells24,27.
The molecular regulatory networks underpinning the molecular 
identity and emergence of 2-cell-like cells have not been established. 
Also, it is unclear whether these cells can self-renew; however, given 
their higher plasticity, knowledge of the underlying biology of 
mouse 2-cell-like cells could potentially be applied to expand the 
potency of existing human pluripotent cells.
Results
Single-cell analysis reconstructs the transition to the 2-cell-
like state. To shed light on the molecular mechanisms underlying 
the emergence of embryonic-like features, we set out to identify 
intermediate steps in the transition from ES to 2-cell-like cells. 
We used transcriptional profiling at the single-cell level, which 
can highlight dynamic cellular states and thereby identify cell fate 
determinants28,29. We focused mainly on chromatin modifiers and 
TFs, which generally display low expression levels. Because of the 
need for highly precise and sensitive gene expression measure-
ments, we used a qPCR-based microfluidics approach based on the 
Biomark Fluidigm platform, as opposed to a poly(A)-based RNA-
seq method30,31.
We performed quantitative gene expression analysis in sin-
gle cells using a mouse ES cell line containing the 2C::turboGFP 
reporter, in which turboGFP expression is driven by the MERVL 
promoter, thereby marking the 2-cell-like state27. We identified 
a representative set of genes to profile on the basis of bulk RNA-
seq data that compared ES cells to endogenous 2-cell-like cells and 
to 2-cell-like cells induced by knockdown of Chaf1a and Chaf1b 
(encoding CAF-1 subunits)27. We selected 93 genes on the basis of 
their differential expression between ES and 2-cell-like cells and 
their functional significance (Fig.  1a, Supplementary Fig.  1a and 
Supplementary Table  1). Using an experimental setup designed 
to enrich for cells at an early stage of the transition toward the 
2-cell-like state (Fig.  1b and Supplementary Fig.  1b,c), we ana-
lyzed gene expression in 136 individual turboGFP– and turboGFP+ 
cells (Supplementary Table 2). Two spike-in controls allowed us to 
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Fig. 1 | Zscan4+ cells exhibit an expression profile intermediate to those of Es and 2-cell-like cells. a, Heat map showing changes in expression levels for 
the genes selected for single-cell analysis in endogenous, Chaf1b-knockdown-induced (p60 KD) and Chaf1a-knockdown-induced (p150 KD) 2-cell-like cells. 
Fold changes were calculated on the basis of bulk RNA-seq data27 and are color-coded relative to the values in ES cells. b, Experimental design for the single-
cell expression profiling experiments. In total, 92 turboGFP– and 44 turboGFP+ cells were profiled. c, Violin plots showing the distribution of the expression 
levels of individual cells for the indicated genes. Higher values correspond to higher expression levels, and a Ct value of 0 indicates that no amplification was 
detected. The median is indicated by a square. Note that the turboGFP and Spz1 transcripts possess no exon junctions; their readings therefore to some extent 
reflect the genomic background. d,e, PCA of the single-cell expression dataset showing all three principal components (d) or comparing two components at 
a time (e). Each point corresponds to a single cell, which is colored according to the expression level of turboGFP. PC1 separates ES cells from 2-cell-like cells. 
Black arrows indicate turboGFP– cells with an expression profile intermediate to those of ES and 2-cell-like cells. f,g, PC2 (f) and PC3 (g) projections of the 93 
genes used for the analysis, showing the contribution of each gene to the first of the three principal components. Only the most influential genes are labeled. 
h,i, PCA as in d,e, but individual cells (dots) are colored according to their levels of Zscan4 expression. Black dots correspond to no expression.
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assess technical noise (Supplementary Fig. 1d). TurboGFP mRNA 
expression was observed in cells that were selected as turboGFP+ 
on the basis of their fluorescence, but not in cells lacking turboGFP 
protein expression (Fig. 1c). Two-cell-like (turboGFP+) cells main-
tained Oct4 mRNA levels and displayed high expression of Zscan4 
transcripts and of the MT2_mm and MT2B/C long terminal repeat 
(LTR)-driven chimeric transcripts Spz1, Naalad2 and Sp110, thereby 
validating our dataset (Fig. 1c).
To identify transitional cellular states, we performed principal-
component analysis (PCA), which showed three main sources of 
variability in the data. Principal component 1 (PC1) separated tur-
boGFP– from turboGFP+ cells, and therefore defined the ES to 2-cell-
like cell transition (Fig. 1d,e and Supplementary Fig. 1e). Expression 
of Zscan4 transcripts and of the chimeric transcripts, in addition to 
that of turboGFP mRNA, provided the strongest identity to PC1 
(Fig.  1f,g). PC2 highlighted heterogeneity within the 2-cell-like 
cell population (Fig. 1d,e). For example, 2-cell-like cells displayed 
graded expression of Id1, Id2 and Id3 (Fig. 1f). PC3 contrasted naive 
with primed pluripotency (Fig. 1g and Supplementary Fig. 1e)32–34. 
Notably, computing the same PCA but excluding turboGFP mRNA 
expression produced the same results (data not shown), suggesting 
that the dispersion of the data is inherent to the global expression 
profile of individual cells and is not determined by expression from 
the 2C::turboGFP reporter. Thus, our single-cell analysis allows us 
to model acquisition of the 2-cell-like state.
Zscan4-expressing cells exhibit an expression profile intermedi-
ate to those of ES and 2-cell-like cells. We next interrogated the 
single-cell dataset for transcripts that showed graded expression 
between the ES and 2-cell-like cells. PCA identified a set of cells 
with an intermediate expression profile that was located between 
the two clusters of cells, along PC1 (Fig. 1e, black arrows). These 
cells lacked expression of turboGFP (Fig. 1d,e), indicating that they 
had not yet entered the 2-cell-like state. However, they expressed 
the TF-encoding Zscan4c, Zscan4d and/or Zscan4f (Zscan4c/d/f) 
(Fig. 1h,i). The intermediate clustering of these cells was maintained 
even when omitting expression data for Zscan4c/d/f and turboGFP 
transcripts (Supplementary Fig. 1f,g). Thus, although expression of 
Zscan4c/d/f delineates an intermediate cellular state, this state is not 
solely determined by changes in expression of these genes, suggest-
ing that cells undergo broader transcriptional reprogramming con-
comitantly with Zscan4c/d/f induction but before the acquisition of 
a 2-cell-like identity.
Two-cell-like cells arise primarily from Zscan4-expressing cells. 
We next addressed whether cells expressing Zscan4c/d/f (hereaf-
ter referred to as Zscan4+ cells) constituted an intermediate state 
during the transition from ES to 2-cell-like cells. Whereas knock-
down of Zscan4 expression in ES cells results in genome instabil-
ity35, its ectopic overexpression can induce a limited part of the 
2-cell-specific transcriptome36,37. We reasoned that, if 2-cell-like 
cells arose from Zscan4+ cells, we could formulate four predic-
tions. First, profiling of single cells expressing Zscan4 but not tur-
boGFP from the 2C::turboGFP reporter should identify a cluster of 
cells that occupy an intermediate position along the original PC1. 
Indeed, additional single-cell expression profiling of Zscan4+ cells 
that were sorted on the basis of fluorescence from expression of the 
Zscan4c::tdTomato reporter (Fig.  2a, Supplementary Fig.  2a and 
Supplementary Note) and projection of the data into the previous 
dataset indicated that Zscan4+ turboGFP– cells localized in the mid-
dle along PC1 (n = 189 cells) (Fig. 2b, red dots). This intermediate 
character persisted when computing the two datasets together and 
when data for turboGFP and Zscan4 were excluded from the analy-
sis (Supplementary Fig. 2b,c). Thus, Zscan4 expression is a marker 
of an intermediate cell population between the ES and 2-cell-
like states, and Zscan4+ cells are not necessarily 2-cell-like cells. 
Second, we reasoned that the majority of—if not all—2-cell-like 
cells should also express Zscan4. We found that all 2-cell-like 
cells expressed both endogenous ZSCAN4 protein (Fig.  2c,d and 
Supplementary Note) and Zscan4 mRNA (Fig.  2d), consistent 
with a recent report38. Thus, the 2-cell-like cell population is con-
tained within the Zscan4+ population. Third, we predicted that 
Zscan4+ cells should convert more frequently to 2-cell-like cells 
than Zscan4– cells. By using a Zscan4c::mCherry reporter encod-
ing destabilized mCherry (Fig.  2e and Supplementary Fig.  2d,e), 
we found that Zscan4+ cells gave rise to significantly more (~9 × ) 
2-cell-like cells than Zscan4– cells (4 ± 2.6% versus 0.5 ± 0.13%; 
P = 0.04) (Supplementary Fig. 2f,g). And, fourth, time-lapse micros-
copy should reveal 2-cell-like cells arising from Zscan4+ intermedi-
ates (Fig. 2e, Supplementary Fig. 2d,e and Supplementary Note). We 
imaged 383 emerging 2-cell-like cells and tracked them individually. 
We found that the majority (81%; 312/383) emerged from Zscan4+ 
cells (Fig. 2f and Supplementary Videos 1–3). The remaining ~19% 
(71/383) appeared directly from Zscan4– cells (Fig. 2f), suggesting 
that 2-cell-like cells may arise through different pathways. Although 
we cannot formally rule out the possibility that these 2-cell-like 
cells were also derived from Zscan4+ cells because of incomplete 
Zscan4c::mCherry reporter penetrance (Supplementary Fig. 2e), our 
results suggest that 2-cell-like cells arise primarily from Zscan4+ pre-
cursors, thereby identifying Zscan4 transcription as the first molecu-
lar marker in the transition from ES cells toward 2-cell-like cells.
We analyzed publicly available transposase-accessible chromatin 
using sequencing (ATAC–seq) profiles of these populations38 and 
further demonstrated that Zscan4+ cells display a pattern of chro-
matin accessibility intermediate to those of ES and 2-cell-like cells 
(Supplementary Fig. 2h). Notably, ATAC–seq analysis38 also showed 
that, although 2-cell-like cells have an open chromatin structure at 
MERVL sites, Zscan4+ cells do not (Fig.  2g,h). This suggests that 
the chromatin landscape of Zscan4+ cells differs from that of 2-cell-
like cells and that Zscan4 activation precedes chromatin opening at 
MERVL sites.
Next, we investigated the dynamics of Zscan4 expression. 
ZSCAN4 proteins are encoded by six genes (Zscan4a through 
Zscan4f)25. Our single-cell dataset showed that three distinct cell 
clusters are defined according to Zscan4 transcript abundance: low, 
mid and high (Supplementary Fig. 3a). Their positions along PC1, 
from lowest to highest mRNA content (Supplementary Fig. 3b,c), 
suggest gradual activation of Zscan4 after exit toward the 2-cell-like 
state (Supplementary Fig. 3a and Supplementary Note). We classi-
fied cells into five groups on the basis of their combined expres-
sion of turboGFP from the 2C::turboGFP reporter and Zscan4: 
(i) ES cells, (ii) Zscan4low (turboGFP–) cells, (iii) Zscan4mid (tur-
boGFP–) cells, (iv) Zscan4high (turboGFP–) cells and (v) 2-cell-like 
(turboGFP+) cells. Oct4 transcript levels did not vary across the 
five groups (Fig. 2i (note Ct values) and Supplementary Table 3). 
Zscan4low cells showed no difference in expression of the chimeric 
transcripts as compared to ES cells; however, the chimeric tran-
scripts showed a bimodal expression distribution in Zscan4mid and 
Zscan4high cells (Fig. 2i). This suggests that LTRs are activated in dif-
ferent subpopulations of cellular intermediates, pointing toward a 
sequential model of transcriptional changes whereby Zscan4 activa-
tion precedes activation of chimeric LTRs and MERVL itself, con-
sistent with the results of the ATAC–seq analysis (Fig. 2g,h).
To address whether the conclusions we derived above reflect 
sequential transcriptional changes across the genome, we interro-
gated available single-cell RNA-seq datasets38. We modeled single-
cell RNA-seq data according to the abundance of Zscan4 transcripts; 
this approach confirmed the presence of subpopulations of cells 
expressing various levels of Zscan4, which we classified into ES 
cells, Zscan4low, Zscan4mid and Zscan4high cells, and 2-cell-like cells 
(Supplementary Fig.  3d,e). Differential expression analysis iden-
tified unique transcriptional changes between each transitional 
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Fig. 2 | Two-cell-like cells arise primarily from Zscan4+ cells. a, Experimental design for the single-cell expression profiling experiment. In total, 53 
Zscan4::tdTomato+ cells were profiled. b, Projection of the individual expression profiles of Zscan4+ cells onto the principal components of the ES and 2-cell-like  
cell dataset from Fig. 1d,e. Each dot represents a single cell and is colored according to whether it corresponds to an ES, Zscan4+ or 2-cell-like cell as indicated.  
c, Immunofluorescence analysis of 2 C::turboGFP and endogenous ZSCAN4. A representative confocal single-section image from five different cell cultures is 
shown. Scale bar, 10 μm. d, Quantification of the number of cells expressing ZSCAN4 protein (left), based on immunofluorescence, and Zscan4 mRNA (right), 
based on the single-cell expression analysis, according to whether cells are ES or 2-cell-like cells (n indicates the number of cells analyzed). e, Design of the reporter 
cell line used for the time-lapse experiment. f, Time-lapse analysis of 2-cell-like and Zscan4+ cell emergence. Spontaneously arising 2-cell-like cells were classified 
according to whether they arose from a Zscan4::mCherry+ cell. Results shown were pooled from 11 independent cultures (n indicates the number of cells analyzed). 
Scale bar, 20 μm. g, Average ATAC–seq signal intensity over all annotated MT2_Mm LTRs in ES, Zscan4+ and 2-cell-like cells. h, Heat maps showing ATAC–seq 
signal intensity over 10-kb genomic windows centered on 914 solo MT2_Mm LTRs. i, Violin plots showing the distribution of the expression levels of individual 
cells for the indicated genes. Higher values correspond to higher expression levels, and a Ct value of 0 indicates that no amplification was detected. The median is 
indicated by a square. ES, n = 75; Zscan4low, n = 21; Zscan4mid, n = 20; Zscan4high, n = 30; 2 cell like, n = 43. Note that turboGFP and Spz1 transcripts possess no exon 
junctions and their readings therefore to some extent reflect the genomic background.
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Fig. 3 | Zscan4+ cells downregulate pluripotency factors. a–e, Immunofluorescence staining using antibodies for OCT4 (a), SOX2 (b), PRDM14 
(c), TFAP2C (d) and REX1 (e) together with 2 C::turboGFP or 2 C::EGFP and ZSCAN4 or Zscan4::tdTomato, as indicated (n indicates the number of 
independent cultures). The merged image (left) shows the DAPI (cyan), ZSCAN4 (red) and 2C reporter (green) expression. Grayscale images of the 
respective TF, ZSCAN4 and GFP reporter channels are shown (right). Dashed lines contour Zscan4+ and 2-cell-like cells. Scale bars, 20 μm.  
f, Quantification of the data in a–e (n indicates the number of cells). Density plots of the distribution of mean fluorescence intensities for the indicated TFs. 
The number of cells quantified for each graph is indicated. P values were calculated using the Mann–Whitney U test. g, PCA of the single-cell dataset from 
Fig. 2b, with single cells color-coded according to their expression level of the indicated TF. Black dots signify no expression. As in Figs. 1 and 2,  
PC1 separates ES from 2-cell-like cells, whereas PC3 segregates naive from primed pluripotency. h, Violin plots showing the distribution of the expression 
levels of individual cells for the indicated genes. Higher values correspond to higher expression levels, and a Ct value of 0 indicates that no amplification 
was detected. The median is indicated by a square. ES, n = 75; Zscan4low, n = 21; Zscan4mid, n = 20; Zscan4high, n = 30; 2 cell like, n = 43.
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Fig. 4 | Entry into the Zscan4+ state and downregulation of pluripotency factors are unrelated to differentiation. a, Experimental design for the pluripotency 
exit experiments. Rex1high and Rex1low tdTomato– cells were sorted on the basis of Rex1::EGFP fluorescence and cultured for 24 h in serum- and LIF-containing 
medium over feeder cells. After this culture period, the number of Zscan4+ cells was determined by FACS. b, Phase-contrast images of Rex1high and Rex1low 
cells 24 h after sorting (n indicates the number of independent cultures). Scale bar, 10 μm. c,d, Representative scatterplots showing Zscan4::tdTomato and 
Rex1::EGFP fluorescence measurements of individual cells as assayed by FACS (c) and quantification of the Zscan4::tdTomato+ population in the Rex1high and 
Rex1low fractions (d). Error bars indicate the s.d. of three independent experiments from different cultures. *P < 0.05 by paired Student’s t test. e, Density 
plots of Rex1::EGFP fluorescence for the Rex1high and Rex1low populations after 24 h of culture in serum- and LIF-containing medium. The entire population 
is indicated in blue, and Zscan4+ cells are indicated in red. Plots are representative of three independent cultures. f, Experimental design. Following 1 week 
of culture with serum- and LIF-containing medium on feeder cells, tdTomato+ cells were removed and Rex1high, Rex1low and Rex1– cells were replated without 
LIF over gelatin for 24 h, after which the proportion of Zscan4+ cells was determined by FACS. g, Density plots of Rex1::EGFP fluorescence for the Rex1high, 
Rex1low and Rex1– populations after sorting and 24 h after LIF withdrawal. Plots are representative of five independent experiments from different cell cultures. 
WT, wild type. h,i, Representative scatterplots showing Zscan4::tdTomato and Rex1::EGFP fluorescence FACS measurements of individual cells (h) and 
quantification of the data (i). Error bars indicate s.d. of five independent experiments from different cell cultures. *P < 0.05 by paired Student’s t test.
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state and confirmed a stepwise transition from ES cells toward the 
2-cell-like state globally, with the Zscan4+ intermediates showing 
an intermediate expression profile (Supplementary Fig.  3f,g and 
Supplementary Table 9).
Zscan4-expressing cells downregulate protein levels of pluripo-
tency factors. ES cell identity relies primarily on a gene regulatory 
network in which OCT4, NANOG and SOX2 are essential compo-
nents39. Two-cell-like cells downregulate OCT4 protein levels24,27. To 
dissect the mechanism by which ES cells transition toward the 2-cell-
like state, we determined at which stage of the transition the down-
regulation of pluripotency-associated TFs occurs. We addressed 
whether other pluripotency-associated factors were also affected 
in 2-cell-like cells (Fig. 3). OCT4 was downregulated in 2-cell-like 
cells, as well as in Zscan4+ intermediates (Fig. 3a,f, Supplementary 
Fig. 4a and Supplementary Note). SOX2, PRDM14 and AP2γ were 
also downregulated in Zscan4+ cells (Fig.  3b–d,f). REX1 local-
ization changed in 2-cell-like cells, suggesting an alteration of 
REX1 function during the emergence of 2-cell-like cells (Fig. 3e). 
In addition to changes in protein levels, the single-cell expression 
dataset highlighted a gradient in the expression of Sox2, Prdm14, 
Tfap2c (encoding AP2γ) and Zfp42 (also known as Rex1), but not 
of Oct4, along PC1 (Fig. 3g). Sox2, Tfap2c and Rex1 transcript levels 
were downregulated in Zscan4high intermediates, to levels similar to 
those seen in 2-cell-like cells (Fig. 3h and Supplementary Table 3). 
We conclude that the pluripotency regulatory network is downreg-
ulated in 2-cell-like cells, consistent with an exit from the ES cell 
state, but that changes in the levels of pluripotency TFs are already 
apparent in the Zscan4+ 2C::turboGFP– state. Therefore, upregula-
tion of Zscan4 precedes changes in the pluripotency core regulatory 
network in the transition toward 2-cell-like cells.
Exit of ES cells toward the 2-cell-like state is unrelated to differ-
entiation. The results above prompted us to investigate whether 
2-cell-like cells emerge through a mechanism similar to differen-
tiation, as both fates entail the eventual downregulation of pluri-
potency TFs. To address whether 2-cell-like cells exit through an 
early differentiation intermediate or rather exit independently of 
differentiation cues, we used a Rex1 knock-in reporter40, as Rex1 
expression faithfully reflects the earliest exit toward differentia-
tion17,22. Rex1– cells, in contrast to Rex1+ cells, lose clonogenic self-
renewal capacity when plated in serum-containing medium21. 
In addition, Rex1low and Rex1– cells differentiate more efficiently 
than Rex1high cells17,22. We reasoned that, if 2-cell-like cells emerge 
from differentiating ES cells, then Rex1low cells should gener-
ate Zscan4+ cells with higher propensityRex1high. Using a double-
reporter cell line (Fig. 4a and Supplementary Fig. 4b,c), we removed 
Zscan4+ cells from ES cells grown in serum- and leukemia inhibitory 
factor (LIF)-containing medium and replated Rex1low and Rex1high 
cells separately (Supplementary Fig.  4d). Rex1low cells showed the 
expected flattened morphology after 24 h of culture (Fig. 4b)17. FACS 
analysis showed that Rex1low cells generated fewer Zscan4+ cells than 
Rex1high cells (Fig. 4c,d), consistent with the single-cell data show-
ing an enrichment of Zscan4+ cells in Rex1high cells (Supplementary 
Fig. 4e,f). To rule out the possibility that Zscan4+ cells within the 
Rex1low fraction were derived from a population that interconverted 
to the Rex1high state17,21,40 (Fig. 4e), we performed the same experi-
ment as described above, but included Rex1– cells, which cannot 
convert to a Rex1+ state21 (Fig. 4f,g). This time, the cells were plated 
without LIF because, after 24 h of LIF withdrawal, Rex1low cells irre-
versibly lose ES cell identity and are closer to lineage specification21. 
FACS analysis confirmed that Rex1low cells had decreased ability 
to generate Zscan4+ cells (Fig.  4h,i). In addition, the number of 
Zscan4+ cells in the Rex1– population was significantly lower than 
that in the Rex1+ fraction. Thus, Zscan4+ cells—and therefore 2-cell-
like cells—do not emerge from a differentiating precursor. In agree-
ment, treatment with siRNAs specific for Oct4, Nanog, Sox2 or Rex1 
did not affect the percentage of Zscan4+ and 2C::turboGFP+ cells 
(Supplementary Fig. 4g–i). We conclude that 2-cell-like cells exit the 
ES cell state through a path that is different from differentiation.
Defining a molecular roadmap during the emergence of the 
2-cell-like state. We next sought to define a molecular roadmap 
for 2-cell-like cell emergence on the basis of sequential changes 
in gene expression across the five cellular states described above 
(Supplementary Fig. 5a,b and Supplementary Table 3). Specific TFs 
showed substantial changes in expression mostly among the Zscan4+ 
intermediates (Fig. 5a). For example, the expression of Foxa1, which 
encodes a pioneer TF, was sharply upregulated at the Zscan4low to 
Zscan4mid transition. Among the 22 chromatin modifiers profiled, 
a few displayed marked changes accompanying each of the transi-
tions between ES and 2-cell-like cells (Fig. 5a). The transition with 
the most changes in the chromatin factors analyzed was between the 
Zscan4mid and Zscan4high states. These observations prompted us to 
undertake a broad functional analysis to identify epigenetic factors 
that promote 2-cell-like fate.
Identification of epigenetic pathways regulating emergence of 
the 2-cell-like state. We performed a screen using an siRNA library 
targeting 1,167 genes41 (Fig. 5b and Supplementary Table 4). On the 
basis of our previous results, we used three readouts to identify bona 
fide 2-cell-like cells: 2C::EGFP expression, ZSCAN4 expression and 
loss of OCT4 protein (Fig. 5c). The screen achieved single-cell reso-
lution through nuclear segmentation (Supplementary Fig. 6a). We 
included siRNAs that targeted Chaf1a, which encodes the p150 sub-
unit of CAF-1, as a positive control27 (Fig. 5c and Supplementary 
Fig. 6b) and applied stringent thresholds based on individual and 
combined z scores for hit selection (Fig.  5d,e and Supplementary 
Fig.  6c). Some hits led to reduced cell numbers (Supplementary 
Fig.  6d), suggesting toxicity and/or cell proliferation effects. 
Chromatin modifiers that have previously been shown to affect 
emergence of 2-cell-like cells, such as KAP1 and LSD1, were also 
in our screen; however, their downregulation had a mild effect on 
2-cell-like cell induction and a lower z score. We extracted the top 
50 hits (for which knockdown resulted in the highest percenages 
of 2-cell-like cells) (Fig. 5f) and validated them using a secondary 
screen (Supplementary Fig. 7a,b). Because the top hits of the pri-
mary screen included Polycomb proteins and histone chaperones, 
we included additional siRNAs to investigate all known components 
of these pathways. We validated all top 50 hits, with the exception 
of Dnmt3b (Supplementary Fig.  7c). In addition, treatment with 
siRNAs targeting transcripts encoding the Polycomb-related pro-
teins MGA, MAX and RYBP42,43 and the histone chaperone DAXX 
induced 2-cell-like cells from 3- to 15-fold relative to cells trans-
fected with negative-control siRNA (Supplementary Fig.  7d,e). 
The combined top 50 hits from both screens varied in their rela-
tive impact on 2C::EGFP, ZSCAN4 and OCT4 expression (Fig. 5f). 
Quantification of 2-cell-like cells in the top 50 hits showed induc-
tion that ranged between 0.28% and 2.52%, which represents a fold 
induction of 3.5 to 32, as compared to the controls (Fig.  5g and 
Supplementary Table 4).
Analysis of the protein networks of the validated top 49 hits 
highlighted five major complexes that seem to regulate 2-cell-
like cell emergence, including 23 components of the spliceo-
some, 4 major members of the EP400–TIP60 (KAT5) complex, 
7 members of Polycomb repressor complex 1 (PRC1) and proteins 
involved in DNA replication (Fig. 6a). The members of the PRC 
identified belong to a non-canonical PRC1 complex44,45 that is 
characterized by the presence of RYBP and PCGF646,47, suggesting 
specificity among the Polycomb group proteins in their ability to 
regulate 2-cell-like cell emergence. Notably, our screen identified 
the second CAF-1 subunit, p60 (encoded by Chaf1b), in agree-
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Fig. 5 | An siRNA screen for chromatin modifiers identifies regulators of 2-cell-like cell emergence. a, Schematic of significantly and differentially 
expressed genes between individual stages of the transition from the ES to 2-cell-like state. Changes were considered significant if they were at least 
twofold across cells in different individual states and had P < 0.05 (Mann–Whitney U test). b, Design of the siRNA screen. c, Representative inverted 
dynamics images for the negative (cells transfected with a scrambled siRNA (neg); n = 270 wells) and positive (cells transfected with a Chaf1a-specific 
siRNA; n = 270 wells) controls of the screen are shown. Nine random images from one well were combined. Scale bar, 500 µm. d,e, Representative images 
(n = 3 technical replicate wells) of the EGFP (d) and ZSCAN4 (e) immunostaining for selected hits from the screen are shown in inverted dynamics. Scale 
bar, 500 µm. Images correspond to cells transfected with siRNAs to the following transcripts as indicated: Snrpd3 (1), Ring1b (2), Pcgf6 (3), Dmap1 (4), 
Ep400 (5), Snrpb (6), Snrpd1 (7), Usp7 (8), Snrpe (9), Lsm6 (10), Snrpd2 (11), Snrp200 (12), Rif1 (13), Chaf1b (14), Sf3b1 (15), Prpf8 (16), Psmd14 (17), Aqr 
(18), Snrpg (19), Gmnn (20), Dnmt3b (21), Ubl5 (22), Rad21 (23), Recql5 (24), Trrap (25), Ddx23 (26), Cdcl5 (27) and Ncl (28). f, Heat map showing the 
effect on OCT4, ZSCAN4 and 2C::EGFP expression of the top 50 hits of the screen, ranked according to the percentage of 2-cell-like cells induced  
after siRNA treatment. Data are combined from the primary and secondary validation screens and include additional hits that were tested during the 
secondary screen. Two-cell-like cells are defined as cells that are positive for EGFP and ZSCAN4 immunostaining but negative for OCT4 immunostaining. 
g, Quantification of 2-cell-like cells (for example, 2C::EGFP+, ZSCAN4+ and OCT4–) induced after transfection with siRNA for the top 50 targets (gray) 
from the primary and secondary screens. The mean values ± s.d. from triplicate wells are shown. Each dot corresponds to measurements of independent 
wells. Negative (NT, non-transfected; Neg, scrambled siRNA) and positive (Chaf1a) controls are shown in red.
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ment with our previous work27. The mRNA expression profiles 
of the identified hits in endogenous and Chaf1a- and Chaf1b-
knockdown-induced 2-cell-like cells suggest that many but not 
all of the siRNA targets analyzed are downregulated in 2-cell-like 
cells (Supplementary Fig. 8a). In the embryo, the expression level 
of all the hits obtained varied across developmental stages, with 
most displaying sharp downregulation or upregulation at the 
4-cell stage (Supplementary Fig. 8b).
We selected 11 hits from the major chromatin pathways identified: 
PRC1 complexes, the EP400–TIP60 complex and the replication fac-
tor RIF1, which we validated individually with single siRNAs, first by 
assessing the efficiency of knockdown (Fig. 6b). Because RNA inter-
ference (RNAi) of transcripts encoding spliceosome proteins resulted 
in increased cell death (Supplementary Fig. 6d), we did not focus on 
these factors for further analysis. Instead, our subsequent analysis 
concentrated on Ep400, Dmap1, Rnf2 (also known as Ring1b), Pcgf6, 
Rif1, L3mbtl2, Usp7, Kat5 (encoding TIP60), Mga, Max and Rybp, 
all of which were effectively and specifically downregulated after 
transfection with specific siRNA (Fig. 6b and data not shown). We 
included siRNAs directed at Chaf1a and Chaf1b in all of our subse-
quent experiments as positive controls. All 2C::EGFP+ induced cells 
displayed robust expression of ZSCAN4 protein, similarly to endog-
enous and Chaf1a- and Chaf1a-knockdown-induced 2-cell-like cells 
(Fig.  6c, Supplementary Fig.  9). In addition, these cells expressed 
the GAG protein, reflecting expression of endogenous MERVL loci 
(Fig. 6d), and indicating that the 2C::EGFP reporter faithfully reca-
pitulates MERVL transcription (Supplementary Fig.  9). RT–qPCR 
analysis demonstrated that siRNAs for all 11 hits provoked a strong 
increase in expression of MERVL loci, major satellites, Zscan4 and 
transcripts from chimeric genes (Fig. 6e and Supplementary Fig. 10a). 
OCT4 protein was undetectable in 2C::EGFP+ cells that emerged 
after knockdown of the 11 hits we analyzed (Supplementary Fig. 9c). 
All of these results together indicate that the 2-cell-like cells induced 
after downregulation of the expression of our 11 new candidates are 
bona fide 2-cell-like cells, as they display the known molecular char-
acteristics of endogenous 2-cell-like cells24,27. FACS quantification of 
2C::EGFP reporter fluorescence showed an induction of 2-cell-like 
cells of between 5- and 30-fold as compared to controls (Fig.  6f). 
Ep400, Dmap1 and Mga were the most effective hits: downregula-
tion of their expression by siRNA treatment resulted in an increase 
in the 2-cell-like cell population, which made up 5–6% of the culture, 
as compared with the only ~0.2% seen in controls (Supplementary 
Table 4). Thus, our screen effectively led to the identification of new 
regulators of 2-cell-like cell emergence.
We next addressed whether selected subunits of the PRC1.6 
and EP400–TIP60 complexes function in the maintenance and/or 
induction of 2-cell-like cells by sorting out Zscan4+ cells and 2-cell-
like cells followed by transfection with siRNAs targeting Pcgf6, 
Ring1b, Ep400 and Dmap1. The percentage of 2-cell-like cells after 
transfection with siRNAs targeting all four subunits was the same in 
cultures in which Zscan4+ and 2-cell-like cells had been removed as 
in cultures with preexisting 2-cell-like cells (Fig. 7a), suggesting that 
the primary function of the corresponding proteins is in the induc-
tion rather than the maintenance of the 2-cell-like state. In addition, 
although siRNA targeting of most of the hits identified affected the 
percentages of Zscan4+ and 2-cell-like cells similarly, some of the 
factors identified had a bigger effect on 2-cell-like cell induction 
(Fig.  7b and Supplementary Fig.  10b). We conclude that compo-
nents of the EP400–TIP60 complex, as well as the PRC1 complexes 
and RIF1, act as inhibitors of the emergence of 2-cell-like cells from 
ES cell cultures.
To understand the molecular nature of PRC1 activity in 2-cell-
like cell formation, we determined which Polycomb complex 
inhibited 2-cell-like emergence by performing siRNA-mediated 
knockdown of the transcripts encoding all known PRC1 subunits 
and associated polypeptides (Supplementary Fig. 11a). Nine of the 
28 siRNAs tested led to a significant increase in the 2-cell-like cell 
population (Supplementary Fig. 11b; protein names highlighted in 
red in Supplementary Fig. 11a), with subunits specific to the non-
canonical PRC1 (ncPRC1) complex PRC1.6, such as PCGF6 and 
L3MBTL2, acting as the main gatekeepers for 2-cell-like cell emer-
gence (Supplementary Fig.  11b). Consistent with this, downregu-
lation of the expression of MGA and MAX, known interactors of 
MYC also known to assemble into PRC1.646,48,49, robustly induced 
2-cell-like cells (Supplementary Fig. 11b). In addition to identify-
ing PRC1.6 as a regulator for 2-cell-like cells, our results suggest 
specificity in the ncPRC1 subunits involved. Downregulation of 
RYBP but not of YAF-2, which is mutually exclusive with RYBP and 
defines different complexes46, induced emergence of 2-cell-like cells 
(Supplementary Fig. 11c–f). Likewise, downregulation of RING1B, 
but not of RING1A, induced 2-cell-like cells (Supplementary 
Fig.  11c–f). In agreement with this observation, downregulation 
of USP7 and SKP1, which are known interactors of RING1B but 
for which specific allocation to a given ncPRC1 subcomplex is 
unknown50, efficiently induced 2-cell-like cells. Notably, siRNAs 
targeting transcripts encoding the PRC2 components EED and 
EZH2 had no effect on 2-cell-like cell emergence or MERVL tran-
scription (Supplementary Fig. 11g–j).
Because PRC1 catalyzes ubiquitination of histone H2A on lysine 
119 (H2AK119Ub), we assessed H2AK119Ub levels in 2-cell-
like cells. Immunostaining for H2AK119Ub showed that endog-
enous and induced 2-cell-like cells have substantially lower levels 
of H2AK119Ub than their neighboring ES cells (Supplementary 
Fig. 12a,b). This is relevant considering that reduced H2AK119Ub 
levels occurred not only after Ring1b and Pcgf6 downregulation—
for which this is expected—but also after downregulation of Ep400 
and, although to a lesser extent, Dmap1, suggesting that emergence 
of 2-cell-like cells, regardless of the molecular pathway involved, 
entails a decrease in H2AK119Ub levels.
We next asked whether the epigenetic pathways identified func-
tion in parallel in regulating 2-cell-like cell fate. siRNAs targeting 
transcripts for combinations of EP400–TIP60 and PRC1.6 subunits 
seemed to have an additive effect (Fig.  7c,e,f and Supplementary 
Note), indicating that EP400–TIP60 and PRC1.6 function through 
different pathways to induce 2-cell-like cells. In agreement, treat-
ment with Rex1 and Nanog-specific siRNAs did not affect the relative 
change in number of 2-cell-like cells after Ep400 and Dmap1 knock-
down, but did slightly affect the extent to which downregulation of 
Pcgf6 and Ring1b expression induced 2-cell-like cells (Supplementary 
Fig. 12c). This suggests that part of the effect of PRC1.6—but not of 
EP400 or TIP60—in inducing 2-cell-like cells is dependent on REX1 
and NANOG function. In addition, culture in the presence of the 
inhibitors CHIR99021 and PD0325901 (hereafter 2i), which stabi-
lize the naive pluripotent state, decreased the number of 2-cell-like 
cells emerging after knockdown of Pcgf6, Ring1b, Ep400 and Dmap1 
(Fig. 7d), and overexpression of Nanog had no effect (Supplementary 
Fig. 12d).
Lastly, to investigate the potential mechanism of action of 
PRC1.6 and EP400–TIP60 complexes in 2-cell-like cell emergence, 
we asked whether they occupy genes that are differentially expressed 
in 2-cell-like cells relative to ES cells and analyzed ChIP–seq data 
for PRC1.6 and EP400–TIP60 subunits in ES cells. We classified 
differentially expressed genes as those that were upregulated or 
downregulated27 and analyzed enrichment of the PRC1.6 subunits 
RING1B, RYBP and MAX, H2AK119Ub, and EP400 and histone 
H3 trimethylated on lysine 4 (H3K4me3) over their transcription 
start sites (TSSs). Because the transcriptional changes observed 
in 2-cell-like cells usually involve upregulation27,51, we focused on 
upregulated TSSs. k-means clustering of ChIP–seq profiles high-
lighted five main binding profiles (Fig. 8a). Of these, three clusters 
were strongly co-occupied by RING1B, RYBP and H2AK119Ub 
(odds ratio for enrichment = 2.84, P = 1.24 × 10−6), suggesting that 
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Fig. 6 | The PRc1.6 and EP400–TIP60 complexes are inhibitors of 2-cell-like cell emergence. a, Protein interaction network for the validated top 49 
hits from the siRNA screens. b, RT–qPCR analysis of the indicated transcripts after transfection with the corresponding siRNAs in the 2C::EGFP reporter 
cell line. Shown are mean values ± s.d. of two technical replicates from four independent cultures performed on different days. c,d, Immunostaining of 
the 2C::EGFP reporter cell line with antibodies to EGFP and ZSCAN4 (c) or to EGFP and the GAG protein encoded by endogenous MERVL loci (d) after 
transfection with siRNA to the indicated transcript. Representative images from two independent cell cultures are shown in inverted dynamics. Nuclei 
were counterstained with DAPI (cyan). Scale bar, 200 µm. e, RT–qPCR analysis of MERVL and Zscan4 expression in the 2C::EGFP reporter cell line after 
transfection with the indicated siRNA. Shown are mean values ± s.d. of two technical replicates from four different cell cultures performed on different 
days. f, Quantification of EGFP+ cells (%) by FACS after transfection with siRNA to the indicated transcripts. The mean ± s.d. from independent culture 
measurements is shown. Each dot represents measurements from independent cell cultures in b, e and f.
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these genes are normally repressed by PRC1 in ES cells. The TSSs 
and associated transcription in these three clusters were mostly 
silent in ES cells while expression was induced in 2-cell-like cells, 
where they represented ~17% of the upregulated TSSs (Fig.  8a). 
Two of the three PRC1-bound clusters comprised mainly ‘bivalent’ 
promoters marked by H3K4me3 and PRC1 occupancy (in addition 
to H3K27me3; data not shown). Approximately half of the upregu-
lated TSSs (~57%) did not show binding of any of the chromatin 
modifiers or modifications analyzed, presumably owing to the low 
mappability of some of these regions (Fig. 8a). Of note, we found 
that many of these TSSs contained a MERVL (MT2_Mm) element 
within 50 kb upstream (Fig. 8a), contrary to downregulated genes. 
The upregulation of the genes within this cluster is therefore pre-
sumably explained by proximity to MERVL1,51,52. Notably, we did not 
observe significant binding of EP400 or PRC1 subunits RING1B or 
RYBP at MERVL, except at a minor fraction of complete MERVL 
elements that were bound by MAX (Fig. 8b and data not shown; see 
Methods). Because a large proportion of the downregulated genes 
in 2-cell-like cells were bound by EP400 (Fig.  8c) (odds ratio for 
enrichment = 3.70, ~60% of downregulated genes, P < 2.2 × 10−16), 
downregulation of the latter may help to repress part of the ES cell 
transcriptome in 2-cell-like cells. This also supports the observa-
tions that simultaneous downregulation of these two complexes 
synergistically induces 2-cell-like cells. Taken together, these data 
suggest that the transition toward the 2-cell-like cell transcriptome 
involves a combination of molecular pathways, including regulation 
through the binding and action of the identified chromatin modi-
fiers and activation of a proximal MERVL element, presumably 
through binding of the TF DUX53,54.
Discussion
We have identified an intermediate cellular state during the tran-
sition to the 2-cell-like state that is characterized by a transcrip-
tional profile distinctive from those of ES and 2-cell-like cells. We 
note that, in contrast to previous findings in which ZSCAN4+ and 
MERVL+ populations have been considered interchangeable38, our 
approach of classifying individual cells on the basis of their single-
cell transcriptome rather than by their fluorescence or population-
wide transcriptome allowed us to uncover differences between the 
populations in a more robust and quantitative manner. ZSCAN4 
expression is a bona fide marker for this intermediate popula-
tion. Although activation of Zscan4 expression demarcates the 
first molecular change that we detect, the transcriptional changes 













































































































1.22 1.18 0.89 0.79
0.95 1.25 1.18 1.27 0.71
1.82 1.95 1.56 1.26 0.83 0.73
1.26 1.53 1.37 1.41 1.04 1.20 1.02
1.32 1.86 1.13 0.42 0.60 1.33 1.01 1.64
1.66 1.84 1.78 1.08 0.88 1.21 0.76 1.01 1.90
1.78 2.01 1.96 2.19 0.91 1.64 0.84 1.21 1.41 1.03
1.10 1.03 1.40 0.88 0.34 0.91 1.16 0.92 1.00 1.03 3.68
1.03 1.28
1.87 2.10 2.01
2.08 2.15 1.43 1.33
1.21 1.73 1.92 1.84 0.97
3.04 3.39 2.21 1.89 1.33 0.88
2.23 2.86 2.17 2.39 1.93 1.62 1.88
2.21 2.60 1.88 0.90 1.04 1.75 1.25 1.82
2.60 3.27 3.21 1.95 1.48 1.75 1.09 1.82 1.50
2.60 3.25 3.75 3.68 1.42 2.28 1.15 1.74 2.46 1.93




































































































































































































































Fig. 7 | The PRc1.6 and EP400–TIP60 complexes synergistically regulate 2-cell-like cell emergence. a, Induction of 2-cell-like cells after transfection with 
siRNA for Pcgf6, Ring1b, Ep400 or Dmap1 in an initial population of cells devoid of 2-cell-like or of Zscan4+ cells. In control, ‘sorted’ cells, cells were passed 
through the FACS sorter but Zscan4+ and 2–cell like cells were not removed. Quantification of turboGFP+ cells by FACS was performed 2 d after siRNA 
transfection. The mean ± s.d. of two different transfected wells (dots) is shown. b, Scatterplot of the top 50 hits of the siRNA screens showing the fold 
change in the percentage of ZSCAN4+ and 2C::EGFP+ cells (x axis) and of cells positive for ZSCAN4 and negative for 2C::EGFP (y axis). Each dot is color-
coded according to its molecular complex. The dashed gray line indicates a 1:1 ratio. c, Quantification of EGFP+ cells (%) by FACS after transfection with 
the indicated siRNAs individually or in pairs. Shown are the mean values ± s.d. of two independent cell cultures. d, Effect of 2i treatment on 2-cell-like cell 
induction after treatment with siRNA targeting Pcgf6, Ring1b, Ep400 or Dmap1. EGFP+ cells (%) were quantified by FACS 48 h after transfection. Cells were 
grown in 2i and were either kept in 2i for the whole experiment or placed in medium from which 2i was removed 1 d before transfection. The mean ± s.d. 
of the indicated number of independent cell cultures (shown by individual dots) is shown. e,f, Summary of the combinatorial siRNA analyses on 2-cell-
like cell induction. Pairs of siRNAs were cotransfected into the 2C::EGFP reporter cell line, and the percentage of EGFP+ cells was measured by FACS. 
Combinatorial additive (e) or synergistic (f) effects were assessed.
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Fig. 8 | The PRc1.6 and EP400–TIP60 complexes occupy genes differentially expressed in 2-cell-like cells relative to Es cells. a, Heat map of the ChIP–seq 
profiles (for references, see Methods) of the indicated chromatin modifiers or histone modifications over all TSSs of the 2,313 upregulated (6,829 TSSs) genes 
in ES cells grown in serum- and LIF-containing medium. Regions of low mappability are depicted in black, and occurrence of an MT2_Mm site within the 50 kb 
upstream of the respective TSS is indicated in orange; expression levels in ES and 2-cell-like cells (2CL) are shown in blue. The number of TSSs per cluster is 
indicated by n. b, Heat map of RYBP and MAX enrichment (fold enrichment over input) in 20-kb windows encompassing complete, internal or solo LTR MERVL 
elements as indicated. The mappability score for the corresponding regions is depicted. c, Heat map of the ChIP–seq profiles of the indicated chromatin modifiers 
or histone modifications over all TSSs of the 951 downregulated (4,189 TSSs) genes, as in a. d, Working model for 2-cell-like cell induction from mouse ES cell 
cultures based on the siRNA screen results. Downregulation of various subunits of the PRC1.6 and EP400–TIP60 complexes leads to induction of the 2-cell-like 
state, which is accompanied by a global reduction in H2AK119Ub levels and increased histone acetylation24,27. The precise interplay of the two complexes, as well 
as the extent to which these mechanisms may operate in vivo to repress the totipotent regulatory program, remains to be established. ICM, inner cell mass.
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ZSCAN4 itself may not necessarily have a directive, essential role in 
the emergence of 2-cell-like cells. Indeed, ZSCAN4 overexpression 
in ES cells seems to elicit cell death and can trigger acquisition of 
some but not all of the repertoire of 2-cell-like cell characteristics36.
Early-differentiating cells generate fewer Zscan4+ cells than naive 
ES cells, indicating that exit toward the 2-cell-like cell stage demar-
cates a process different from the loss of pluripotency after differ-
entiation. Our data also indicate that 2-cell-like cells themselves are 
heterogeneous, but the nature of their heterogeneity differs from that 
of ES cells. Although 2-cell-like cells have been proposed to consti-
tute a metastable state24, it remains to be seen whether such a state is 
also in an internal dynamic equilibrium or whether the heterogene-
ity that we observed represents additional transitional states.
A more open chromatin state characterizes the 2-cell state in vivo 
and in vitro26,54,55. The EP400–TIP60 complex regulates nucleosome 
stability56,57, and this complex could potentially provide a molecular 
basis for chromatin opening. Our data suggest that several activities 
are in play to regulate the transition from ES to 2-cell-like cells. This 
is supported by the additive effects of PRC1.6 and EP400–TIP60 
downregulation in 2-cell-like cell emergence. In addition, PRC1.6 
is the only PRC1 complex that possesses histone deacetylation 
activity46,47, which may also affect the global histone hyperacety-
lation observed in 2-cell-like cells24,27. Notably, specific components 
of PRC1.6, such as L3MBTL2 and RYBP, are either present at low 
levels or absent from embryonic chromatin in 2-cell-stage embryos58. 
Although work on induced pluripotency indicates that reprogram-
ming does not necessarily recapitulate developmental progression 
in reverse, investigating whether the factors that we identified are 
responsible for regulating the 2-cell-like cell transition in vivo will 
be an important task for the future.
Our data support a role for several biochemical activities—includ-
ing chromatin assembly, nucleosome remodeling, and histone acety-
lation and ubiquitination—in reshaping the chromatin landscape in 
the transition from ES to 2-cell-like cells (Fig. 8d). Altogether, our 
work identifies intermediate states during the transition from ES to 
2-cell-like cells and the chromatin pathways involved.
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Methods
Cell culture. All cell lines in this study, unless otherwise stated, were grown 
in DMEM supplemented with Glutamax-I, 15% FCS, 2 × LIF, 0.1 mM 
2-mercaptoethanol, non-essential amino acids, penicillin and streptomycin over 
a bed of feeder cells. For the LIF withdrawal experiment, LIF and feeder cells 
were omitted from the culture conditions. Medium supplemented with 2i (3 µM 
CHIR99021 and 1 µM PD0325901, Miltenyi Biotec) was used for the establishment 
of stable cell lines and for their expansion and maintenance. After removal of 2i, 
cells were always cultured for at least 7 d in serum and LIF conditions over a bed of 
feeder cells before being used for experiments (except for siRNA transfection).
siRNA transfection. Two days before transfection, cells were plated in gelatin-
coated dishes. The 2i inhibitors were removed from the medium 1 d before 
transfection. Lipofectamine RNAiMAX (Life Technologies) was used for siRNA 
transfection according to the manufacturer′s instructions. 75,000 cells were reverse 
transfected in 24-well gelatin-coated plates using a final concentration of 30 nM for 
each siRNA condition (the siRNAs are listed in Supplementary Table 5). We used 
Silenced Negative Control No.1 siRNA (Life Technologies) as a negative control 
for siRNA treatment. The effect of RNAi was examined 2 d after transfection. The 
effects of Pcgf6, Ring1b, Ep400, Dmap1, Mga, Max and Rybp siRNAs on 2-cell-
like cell induction were validated by FACS, immunofluorescence and RT–qPCR 
(qPCR primers are listed in Supplementary Table 6) with an additional second 
siRNA sequence available upon request (data not shown). The effects of treatment 
with Snrpd1- and Lsm6-specific siRNAs on 2-cell-like cell induction observed in 
the screen were validated by FACS, immunofluorescence and RT–qPCR (data not 
shown). However, because of the high cell toxicity observed after treatment with 
siRNAs targeting transcripts encoding spliceosome components (Supplementary 
Fig. 5d), we did not focus on these hits for the remainder of the work. 
Lipofectamine 2000 (Life Technologies) was used for cotransfection with siRNA 
and the Nanog expression vector59, according to the manufacturer’s instructions. 
Cells were analyzed by RT–qPCR 2 d after transfection.
RNAi screening. Screening was performed in the high-throughput screening 
facility of the IGBMC, using a custom siRNA library (Dharmacon) of chromatin-
factor-related siRNAs, the siGenome smartpool (four different siRNAs/pool). 
Controls were performed with smartpool siRNAs from Dharmacon. Transfection 
efficiency was optimized using a cell death siRNA, which triggers cell death when 
transfected into cells (transfection efficiency quantified by assessing toxicity), 
and the Chaf1a-specific siRNA (transfection efficiency quantified by measuring 
the induction of 2-cell-like cells). For each target, 20 nM (final concentration) 
of siRNA was reverse transfected in triplicate into 5,000 mouse ES cells by 
using INTERFERin-HTS (Polyplus-Transfection). For the primary screen, 
1,167 genes were targeted (Supplementary Table 4). The screen was performed 
in 96-well microplates coated with gelatin. 2 d after siRNA transfection, cells 
were fixed with 1.5% paraformaldehyde, permeabilized with 0.1% Triton X-100, 
blocked with 2% BSA, and incubated with antibodies to EGFP, ZSCAN4 or 
OCT4 followed by incubation with Alexa-Fluor-647-, Alexa-Fluor-555- or 
Alexa-Fluor-488-conjugated secondary antibodies (Invitrogen). Cell nuclei 
were counterstained with 1 μg/ml DAPI. Screening was achieved on a Tecan 
Freedom EVO 150 (for cell transfection, staining and immunocytochemistry) 
and an Orbitor RS Microplate Mover robotic arm coupling microplate stacks 
to a Cellomics CellInsight NXT High-Content Screening Platform (Thermo 
Scientific). Images were acquired with CellInsight NXT (Thermo Scientific) 
and analyzed with HCS Studio Cell Analysis Software (nuclear segmentation 
and EGFP, ZSCAN4 and OCT4 intensities). Quantification of positive cells for 
each of these factors was done automatically, based on nuclear segmentation and 
across >5 fields (for actual cell counts, see Supplementary Tables 7 and 8). The 
percentage of cells positive for EGFP, ZSCAN4 or OCT4 staining was quantified 
for each well. Two-cell-like cells were defined as cells that were positive for EGFP 
and ZSCAN4 staining but negative for OCT4 staining.
To validate selected targets from the siRNA screen, a secondary screen was 
performed with individual siRNAs. In the secondary screen, the expression of 
81 genes from the primary screen was assessed by transfecting four different 
individual siRNAs, in triplicate, for each target. The secondary screen showed high 
reproducibility with the primary screen (Supplementary Fig. 7a,b). In addition, 32 
new genes were investigated in the secondary screen by transfecting with a pool of 
four siRNAs per target, as were 9 genes present in the primary screen as internal 
controls (Supplementary Table 4). The methods used for the secondary screen were 
as described for the primary screen. For each condition, z scores were calculated 
as mean ̄−( )x xsi , where xi is the value for each triplicate experiment and ̄x  and s are the mean value and the s.d. for the negative-control conditions, respectively.
Reporter cell lines. EGFP and turboGFP 2C reporter cell lines have previously 
been described27. To generate the Zscan4 reporter cell line, we replaced the emerald 
cassette of the reporter plasmid (kindly provided by M. Ko)35 with a cassette 
encoding nuclear localization sequence (NLS)-tagged destabilized tdTomato or 
mCherry. The 2C::turboGFP reporter cell line was transfected with the respective 
plasmids using Lipofectamine 2000, and a single clone was then selected.  
In the case of the Rex1 and Zscan4 reporter, a stable cell line carrying an EGFP 
cassette knocked into the ORF of Rex1 was kindly provided by the laboratory 
of A. Smith40, and these cells were transfected with the Zscan4c::tdTomato 
reporter construct. The reporter cell lines used in this study are summarized in 
Supplementary Table 10.
Analysis of RNA-seq data and selection of genes for the single-cell expression 
profiling experiments. RNA-seq data for 2-cell-like cells were reported 
previously27. Genes used in the Biomark single-cell analysis were selected on the 
basis of their functional significance and differential expression from our previous 
bulk RNA-seq analysis. Chimeric genes were defined on the basis of transcription 
starting from an LTR belonging to the MT2 families by genome browser analysis 
of the RNA-seq analysis in Ishiuchi et al.27. Heat maps of these transcriptomic data 
were generated using the ggplot2 R package.
Validation of TaqMan assays and custom designs. TaqMan assays (Thermo 
Fisher Scientific) were first tested on three different fivefold serial dilutions of 
cDNA from turboGFP+ cells on a LightCycler qPCR instrument. TaqMan assays 
that failed to amplify or that did not exhibit linearity in their measurements 
when the different dilutions were compared were omitted from the single-cell 
analysis. All TaqMan assays used are described in Supplementary Table 1. The 
TaqMan assay used for Zscan4 amplifies Zscan4c, Zscan4d and Zscan4f. Custom 
primers were designed to target the turboGFP reporter and were mixed to a final 
concentration equal to that of the components in the TaqMan assays (18 μM for the 
primer and 4 μM for the probe).
Single-cell expression profiling. After thawing, reporter cell lines were cultured 
for 6 d in serum- and LIF-containing medium over a bed of feeders and passaged 
every day, except for the second day of culture. On the sixth day of culture, cells 
were sorted with the help of a FACS machine, and only turboGFP– cells were 
replated; 2-cell-like cells were discarded. 24 h later, cells were sorted once again, but 
this time the ES, 2-cell-like or Zscan4+ cell fraction was preserved and prepared 
according to the manufacturer’s protocol (Fluidigm, PN1006117) for use in 
Fluidigm’s C1 microfluidics-based single-cell sample preparation platform. Of 
note, 1 μl of a 1:286 dilution of ERCC spike-in mix was added to the lysis solution 
of each C1 run instead of water. Single-cell expression data were generated in 
Fluidigm’s Biomark qPCR platform in technical duplicates using TaqMan probes 
(Thermo Fisher Scientific) according to the manufacturer’s protocol (Fluidigm, 
PN68000130). Only cells that passed the quality control check were included in 
the analyses performed throughout the manuscript. In total, we profiled 189 cells 
across four biological replicates. A constitutive pCAG promoter driving NLS-
tdTomato expression allowed us to sort feeder cells out (Fig. 1b and Supplementary 
Fig. 1c). In addition, we used two spike-in controls, which allowed us to assess 
the quality of the normalization to endogenous control genes and therefore to 
constrain technical noise (Supplementary Fig. 1d).
Normalization, quality control and modeling of single-cell data. Ct values 
obtained from the Biomark platform were processed as described previously60. 
Briefly, Ct values higher than 28 or with quality scores lower than the threshold of 
0.65 were substituted with Ct values of 28. Subsequently, Ct values were subtracted 
from a baseline value of 28, such that 0 implied no expression and 28 implied a 
high level of expression. For normalization purposes, the average of the Actb and 
Gapdh Ct values was subtracted from the values for all other genes for the same 
cell and the minimum dataset-wide value was substracted obtain positive values in 
all assays and samples. The average of the Ct values for the two technical replicates 
for the same cell was used. Note that, unlike in RNA-seq approaches, higher levels 
of expression of specific genes relative to others is unlikely to bias gene expression 
data because the usage of a pool of primers specific for each of the assayed 
genes during preamplification provides additional robustness to a single highly 
expressed gene being preferentially amplified and biasing a cell’s transcriptional 
profile. For PCA, the principal components of the dataset were computed using 
the svd method in R, and no scaling was performed. For projection of the Zscan4 
dataset into the principal components of the ES and 2-cell-like dataset, principal 
components were calculated using the svd method for the ES and 2-cell-like 
dataset, and its loadings matrix and the Zscan4 dataset’s matrix were then 
multiplied. All plotting was done in R with the ggplot2 package. To classify cells 
into the ES, Zscan4low, Zscan4mid, Zscan4high and 2-cell-like cell categories, we first 
classified them into two groups based on whether they expressed Zscan4c/d/f. 
Cells that did not express Zscan4 were termed ES cells. The remaining cells 
were subsequently classified based on whether the turboGFP transcript level 
exceeded the established cutoff, which was determined with the help of the 
density function of turboGFP transcript expression. Cells with expression values 
above the cutoff were classified as 2-cell-like cells. Note that this threshold had 
to be defined because the turboGFP reporter is intronless and therefore has to 
be distinguished from the genomic background (Fig. 1c, threshold selection not 
shown). The remaining cells were classified into Zscan4low, Zscan4mid or Zscan4high 
cells according to the thresholds that were set over the density function for Zscan4 
in Supplementary Fig. 3a.
Gapdh and Actb were used as internal controls for normalization, as they  
reflect independent molecular pathways and are unrelated to pluripotency.  
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Indeed, their expression was stable across samples and showed a high correlation. 
The Ct values for ES cells (GFP–) and 2-cell-like cells (GFP+) were consistently 
similar for the spike-in RNAs after normalization (Supplementary Fig. 1c), 
supporting the robustness of the normalization. Once data processing was 
performed, all cells expressing outlier values for Actb, Gapdh or the spike-in RNAs 
were removed from the analysis.
Flow cytometry. Cells were washed with room-temperature sterile PBS, 
trypsinized and resuspended in ice-cold sterile 0.5% BSA–PBS solution. Sorting 
was performed using a BD Biosciences FACSAria II or III. During sorting, cells 
were collected in culture medium and kept at 4 °C during the sort. Analysis of 
FACS data was performed using FlowJo software, and the same gating parameters 
were used for all replicates of the same experiment. Cells were not index sorted, 
and the purity of the sort was estimated at 96% for 2-cell-like cells and at 97% 
for ES cells. A control flow profile for wild-type (WT) ES cells is shown in 
Supplementary Fig. 1c. For the REX1 experiments, the REX1– gate was defined 
based on the fluorescence of WT ES cells and the REX1high gates were defined based 
on the fluorescence of Rex1::EGFP+ cells cultured in 2i medium. A FACSCalibur 
(BD Biosciences) was used to quantify the population of EGFP+ cells. Cells that 
had been frozen in 2i medium were thawed, and the REX1-based sorting was 
performed 4 d after 2i withdrawal. For data presented in Fig. 7a, the 2C::turboGFP 
and Zscan4c::mCherry cell line was FACS sorted just before transfection, and the 
2-cell-like cells and Zscan4c::mCherry+ cells were removed, from the population.
Immunofluorescence, image processing and quantification. Cells were 
cultured over feeder-coated coverslips, fixed in paraformaldehyde for 10 min 
at room temperature and permeabilized with 0.2% Triton X-100 for another 
10 min. Cells were incubated with primary antibodies overnight followed by 
three washes in PBS. Cells were then incubated with secondary antibodies 
for 1 h. Mounting was done in Vectashield mounting medium (Vector Labs). 
Image acquisition was performed using a Leica SP8 confocal microscope. For 
quantification of immunofluorescence, manual segmentation of the cell nucleus 
was performed on the DAPI channel using ImageJ, and the average fluorescence 
intensity was measured. Afterward, the average fluorescence intensity was 
measured. Only ES cells, Zscan4+ cells and 2-cell-like cells from the same 
coverslip and imaging session were used for each comparison. Density plots for 
each of these groups were computed using the kernel density estimation function 
in R with the Sheather and Jones bandwidth-selection method. For 2C::EGFP 
immunostaining, cells were fixed as described and blocked for 30 min at 37 °C in 
10% FCS, 3% BSA and 0.1% Triton X-100 in PBS (blocking buffer). Cells were 
incubated with primary and secondary antibodies 30 min each at 37 °C in the 
blocking buffer solution.
Real-time PCR. Total RNA was extracted from ES cells with the RNeasy Plus 
mini kit (Qiagen) and treated with turbo DNase (Life Technologies) to remove 
genomic DNA. Reverse transcription was performed with SuperScript II (Life 
Technologies) using random hexamers. Real-time PCR was performed with 
LightCycler 480 SYBR Green I Master Mix (Roche) on a LightCycler 96 Real-
Time PCR System (Roche). The relative expression level of each gene was 
normalized to those of Gapdh and Actb. The primers used in this study are listed 
in Supplementary Table 6.
Antibodies. Antibodies used in this work were the following: mouse antibody to 
turboGFP (OTI2H8, Origene), rabbit antibody to turboGFP (PA5-22688, Thermo 
Fisher), rabbit antibody to ZSCAN4 (AB4340, EMD Millipore), rabbit antibody to 
MuERVL–Gag (R1501-2, Hangzhou HuaAn Biotechnology), chicken antibody to 
EGFP (ab13970, Abcam), rabbit antibody to H2AK119Ub (8240, Cell Signaling), 
goat antibody to REX1 (sc-50670, Santa Cruz), goat antibody to OCT4 (sc-8628, 
Santa Cruz), mouse antibody to OCT4 (611203, BD Biosciences), goat antibody  
to SOX2 (sc-17320, Santa Cruz), rabbit antibody to PRDM14 (a gift from  
D. Reinberg)62, rabbit antibody to TFAP2C (sc-8977, Santa Cruz).
Time-lapse experiments. Prior to time-lapse analysis, cells were cultured 
overnight on glass-bottom laminin-coated (Sigma-Aldrich) Ibidi micro-Insert 
cell culture dishes to allow the cells to attach. Image acquisition was carried out 
over the entire well with a 20 × 0.75 NA Plan-Apochromat objective lens every 
30 min for 48 h using a Nikon Ti-E system equipped with the Bruker Opterra II 
multipoint confocal system. Images were recorded on an EMCCD camera using 
emission filters for turboGFP (BP520/40), mCherry (570LP) and iRFP (655LP) 
mounted on a FLI filter wheel. Spontaneously arising 2-cell-like cells were 
manually identified using ImageJ software and scored based on whether they 
arose from a Zscan4+ cell as determined by the intensity of the mCherry channel. 
This analysis was run independently by two different people, and results were 
cross-compared for accuracy.
ATAC–seq data analysis. Previously published ATAC–seq data in ES, Zscan4+ 
and 2-cell-like cells were obtained from GEO accession GSE7575138. Paired-end 
reads were trimmed for adaptor sequences using trimmomatic 0.36 and mapped 
to the mm10 reference genome using bowtie2 with parameters --dovetail -X 2000 
--no-discordant --no-mixed. The resulting bam files were then filtered for non-
uniquely mapping reads using SAMtools with a MAPQ threshold of 10 and filtered 
for duplicates using MarkDuplicates in Picard Tools. Finally, mitochondrial reads 
were removed using SAMtools, and signal tracks were generated using macs2.1.163 
with parameters --SPMR --nomodel --nolambda=shift --100 --extsize 200 for 
the combined reads of all replicates of the same population. For the MERVL/
MT2_Mm analysis in Fig. 2g,h, MT2_Mm coordinates were obtained from 
RepeatMasker release 20140131, and plots were generated using deepTools. For 
clarity, only solo LTRs are shown in Fig. 2h, but the same pattern of enrichment 
was also observed for full-length MERVLs. For the differential accessibility analysis 
in Supplementary Fig. 2h, regions of differential accessibility between ES and 
2-cell-like cells were called using the bdgdiff macs2 command, and plots were 
generated using deepTools.
Single-cell RNA-seq data analysis. Single-cell RNA-seq data for ES, Zscan4+ 
and 2-cell-like cells were obtained from ArrayExpress accession E-MTAB-505838. 
Paired-end reads were trimmed for adaptor sequences using trimmomatic 0.36 
and mapped to the mm10 reference genome using STAR 2.5.3a64. The resulting 
bam files were then filtered for unmapped reads and secondary alignments 
using SAMtools. Finally, reads intersecting repetitive elements were quantified 
by intersecting the RepeatMasker annotation with the aligned bam files using 
bedtools intersect with the --split parameter. To classify the individual cells in 
a comparable manner to the classification performed on the single-cell qPCR 
data, the counts of uniquely mapping reads that mapped to the full-length Zscan4 
isoforms Zscan4c, Zscan4d and Zscan4f were summed. Note that the Zscan4 
TaqMan assay used for the single-cell qPCR experiments could not discriminate 
between the Zscan4c, Zscan4d and Zscan4f isoforms, and hence we decided to pool 
the read counts for these isoforms. The following thresholds were used to classify 
individual cells: cells with log2 (MT2_Mm, CPM + 1) > 12.25 were considered 
2-cell-like cells; cells with log2 (Zscan4c, Zscan4d and Zscan4f, CPM + 1) > 24 were 
considered Zscan4high; cells with log2 (Zscan4c, Zscan4d and Zscan4f, CPM + 1) > 12 
were considered Zscan4mid; cells with log2 (Zscan4c, Zscan4d and Zscan4f, 
CPM + 1) > 2 were considered Zscan4low; all remaining cells were considered ES 
cells. The positioning of these thresholds in the context of the population-wide 
distribution of expression levels is shown in Supplementary Fig. 3d. For the heat 
map shown in Fig. 2g, 2,313 upregulated and 951 downregulated genes were selected 
based on the 2-cell-like and ES cell RNA-seq data reported in Ishiuchi et al.27.  
The mean expression level for each gene within each respective group of single-cell 
transcriptomes was taken, and the row-wise z score was calculated. Plotting was 
performed using ggplot2. The differential expression analysis in Supplementary 
Fig. 3f was performed using DESeq265 by considering each individual cell as a 
replicate. Changes were considered statistically significant  
when P (adj.) < 0.05.
ChIP–seq data analysis. ChIP–seq data for H3K4me3 (GSE74112)66, EP400 
(GSE64825)67, H2AK119Ub (GSE89949)68, RING1B (GSE40860)69, RYBP 
(GSE42466)70 and MAX (GSE48175)71 from ES cells grown with serum- and LIF-
containing medium were obtained from GEO. Note that none of these datasets 
were generated in the presence of the 2i inhibitors. Single-end reads were trimmed 
for adaptor sequences and low-quality bases using trimmomatic 0.36 and mapped 
to the mm10 reference genome using bowtie with parameters -S --best --strata -v 
2 -M 1. The resulting bam files were then filtered for non-uniquely mapping reads 
using SAMtools with a MAPQ threshold of 10 and filtered for duplicates using 
MarkDuplicates in Picard Tools. Finally, fragment size was estimated using MaSC, 
and sequencing-depth-normalized signal tracks were generated using macs2.1.1 
with the MaSC-estimated72 fragment size. Biomart was used to obtain 10-kb-wide 
genomic windows centered on all TSSs for the 2,313 upregulated (6,829 TSSs) and 
951 downregulated (4,189 TSSs) genes in 2-cell-like cells relative to ES cells, as 
reported27. Mappability tracks were generated using the GEM suite with a 36-bp 
window. The heat maps shown in Fig. 8a,c were plotted using deepTools73 and 
custom scripts. A TSS was considered to be associated with MT2_Mm if an MT2_
Mm copy was found within 50 kb upstream of it. For the enrichment calculation 
of given chromatin modifiers, peaks were called using macs2.1.1 with a q-value 
cutoff of 10−6 and peaks within 1 kb of each other were merged. Genes with at 
least one of their TSSs occurring within 5 kb of a ChIP–seq peak were considered 
to be bound by the respective factor. Fisher’s exact tests for these overlaps were 
performed using R.
ChIP–seq enrichment at MERVL and MT2_mm. Input and treatment reads  
were mapped individually to the mm10 reference genome using bowtie74 (1.1.1) 
with the following options: -k 201 --best --strata --m 200, allowing for up to 200 
alignments of the highest quality to be reported. macs63 (2.1.1) predictd --g mm 
was used to estimate the fragment size of the uniquely mapping treatment reads. 
Because repetitive regions were the focus of this analysis, CSEM75 (2.4) was used  
to assign multi-mapping reads to their most likely origin. It was run with the  
option --upper-bound 500, and fragment size was estimated as described above.  
For each multi-mapping read, only the most likely alignment was selected.  
If multiple equally likely alignments existed, one was selected at random. macs 
bdgcmp was used to generate fold enrichment tracks from these input and 
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treatment alignments. Mappability tracks were generated by splitting the mm10 
genome into overlapping reads of 36 bp in length, starting at each base, and 
aligning them back to the reference genome using bowtie74 (1.1.1). A base was 
‘mappable’ if it could be aligned to the reference genome uniquely; otherwise, 
it was ‘unmappable’. To avoid mappability issues, for the transposable elements 
MERVL and MT2_Mm, enrichment P values were calculated using a permutation 
test. First, the enrichment profile was calculated as the mean of all rows in the 
enrichment heat map. Then, the maximum value of the enrichment profile emax was 
recorded around windows 1 kb upstream and 1 kb downstream of the transposable 
element. A permuted set of regions was then generated by selecting random 
genomic locations that matched the number, size and chromosome distribution 
of the original elements. As before, the maximum value of the enrichment profile 
in the random set rmax was recorded. The permutation P value was then calculated 
as P = emax/Σi rimax, where i denotes the ith permutation. For every P value, 10,000 
randomizations were performed. For the analysis, MERVLs were classified into 
complete MERVL elements according to the presence of contiguous MT2_Mm 
LTRs within 7 kb with the same 5′-to-3′ orientation interspersed with an internal 
MERVL element as annotated by RepeatMasker (v4.0.3). MT2_Mm LTRs without 
a corresponding MERLV internal part or a nearby (< 7 kb) LTR pair in the same 
orientation were classified as solo LTRs. Occurrences of MERVL internal elements 
without matching MT2_Mm LTRs flanking these elements were classified as 
internal MERVLs. The P values for enrichment for the following factors for the 
MERVL ChIP–seq analyses are as follows: for MAX: 0.0001, 1.0 and 0.9801 for 
complete MERVL, MT2_Mm and MERVL-int, respectively; for RYBP: 0.0537, 
0.9610 and 0.5597 for complete MERVL, MT2_Mm and MERVL-int, respectively; 
and for H2AK119Ub (data not shown): 0.6739, 1.0 and 1.0000 for complete 
MERVL, MT2_Mm and MERVL-int, respectively.
Statistical analyses. Statistical tests were performed keeping in mind data 
distribution and the number of data points available. Details on sample sizes, in 
addition to the statistical tests conducted, are presented in the corresponding figure 
legends. Asterisks indicate P values below the 0.05 threshold.
Primers and TaqMan assays in this study. The list of TaqMan assays is in 
Supplementary Table 1, and the list of primers used is in Supplementary Table 6.
Life Sciences Reporting Summary. Further information on experimental design is 
available in the Life Sciences Reporting Summary.
Data availability. The data supporting this study are available from the authors 
upon reasonable request.
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Supplementary Figure 1 
Controls for the single-cell expression profiling experiments of ES and 2-cell-like cells 
a, List of genes selected for the single-cell analysis classified according to their pathway or function. b, Immunofluorescence analysis 
using a turboGFP and an OCT4 antibody in the 2C::turboGFP cell line before and after sorting out 2-cell-like cells as indicated in Fig. 
1b. Scale bar, 100 m. c, Scatterplots of turboGFP fluorescence versus tdTomato fluorescence for feeder cells only (bottom), WT ES 
cells and feeder cells (middle), and the 2C::turboGFP/CAG-tdTomato reporter line with feeders (top) assayed by FACS. The presence 
of constitutively expressed NLS-tdTomato in the reporter line allows efficient discrimination from feeder cells. d, Normalized Ct values 
for the ERCC-943 spike-in comparing turboGFP– and turboGFP+ cells. Note that the turboGFP– and turboGFP+ cells analyzed in these 
plots come from independent sample preparation experiments but were processed on the same Biomark chip. Because the two groups 
both exhibit constant expression that is highly similar for ERCC-943, we conclude that they were normalized properly and that their 
expression levels are therefore comparable. Boxes indicate 25% and 75% quartiles, and the whiskers extend to 1.5 times the 
interquartile range. e, Graphic interpretation of the features contrasted across the first three principal components of the principal-
component analyses shown in Figs. 1–3. f,g, Different viewpoints of the principal-component analysis of the ES and 2-cell-like single-
cell dataset. This PCA was computed without the expression data from turboGFP and Zscan4. Each point corresponds to a single cell 
and is color-coded based on the original expression level of turboGFP (f) or Zscan4c/d/f (g) as indicated on the right. Black dots 










Supplementary Figure 2 
Zscan4 cells are an intermediate cellular state between the ES and 2-cell-like states 
a, Accuracy of the Zscan4c::tdTomato reporter cell line used for the single-cell profiling described in Fig. 2. The graph shows the 
number of tdTomato+ cells that scored positive as assessed by FACS in relation to whether they belong to ES cells (no Zscan4c/d/f 
transcripts detected), Zscan4+ cells (Zscan4c/d/f transcripts detected) or 2-cell-like cells (Zscan4c/d/f and turboGFP transcripts 
detected). b,c, Principal-component projection of all datasets combined. Principal components were calculated for the aggregate of the 
ES, Zscan4+ and 2-cell-like datasets (Figs. 1 and 2), unlike the analyses in Figs. 2 and 3 where the Zscan4 dataset (from Fig. 2) was 
projected onto the principal components of the ES and 2-cell-like datasets. In b, turboGFP and Zscan4c/d/f were omitted from the 
calculation of the principal components. d,e, Validation of the Zscan4c::tdTomato and 2C::turboGFP cell line used for the time-lapse 
analysis in Fig. 2e. d, Representative immunostaining for mCherry and ZSCAN4 (top) and mCherry and turboGFP (bottom) from three 
independent cell cultures. e, Quantification of the percentage of (endogenous) ZSCAN4+ cells that also express mCherry. The reporter 
recapitulates endogenous expression of ZSCAN4 protein with ~92% accuracy. Error bars, s.d. Scale bar, 10 m. f,g, Zscan4– and 
Zscan4
+ cells were FACS sorted based on the Zscan4::mCherry reporter and cultured for 24 h, after which the percentage of 
turboGFP+ cells was quantified by FACS. Shown are the means ± s.d. of four independent experiments. During the 24-h window, 4% of 
the Zscan4+ cell population became 2C-like cells, 63% remained Zscan4+ cells and 33% lost Zscan4 reporter expression. h, Heat maps 










Supplementary Figure 3 
Gradual transcriptional changes accompany Zscan4 upregulation and precede entry to the 2-cell-like state 
a, The graph combines two parameters: the line (left y axis) depicts probability density and the histogram under it (right y axis) refers to 
absolute frequency of occurrence. The probability density function of Zscan4c/d/f expression in ES (blue), Zscan4+ (orange) and 2-cell-
like (green) cells is plotted against the normalized expression of Zscan4c/d/f (x axis) in each individual cell. These three distinct levels 
were classified as low, mid and high based on the histogram data, which derive from the Biomark analysis. b,c, Projection of the 
expression profiles of Zscan4+ cells onto the principal components of the ES and 2-cell-like cell dataset (Fig. 1d). Each dot represents a 
single cell and is color-coded according to whether it corresponds to an ES cell, a Zscan4low, Zscan4mid or Zscan4high cell, or a 2-cell-like 
cell according to the legend on the right. In c, cells are colored based on their expression levels of Zscan4/c/d/f as indicated on the 
right. Black indicates no expression. d, Density plots for Zscan4c/d/f and MT2_Mm based on single-cell RNA-seq data39. Dotted lines 
represent the thresholds used to classify individual cells into ES cells, Zscan4low, Zscan4mid or Zscan4high cells, and 2-cell-like cells. e, 
Violin plots for the MT2_Mm LTR, Zscan4c/d/f and two MERVL-driven chimeric genes in the single-cell RNA-seq dataset. f, MA plots 
showing significantly differentially expressed genes (red) for each transitional state analyzed from single-cell RNA-seq data. The list of 
differentially expressed genes for each transition is shown in Supplementary Table 9. g, Heat map showing a gradual transition in the 










Supplementary Figure 4 
Pluripotency transcription factors and the 2-cell-like state 
a, Scatterplot showing the fluorescence intensity measurements for OCT4 and ZSCAN4 in individual cells as judged by 
immunostaining. r depicts the Pearson correlation coefficient between OCT4 and ZSCAN4 expression for each group of cells, as 
indicated. b,c, Validation of the Rex1::EGFP and Zscan4::tdTomato cell line by immunofluorescence. A representative single confocal 
section from three independent cell cultures is shown. The Rex1 knock-in construct was validated previously44. d, Density plot showing 
the gating parameters used for sorting the Rex1high and Rex1low cells in Fig. 4a. e,f, Violin and density plots showing the distribution of 
single-cell expression for Rex1 and Nanog. Note that in these plots ES cells were further classified into two groups according to 
whether they express high or low levels of Rex1, which highlights naive versus primed pluripotent states, as confirmed also by the 
abundance of Nanog transcripts in the same cells. g, Percentage of OCT4+, EGFP+ and ZSCAN4+ cells 48 h after transfection with 
siRNA for Oct4 or the scrambled control. Data shown are the means ± s.d. for three independent cell cultures. h, Percentage of EGFP+, 
ZSCAN4+ and 2-cell-like cells after transfection with Oct4, Nanog, Sox2 or Rex1 siRNA as compared to p150 siRNA and to the 
negative controls (NT and Neg). Transfection and analysis were performed as described in the Methods for the RNAi screen. Shown 
are the means ± s.d. from triplicate cell cultures. i, RT–qPCR analysis of MERVL and Zscan4 in the 2C::EGFP reporter cell line after 










Supplementary Figure 5 
Sequential gene expression changes during the transition to the 2-cell-like state 
a, Violin plots showing the distribution of expression levels of individual cells for the indicated genes. Higher values correspond to 
higher expression levels, and a Ct value of 0 indicates that no amplification was detected. The median is indicated by a square.  
b, Schematic of significantly and differentially expressed genes related to germline development between individual stages of the 
transition from the ES to the 2-cell-like state. Changes were considered significant if they exhibited at least 2-fold changes across cells 











Supplementary Figure 6 
Pipeline and controls for analysis of the primary siRNA screen 
  
a, Screening was based on nuclear segmentation, following DAPI staining, for which a representative image is shown. Nuclei were 
segmented based on DAPI intensity, and only nuclei that met the quality control were used for further analysis (blue outlines). Scale 
bars, 100 m (left) and 5 m (right). b, Box-and-whisker plots for the negative (non-transfected cells (NT; n = 45 wells) and negative-
control-siRNA-transfected cells (neg; n = 270 wells)) and positive (p150-siRNA-transfected cells (p150; n = 270 wells)) controls from the 
primary screen. The percentage of EGFP+, ZSCAN4+ and OCT4+ cells was determined for each cell culture well. Two-cell-like cells 
were defined as cells fitting all three criteria, namely: positive for EGFP and ZSCAN4 but negative for OCT4. On the graphs, boxes 
indicate 25% and 75% quartiles, and the whiskers extend to 1.5 times the interquartile range. Outlier wells are not shown. c, Complete 
results from the primary screen depicting the z scores of the 1,167 targets (mean z score of triplicate wells for each target) relative to 
the negative controls. The positive control p150 is depicted in red. d, Analysis of cell toxicity, as inferred by cell number, elicited upon 
treatment with siRNA for the top 50 hits. The heat map displays the top 50 hits ranked by their ability to induce 2-cell-like cells (left) and 
the cell number per well upon siRNA transfection (right). Note that, because all siRNAs were transfected using the same number of 










Supplementary Figure 7 
Validation of the hits obtained in the primary screen by a secondary screen and identification of new hits 
 
a, Box-and-whisker plots representing the results of the secondary screen for the non-transfected cells (NT), scrambled-siRNA-
transfected cells (Neg) and cells transfected with siRNA for p150 (positive control). n indicates the number of cell culture wells 
analyzed. Two-cell-like cells are defined as cells positive for EGFP and ZSCAN4 but negative for OCT4. Boxes indicate 25% and 75% 
quartiles, and the whiskers extend to 1.5 times the interquartile range. Outlier wells are not shown. The mean ± s.d. of two technical 
replicates is shown. b, Comparison of the primary and secondary screen results for three selected hits (Ep400, Dmap1 and Ring1b). 
Fold changes relative to the negative control are indicated. c, Validation of individual siRNAs from the siRNA pool for the top 50 hits. 
The top 50 hits from the primary screen were selected for validation in the secondary screen by transfecting four different individual 
siRNAs, and the effect of each individual siRNA on 2-cell-like cell emergence was assessed. The number of validated hits (z score > 2 
as compared to the negative control) by 4, 3, 2 or 1 siRNA is depicted. Only one hit (Dnmt3b) from the primary screen was not validated 
by any of the four individual siRNAs. d, Representative random, inverted dynamics merged fields of view from the secondary screen for 
the indicated siRNAs as compared to the negative and positive controls. Scale bar, 500 m. e, Percentage of EGFP+, OCT4+ and 
ZSCAN4+ cells and of 2-cell-like cells obtained in the secondary screen for Mga, Max, Rybp and Daxx as compared to the negative (NT 






Supplementary Figure 8 
Gene expression dynamics of the novel regulators of the 2-cell-like state in the preimplantation mouse embryo and 2-celllike 
cells 
a, Heat map showing the changes in mRNA levels for the top 50 candidates in endogenous, p60-knockdown-induced and p150-
knockdown-induced 2-cell-like cells. Log fold changes were calculated based on bulk RNA-seq data27 and are color-coded relative to 
ES cells. Genes are ranked according to differential expression in endogenous 2-cell-like cells. b, Heat map showing unsupervised 
clustering of the relative expression levels of the top 50 candidates during early mouse development (zygote, early, mid and late 2-cell, 
4-cell, 8-cell, 16-cell stages, and early, mid and late blastocyst stages). Protein names are color-coded according to the complex to 
which they belong. Expression data are derived from ref.66. Notably, while most spliceosome proteins were enriched upon development 
to the morula stage, PRC1 subunits peaked in expression at different time points during the 2-cell stage, further suggesting that parallel 







Supplementary Figure 9 
Characterization of 2-cell-like cell protein markers in 2-cell-like cells induced upon siRNA of the hits identified in the 
siRNA screen 
Characterization of 2-cell-like cell markers in 2-cell-like cells induced upon siRNA targeting of the hits identified in the siRNA screens. 
a,b, Immunostaining with an antibody against the protein from MERVL reveals expression of endogenous MERVL loci in cells 
expressing the 2C::EGFP reporter in controls (a) as well as in 2-cell-like cells induced upon siRNA targeting of the indicated chromatin 
modifiers (b). c, Immunostaining for ZSCAN4 and EGFP in the 2C::EGFP reporter ES cell line. Representative images from at least 










Supplementary Figure 10 
Characterization of 2-cell-like cell transcriptional markers in 2-cell-like cells induced upon siRNA of the hits identified in 
the siRNA screen 
a, Expression of 2-cell-like genes upon siRNA targeting of the identified hits. RT–qPCR analysis was performed for repetitive elements 
(top) and chimeric LTR transcripts (bottom) upon transfection with the indicated siRNAs. Shown are the mean values ± s.d. from four 
independent cell cultures performed on two different days. b, FACS analysis of the 2C::turboGFP and Zscan4::mCherry cell line after 
transfection with the indicated siRNAs individually or in pairs. Fold changes in turboGFP+, mCherry+ and double-positive (2-cell-like) 










Supplementary Figure 11 
PRC1.6 subunits negatively regulate the 2-cell-like state 
a, Schematic of PRC1 complexes identified in mammals. PRC1 complexes are divided into cPRC1 (canonical PRC1) (left) and ncPRC1 
(non-canonical PRC1) (right). RING1a and RING1b interact with distinct PCGF proteins. PCGF2 and PCGF4 are present only in 
canonical PRC1 complexes (PRC1.2 and PRC1.4, respectively). PCGF1, PCGF3, PCGF5 and PCGF6 proteins associate with RYBP 
or YAF2 to form the non-canonical PRC1 complexes (PRC1.1, PRC1.3, PRC1.5 and PRC1.6, respectively). b, Two-cell-like cell 
induction after transfection with siRNAs for all PRC1 components. Results for the siRNA pools identified in the primary or secondary 
screen are shown as a z score. c,g, RT–qPCR analysis was performed to measure siRNA efficiency for Yaf2 and Ring1a (c) or Eed 
and Ezh2 (g) after transfection with the corresponding siRNAs as compared to scrambled siRNA in the 2C::EGFP reporter cell line. 
Mean values ± s.d. from four independent cell cultures performed on two different days are shown. d,h, Quantification of EGFP+ cells 
(%) by FACS after transfection with the indicated siRNAs. Shown are the means ± s.d. of the indicated number of cell cultures. e,f,i,j, 
Expression of 2-cell-like genes upon treatment with the indicated siRNAs. RT–qPCR analysis was performed of MERVL (e,i) and 
Zscan4 (f,j) expression in the 2C::EGFP reporter cell line after transfection with the indicated siRNA. The mean values ± s.d. from four 






Supplementary Figure 12 
Two-cell-like cells are characterized by low levels of H2AK119Ub 
  
a, Immunostaining for OCT4, EGFP and H2AK119Ub in the 2C::EGFP reporter ES cell line depicting endogenous (Neg siRNA) as well 
as p60- and p150-knockdown-induced 2-cell-like cells. Representative single-section confocal images of at least three independent cell 
cultures are shown. Dashed white lines demarcate EGFP+ cells. Scale bar, 20 m. b, H2AK119Ub levels in endogenous 2-cell-like cells 
and in 2-cell-like cells induced upon transfection with the indicated siRNAs. EGFP (top), OCT4 (middle) and H2AK119Ub (bottom) 
fluorescence was quantified in ES cells (blue, EGFP negative) and in 2-cell-like cells (red, EGFP positive). Each dot represents a single 
cell. Shown are raw values obtained in one representative experiment of three independent biological replicates performed on different 
days. c, Quantification of EGFP+ cells (fold change as compared to negative control Neg) by FACS after transfection with the indicated 
siRNAs in combination with Rex1 (left) or Nanog (right) siRNA. The mean ± s.d. of the indicated number of cell cultures is shown. d, 
RT–qPCR analysis of MERVL, Zscan4 and Gm6763 in the 2C::EGFP reporter cell line after transfection with the indicated siRNAs 
and/or overexpression of Nanog (OE Nanog). Expression of Pcgf6 (lower left), Dmap1 (lower middle) and Nanog (lower right) is shown 
as controls for siRNA and overexpression efficiency. The mean ± s.d. of the indicated number of cell cultures performed on different 








-RNA-seq data in Fig. 1 
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- Time-lapse experiments in Fig. 2 
- FACS analysis experiments in Fig. 7a, 7c 
and Supplementary Fig. 7.  
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The transient capacity to autonomously form and organize all of the embryonic and extra-
embryonic tissues involved in the development of a complete organism is termed totipotency. 
However, our understanding of the regulatory mechanisms responsible for the establishment and 
termination of such a highly plastic regulatory state is greatly limited. Transposable elements 
constitute some of the earliest sequences to be transcribed in the early mammalian embryo, and 
their activity at this time has been ascribed regulatory roles in both mouse and humans. Using a 
low-input hybrid full-length + 5’ RNA-sequencing approach, we have generated transcriptional 
profiles at seven different developmental timepoints across five different mammalian species. 
Using this data, we have determined the transcriptional dynamics of transposable elements 
during this developmental period. Our results pave the way to understand the contribution of 
transposable elements to mammalian pre-implantation development. 
 
Introduction 
How does a single cell give rise to an entire multicellular organism is one of the most fascinating 
questions in biology. This transient capacity to autonomously form and organize all of the 
embryonic and extra-embryonic tissues involved in the development of a new organism is termed 
totipotency. In mammals, totipotency is a feature restricted to the earliest cells of the pre-
implantation embryo, and its developmental timing differs depending on the species in question. 
Over the course of mouse development, only the zygote and each of its two daughter cells are 
strictly totipotent since only they can produce an entire organism on their own (Tarkowski, 1959). 
For example, if both of the 2-cell stage blastomeres from the mouse embryo are physically 
separated and allowed to continue to develop, genetically identical mouse offspring can be 
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obtained. This capacity is lost by the time the next cell cycle occurs, and no mouse pups have 
been reported to arise from single 4-cell or 8-cell stage blastomeres, owing to the fact that the 
resulting blastocysts tend to lack an Inner Cell Mass (Rossant, 1976; Tarkowski, 1959). In a series 
of classical experiment conducted over the course of the last six decades, the totipotent windows 
for a series of mammalian species have been defined. While both cow and rhesus embryos have 
been reported to retain totipotency until up to the 4-cell stage (Chan, 2000; Johnson et al., 1995), 
single blastomeres of the 8-cell stage in pigs, sheep and rabbit have all been reported to be able 
to give rise to live offspring (Moore et al., 1968; Saito and Niemann, 1991; Willadsen, 1981). 
 
The molecular determinants underlying this singular capacity to initiate development of an entire 
organism have proven elusive, and it remains an open question whether a gene regulatory 
network akin to the one underlying pluripotency exists in totipotent cells, or whether some other 
factor might underlie it. In mouse, totipotency is accompanied by a set of highly-intermingled 
biological processes such as global chromatin remodeling (Burton and Torres-Padilla, 2014; 
Eckersley-Maslin et al., 2018), an unusual set of metabolic characteristics (Kaneko, 2016; 
Nagaraj et al., 2017) and the de-repression of the vast majority of transposable elements (Fadloun 
et al., 2013b; Jachowicz et al., 2017; Peaston et al., 2004; Rodriguez-Terrones and Torres-
Padilla, 2018). In particular, while transposable elements (TE) such as ERV-L have been shown 
to provide promoter sequences for a wide variety of genes activated at the time of Zygotic 
Genome Activation (ZGA) (Peaston et al., 2004), other transposable elements such as L1 have 
been proposed to directly regulate the early developmental process through their RNA or even 
through the act of transcription itself (Jachowicz et al., 2017; Percharde et al., 2018).  
 
In spite of their emerging roles as essential regulators of pre-implantation development, their 
study during early development has been hampered by the low cell numbers present at these 
stages, the lack of RNA-sequencing methods capable of distinguishing read-through 
transcription from transcription initiation roles, and from the computational challenges inherent to 
highly repetitive sequences (Goerner-Potvin and Bourque, 2018). In addition, transcriptional 
dynamics of transposable elements have yet to be characterized beyond mouse (Fadloun et al., 
2013b) and human (Göke et al., 2015), and it remains an open question how can the highly 
divergent repetitive landscapes seen in mammalian genomes mediate such a conserved 
developmental process. In this work, we present a low-input hybrid full-length + 5’ RNA-
sequencing approach capable of simultaneously distinguishing read-through transcription from 
transcription initiation sites and employ it to characterize the transcriptional landscapes of pre-
implantation development across five different mammalian species. While still in progress, our 
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work aims to ultimately assess the contribution of transposable element transcription to early 
development and to identify a common transcriptional program underlying the totipotent state.  
 
Materials and methods 
 
Embryo collection 
Because of the higher cDNA yields obtained compared to the Qiagen TCL lysis buffer (Cat. 
#1031576), the Clontech 10X lysis buffer (Cat. #635013) was used for all embryo collections. A 
1:581,000 dilution of ERCC RNA spike-ins was included at the moment of lysis buffer 
preparation. Lysis buffers were prepared from a single working solution and aliquoted in low-
binding PCR strips (Sarstedt, 72.991.002) carrying 5.8 μL of lysis buffer in each tube. For the 
single-cell RNA-seq method comparisons, pools of 5x mid-2-cell stage C57BL6 mouse embryos 
were collected at ~46 hours post-fertilization from natural matings, washed in PBS and deposited 
in the lysis buffer with the zona pellucida intact. Lysates were then flash frozen in liquid nitrogen 
and no pipetting of the lysate was performed. For the systematic comparison of mouse, pig, cow 
and rabbit pre-implantation transcriptomes, embryos were collected at the timings shown in 
Supplementary Table 1, washed in PBS and a single embryo was deposited in an individual tube 
of a PCR strip as described above. PBS washes consisted of 2x 2-min washes and 1x 5-min 
wash in sterile PBS. 
 
Preparation of Smart-seq+5 samples 
Samples were prepared as per the Smart-seq2 protocol (Picelli et al., 2014) with a few 
modifications (Supplementary Table 2). Following unfreezing of the embryo lysates at room 
temperature, RNA was purified using 15 μL of AMPure RNA magnetic beads (Beckman Coulter, 
A63987), washed once in 100 μL of 80% ethanol and resuspended in 3 μL of Annealing mix 
containing 1 μL dNTP mix (ThermoFisher, R0192), 1 μL oligo-dT30 (Sigma, 5’-
AAGCAGTGGTATCAACGCAGAGTACT30V-3’) at 10 μM and 1 μL nuclease free water with 5% 
RNAse inhibitor (Clontech 2313A). Following a 3 min incubation at 72° C, samples were held at 
4° C or in ice. Afterwards, 7 μL of reverse transcription mix were added containing: 2 μL 
Superscript II RT buffer (ThermoFisher, 18064014), 2 μL 5M Betaine solution (Sigma, B0300-
1VL), 0.5 μL DTT, 0.5 μL Superscript II RT, 0.25 μL RNAse inhibitor (Clontech 2313A), 0.1 μL 
rGrG+G TSO (TIB MolBiol, 5’-AAGCAGTGGTATCAACGCAGAGTACATrGrG+G-3’) at 100 μM, 
0.06 μL 1M MgCl2 (Sigma, M1028) and 1.6 μL of 40% PEG-8000 solution (Sigma, P1458). 
Samples were then incubated for 90 min at 42° C and the enzyme was afterwards inactivated at 
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70° C for 15 min. PCR was performed using the KAPA HiFi ReadyMix (KM2605) for 14 cycles 
and further purified as described in the Smart-seq2 protocol, although using 12.5 μL of AMPure 
beads instead. Finally, tagmentation was carried out with the Nextera XT kit (Illumina, 15032354) 
as described in the Smart-seq2 protocol, with a few modifications. Namely, 2.5 μL of 120 pg/uL 
cDNA were used per reaction (for a total of 300 pg) and mixed with 2.5 μL of Amplicon Tagment 
Mix and 5 μL of Tagment DNA buffer. After incubation for 5 min at 55° C, 2.5 μL of NT buffer 
were pipetted into each sample and another incubation for 5 minutes at room temperature was 
performed. Finally, 5 μL of a custom sequencing adaptor mix (IDT) was added. This mix contained 
two standard i5 and i7 Nextera Unique Double Indexes and an additional tailed i7 index with an 
overhang overlapping the Smart-seq2 adaptors (Index and overhang shown in bold: 5’-
CAAGCAGAAGACGGCATACGAGATNNNNNNNNGTCTCGTGGGCTCGGAGATGTGTATAAGA
GACAGAAGCAGTGGTATCAACGC*A*G-3’), all at 2.5 μM concentration. Afterwards, 7.5 μL of 
NPM mix was added and PCR was carried out for 12 cycles. Libraries were sequenced in a 
Hiseq4000 using 2 x 150 bp reads. All oligo sequences are described in Supplementary Table 
3. 
 
Preparation of mcSCRB-seq and Hybrid protocols 
Samples were prepared as described above, except for alternative reverse transcription mixes. 
In the case of the mcSCRB-seq based protocol (Bagnoli et al., 2018), the reverse transcriptase 
mix consisted of 7 μL containing: 2 μL Maxima H- RT buffer (ThermoFisher, EP0752), 0.5 μL 
Maxima H- RT, 0.25 μL RNAse inhibitor (Clontech 2313A), 0.1 μL rGrGrG TSO (Sigma, 5’-
AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3’), 2.55 μL nuclease free water and 1.6 μL of 
40% PEG-8000 solution (Sigma, P1458). In the case of the Hybrid protocol, the reverse 
transcriptase mix consisted of 7 μL containing: 2 μL Maxima H- RT buffer (ThermoFisher, 
EP0752), 0.5 μL Maxima H- RT, 0.25 μL RNAse inhibitor (Clontech 2313A), 0.1 μL rGrG+G TSO 
(TIB MolBiol, 5’-AAGCAGTGGTATCAACGCAGAGTACATrGrG+G-3’), 2 μL 5M Betaine solution 
(Sigma, B0300-1VL), 0.01 μL 1M MgCl2 (Sigma, M1028), 0.54 μL nuclease free water and 1.6 
μL of 40% PEG-8000 solution (Sigma, P1458). Smart-seq2 adaptor sequences – with the 
possible exception of the LNA base in the TSO – were used in all protocols tested to ensure an 
even comparison. 
 
Preparation of Smart-seq2+PA libraries 
Pools of 5x 2-cell stage mouse embryos were collected in 10 μL Qiagen TCL lysis buffer (Cat. 
#1031576) and flash frozen. Upon thawing, RNA was purified using AMPure RNA magnetic 
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beads (Beckman Coulter, A63987), washed once in 100 μL of 80% ethanol and resuspended in 
10 μL of Polyadenylation mix containing 7 μL water, 0.5 μL E. coli Poly(A) polymerase (NEB, 
#M0276), 1 μL 10 Polymerase reaction buffer, 1 μL ATP and 0.5 μL RNAse inhibitor (Clontech 
2313A). Following a 10 min incubation at 37° C, RNA was purified using magnetic beads once 
again and resuspended in annealing mix as per the standard Smart-seq2 protocol (Picelli et al., 
2014). 
 
Bioinformatic analyses used for protocol comparisons 
Following sample demultiplexing, Nextera adaptors were trimmed using Trimmomatic’s 
palindrome mode and reads shorter than 20 bases were discarded. In order to sort reads into 
internal, 5’ or 3’ fragments, a custom python script was used that operated as following. Using 
the biopython library, the first 25 bases in read #2 (in the case of the Hiseq 4000, since the i7 
adaptor carried the overhang in our setup) were aligned to the 25 bases in common between 
both the 5’ and 3’ adaptors (5’-AAGCAGTGGTATCAACGCAGAGTAC-3’). If less than 20 
identities were found between the adaptor and the beginning of the read, the read was 
considered an internal fragment and sorted to its respective fastq file. If 20 or more bases 
overlapped between the adaptor and the beginning of the read, the first 30 bases of the read 
were taken and aligned to the 30 bases of the 5’ adaptor 
(5’AAGCAGTGGTATCAACGCAGAGTACATGGG-3’) and the first 30 bases of the 3’ adaptor (5’-
AAGCAGTGGTATCAACGCAGAGTACTTTTT-3’). The read was defined as a 5’ or 3’ fragment 
depending on which of these two adaptors provided the best score. Subsequently, reads from 
each fragment type were aligned to the mouse reference genome using Star. For the metagene 
analyses in Fig. 1B, sequencing depth normalized pileup tracks were generated using bedtools 
genomecov and plotting was performed using deeptools. Pileup tracks for the 5’ fragments were 
generated based solely on the coordinates of the 5’ end of read #2. For the visualization of the 
representative examples shown in Fig. 1C, the Gviz R package was employed using the 
aforementioned tracks. All differential expression analyses were performed using the DESeq2 R 
package.  
 
For the 5’ specificity measurements over ERCC RNA spike-ins shown in Figs. 2F and 2G, reads 
were considered at the true +1 base if the 5’ coordinate of the 5’ fragment was exactly the first 
base of the ERCC spike-in. For the 5’ specificity measurements over annotated transcripts 
shown in Figs. 2H and 2I, rRNA mapping reads were removed based on the RepeatMasker 
annotation and the proportion of 5’ fragments aligning within a 500 bp window on either side of 
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annotated TSSs in the GENCODE M18 release was calculated. For the precision and sensitivity 
analysis in Fig. 2J, 5 million reads from each of the three 5’ methods tested were sampled, and 
the 5’ fragments extracted and processed as described (resulting in a variable number of 5’ tags 
per method, depending on the proportions shown in Fig. 2E). Paraclu was employed to identify 
5’ tag peaks using a minimum size parameter of 1. Subsequently, all integer combinations of d 
and s parameters between 0 and 50 were tested, and the paraclu peaks were filtered using these 
cutoffs. The p parameter was not used for filtering. For each of these parameter combinations, 
the precision, sensitivity and F1 statistic was calculated, and ultimately the best parameter 
combination was chosen based on the F1 statistic. Using these method- and replicate- specific 
optimal d and s parameters, paraclu peaks were filtered and used to calculate the precision, 
sensitivity and F1 statistic shown in Fig. 2J. These statistics were calculated as described 
elsewhere from the number of True positives (TP), False positives (FP) and False Negatives (FN), 
which were calculated as follows. The number of TPs were calculated as the number of peaks 
overlapping a 500 bp window centered on the 5’ ends of transcripts in the GENCODE M18 
release (i.e. from here on out ‘promoter regions’). The number of FPs were calculated as the 
number of peaks overlapping a transcript but not any promoter region. The number of FNs was 
calculated as FN = (FN_rate / (1 - FN_rate)) * TP. To calculate the FN rate, we first selected a set 
of high confidence genes. A high confidence gene was considered as such if it exhibited more 
than 100 counts (across both 5’, 3’ and internal fragments) in all of the methods tested. The FN 
rate was calculated as the number of promoter regions belonging to high confidence genes that 
don’t overlap any peak. Finally, for the determination of TSSs from vanilla Smart-seq2 data shown 
in black in Figs 2J and 2K, 5 million sampled reads were used to assemble transcripts using 
Stringtie without a reference GTF. Calculation of the variables defined above was performed in 
the same manner but employing the 5’ ends of the assembled transcripts rather than paraclu 





Smart-seq+5 allows for the identification of TSSs from full-length scRNA-seq data  
We first set out to establish a transcriptional profiling method capable of distinguishing read-
through transcription from transcription initiation sites in low RNA input amounts. While recent 
advances in single-cell RNA-sequencing technologies have permitted the routine interrogation of 
single-cell transcriptomes in a highly sensitive manner, these approaches are typically tailored to 
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either the internal or the terminal ends of a transcript and so far, do not allow for the joint 
interrogation of both of them. 
 
Cap Analysis of Gene Expression (CAGE) is a cap-trapping-based method that enables the 
identification of transcription start sites (TSSs) throughout the genome (Carninci et al., 2006; 
Faulkner et al., 2009). By selecting for the transcript sequence proximal to the RNA cap, it 
identifies TSSs with base-pair resolution and permits the elucidation of promoter architectures. 
However, even in its most advanced versions (Cvetesic et al., 2018), CAGE protocols still require 
nanogram-amounts of RNA. Although the technological development of both CAGE and single-
cell RNA-sequencing (scRNA-seq) approaches has occurred in parallel in recent years, recent 
installments of both methodologies are both based on the template switching activity of the 
reverse transcriptase, and therefore share most of their molecular intermediates. Thus, because 
of the extensive similarities between both sets of protocols, we conjectured that we could achieve 
full-length transcript coverage and TSS identification from a protocol combining different aspects 
of the two approaches. 
 
Because of its high sensitivity, full-length transcript coverage and adequate throughput, we chose 
to adapt the scRNA-seq Smart-seq2 protocol to also provide TSS information (Ziegenhain et al., 
2017). Smart-seq2 generates full-length cDNAs of the target transcripts by incorporating primer 
sequences on the 3’ end through poly-A priming, and on the 5’ end through a template-switching 
reaction (Picelli et al., 2013, 2014). Thus, addition of ‘tailed’ sequencing adaptors harboring an 
overhang overlapping these adaptors should allow for sequencing of the terminal ends in addition 
to the internal fragments generated during the standard tagmentation reaction (Fig. 1A). Indeed, 
this approach is used routinely in scRNA-seq protocols to sequence the 3’ of molecules in 
molecular barcode approaches (Soumillon et al., 2014), and when applied to the Smart-seq2 
protocol it indeed permitted us to capture the 5’ ends of transcripts. In addition, recent reports 
indicate that the addition of molecular crowding agents such as polyethylene glycol (PEG) allows 
for a considerable increase in sensitivity when applied to the SCRB-seq scRNA-seq protocol 
(Bagnoli et al., 2018). When applied to the Smart-seq2 protocol, we indeed observed a dramatic 
increase in the efficiency of the reverse transcription reaction which resulted in 2 PCR cycles less 
being required to obtain equivalent yields of full-length cDNAs (data not shown). Throughout this 
work, we refer to this molecular crowding variant of the Smart-seq2 protocol, and its subsequent 





In order to assess 5’ specificity and identify any changes in sensitivity in the modified Smart-
seq+5 protocol, we generated RNA-seq profiles in pre-implantation mouse embryos using both 
the original and the modified protocols. For this comparison, we employed pools of 2-cell stage 
mouse embryos in order to minimize biological variability in this technical comparison and 
included ERCC RNA spike-ins as a positive control because of their synthetically-defined 5’ 
coordinates. In order to ensure an even comparison, PEG was employed at an equal 
concentration in both protocols. Following preparation and sequencing of these libraries, we 
bioinformatically sorted 5’ fragments from internal fragments based on the presence of the 5’ 
adaptor in the first positions of the i7 read (Fig. 1A) and aligned them to the mouse genome. This 
strategy successfully permitted us to identify the +1 base of both ERCC spike-ins and annotated 
protein coding transcripts, without impacting the distribution of reads corresponding to the 
internal regions of transcripts (Fig. 1B-C). Indeed, while the synthetically-defined ERCC spike-ins 
exhibited a sharp peak at their true +1 base but not at their +2 base (Fig. 1B), protein coding 
transcripts exhibited a broader distribution centered on the annotated start of the transcript, 
reflecting the existence of various promoter architectures (Carninci et al., 2006). 
 
This approach had no impact on the sensitivity of the protocol, as a differential expression 
analysis performed between the internal reads of the samples prepared using the Smart-seq2 
and the Smart-seq+5 variant showed no changes in gene expression (Fig. 1D). Intriguingly, when 
both internal reads and 5’ fragments were included in the analysis (of course, for the Smart-
seq+5 samples only), 33 genes were shown to be enriched in the Smart-seq+5 samples. Upon 
further examination, these genes were revealed to possess significantly shorter exonic gene 
lengths compared to all other detected genes (Fig. 1E), suggesting an increased sensitivity of the 
Smart-seq+5 variant to short transcripts compared to the Smart-seq2 protocol. Because the 
Smart-seq+5 tagmentation approach requires only a single transposition reaction to occur along 
the length of a cDNA molecule for it to be captured, this suggest that this protocol provides a 
better representation of short transcripts compared to the Smart-seq2 tagmentation approach, 
which requires one additional transposition reaction to occur along a cDNA molecule in order for 
it to be captured (Fig. 1F). 
 
Smart-seq+5 provides better sensitivity and specificity for the 5’ end of transcripts 
Having determined that the tagmentation strategy employed in the Smart-seq+5 protocol 
efficiently identified the 5’ ends of transcripts without an impact on sensitivity, we assessed its 
115 
 
specificity for 5’ ends. Since reverse transcription conditions are known to affect the efficiency of 
the template switching reaction and to favor or hinder the appearance of strand invasion artifacts 
by the template switching oligo – which would affect specificity for the 5’ end – we decided to 
compare three contrasting reverse transcription conditions (Fig. 2A). While the Smart-seq2 
scRNA-seq protocol relies on the addition of additives such as betaine, additional magnesium 
and an LNA TSO for optimal yields (Picelli et al., 2013), the mcSCRB-seq protocol (Bagnoli et al., 
2018) relies instead on a highly processive reverse transcriptase and doesn’t require any of those 
additives because of the use of an RNA TSO. We explored whether a higher cDNA yield could 
be obtained by systematically combining different concentrations from all these components. We 
obtained maximum cDNA yields when we employed the Maxima H- RT from the mcSCRB-seq 
protocol in the Smart-seq2 protocol, in the presence of diminished MgCl2 concentrations (data 
not shown and Fig. 2A-B). Finally, we applied these three protocols to pools of 2-cell stage 
mouse embryos as described above. 
 
Overall, the Smart-seq+5 protocol offered the best performance, as it exhibited the highest 
sensitivity (Fig. 2C) and the lowest proportion of rRNA mapping reads (Fig 2D). While the hybrid 
protocol had exhibited the highest cDNA yields (Fig. 2B), it actually exhibited the lowest sensitivity 
and the highest proportion of rRNA mapping reads (Fig. 2C-D), suggesting that the increases in 
cDNA yield obtained from the intermixed reverse transcription reaction conditions resulted from 
strand invasion artifacts of the TSO. Thus, cDNA yield is a poor proxy for the sensitivity of scRNA-
seq protocols and should be avoided when optimizing them. Intriguingly, the 3’ ends of 
transcripts were essentially uncaptured (constituting less than 1% of the reads, Fig. 2E) by the 
hybrid tagmentation approach used across all protocol variants, despite this end of the transcript 
being used in both the SCRB-seq (Soumillon et al., 2014) and Drop-seq protocols (Macosko et 
al., 2015). Given that those protocols specifically and selectively amplify the 3’ ends of transcripts, 
we speculate that when both ends are amplified simultaneously, the AT-richness of the 3’ end 
poly-A tail places these sequences on an amplification disadvantage relative to the 5’ end. 
 
Next, we compared the 5’ end specificity of the different protocols over the length of the ERCC 
RNA spike-ins, because of their synthetically-defined defined 5’ ends. While all three variants 
performed similarly (Fig. 2F), the mcSCRB-seq+5 protocol performed best both when assessed 
across all ERCC mapping reads (Fig. 2F) and when its performance was evaluated in each ERCC 
transcript individually (Fig. 2G). In contrast, when determined across protein coding transcripts 
(Fig. 2H-I and 2K), the Smart-seq+5 protocol came out on top, providing the best sensitivity, 
precision and F1 statistic (Fig. 2J). Thus, because of its overall better performance across 
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endogenous transcripts, we selected the Smart-seq+5 protocol for the subsequent 
characterization of pre-implantation transcriptomes across mammals. Importantly, it’s worth 
noting that because of the alternative lysis conditions, the use of different adaptor sequences 
and the alternative tagmentation approach, these results should not be interpreted as indicative 
of the existence of a superior protocol among the three, but rather of the identification of – 
marginally – better performing reverse transcription conditions for our 5’ tagging approach.  
 
In vitro RNA poly-adenylation permits the detection of non-poly-A transcripts in single-
cell protocols 
In many RNA-sequencing protocols, oligo-dT priming serves an important role in reducing the 
amount of rRNA sequenced and greatly improving their cost effectiveness. By priming the reverse 
transcription reaction at the transcript’s poly-A tail, this approach permits for the selection of 
mRNA molecules while excluding rRNA, tRNAs and numerous other coding and non-coding 
transcripts that lack a poly-A tail (Fig. 3A). However, because of the high levels of pervasive 
transcription seen in pre-implantation embryos and the possible existence of abundant non-
polyadenylated transcripts during these stages, we explored the effectiveness of polyA-
independent priming mechanisms. We reasoned that perhaps the easiest way to extend a polyA-
dependent protocol such as Smart-seq2 into capturing non-poly-adenylated transcripts would 
be to in vitro poly-adenylate all transcripts. Therefore, we decided to introduce an additional step 
after purification of sample RNA where we would poly-adenylate all transcripts using the E. coli 
Poly(A) polymerase (Fig. 3A), before proceeding with the standard Smart-seq2 protocol 
(throughout this text, this polyadenylation protocol is referred to as Smart-seq2+PA).  
 
While both the Smart-seq2 and the poly-adenylation-dependent Smart-seq2+PA variant 
exhibited similar levels of sensitivity, the standard Smart-seq2 detected slightly more genes at 
each sampling level (Fig. 3B), probably due to the higher rRNA capture seen in the poly-
adenylation variant (Fig. 3C). Notably, the Smart-seq2+PA succeeded in capturing non-
polyadenylated transcripts such as histone genes, although at the expense of the less efficient 
capture of other protein-coding transcripts (Fig. 3D). Thus, because of the overall lower – 
although extended – sensitivity in the polyadenylation variant, we decided to proceed with the 







A comparison of pre-implantation development transcriptomes across mammals 
Because of their known totipotent windows, the availability of a reference genome and the 
attainability of pre-implantation embryos, we decided to characterize the mouse, cow, pig, rabbit 
and rhesus macaque pre-implantation transcriptomes. Since the rhesus macaque embryo 
collection and preparation is still ongoing at the time of this submission, in this thesis I will only 
present the four other species. We have generated transcriptional profiles using the Smart-seq+5 
protocol in single embryos for 7 pre-implantation development stages – ranging from oocytes to 
morula – across each of these different mammalian species, amounting to more than 330 
samples at the time of writing. We aim to investigate the conservation of the oocyte and zygotic 
genome activation transcriptomes, as well as the transcriptional dynamics of transposable 
elements during this developmental window. However, because this work is still ongoing, in 
this thesis I will only briefly present an initial assessment of the conservation of 
transposable element expression during early development. 
 
Ancient transposable element families exhibit conserved expression patterns 
Because transposable element landscapes quickly diverge in-between species, assessing the 
degree of conservation of their expression dynamics during pre-implantation development must 
necessarily focus on older families preceding the speciation events. The L2 and L3 clades of 
LINE elements jointly constitute ~4% of the human genome and are amongst the most ancient 
transposable element groups found in mammals, having amplified approximately 200-300 mya 
(Pavlicek and Jurka, 2006), at the time of the radiation between reptiles, birds and mammals. 
Interestingly, despite their extraordinary age, we were able to detect transcription initiating within 
these elements using our 5’ transcript profiling approach, suggesting that the regulatory 
sequences housed within have remained functional throughout this time. Indeed, with the 
possible exception of L2 in rabbit, both L2 and L3 appear to have retained a conserved 
expression pattern across the four species analyzed (Fig. 4A and 4B), exhibiting elevated 
expression levels in-between the oocyte and the species-specific timing of major zygotic genome 
activation. Similarly, the MIR family of SINEs – which is of a comparable age, and when active 
relied on L2 for its transposition – shows a similar expression pattern across these four species, 
being enriched in the oocyte, dropping at the zygote and further dropping off around the morula 
stage (Fig. 4C). L1 elements in mammalian genomes appear to evolve in a series of single non-
branching lineages of successively dominant L1 families, among which the 80-150 million year 
old L1M4 family stands out for being one of the oldest (Lander et al., 2001; Smit et al., 1995), 
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and is present across the four species analyzed. Indeed, similarly to the other families described 
above, L1M4 also exhibited a remarkably consistent expression pattern that increases following 
the major zygotic genome activation event (Fig. 4D). Thus, ancient non-LTR elements appear to 
have retained a consistent expression pattern across the mammalian species assayed.  
 
Stage-specific expression of DNA transposons 
While numerous retrotransposon families have been ascribed stage-specific expression patterns 
and even functional roles in both mouse and human, the transcriptional dynamics of DNA 
transposons during pre-implantation development have remained so far unexplored. As before, 
we explored whether DNA transposons are expressed in pre-implantation embryos by analyzing 
the distribution of 5’ reads generated though our approach. We identified stage-specific 
expression of various DNA transposons families across the four species, including the four 
representative examples shown in Fig. 4E. Further analyses are currently underway to identify 
orthologous DNA transposon families, assess the conservation of their expression and determine 
whether they have been co-opted into alternative promoters. Overall, our 5’ transcriptional 
profiling approach permits us to examine the transcriptional dynamics of transposable elements 
during pre-implantation development, without the confounding influence of read-through 






Figure 1. Identification of Transcription Start Sites from single-cell samples.  
A) Schematic representation of the Smart-seq2 single-cell RNA-seq protocol and its molecular 
intermediates. Upon binding of an oligo-dT 3’ adaptor to the transcript’s poly-A tail, the target 
mRNA is reverse transcribed and incorporation of the 5’ adaptor is performed through template 
switching of the reverse transcriptase. Following PCR amplification of full-length cDNAs, the 
sequencing library is prepared by incubating these cDNAs with adaptor-loaded Tn5 transposase. 
In the classical Smart-seq2 protocol, sequencing adaptors are incorporated by performing PCR 
using primers complementary to the adaptors inserted by the Tn5 transposase, thus omitting the 
terminal ends of the cDNA molecules, where there the transposase cannot bind. In the alternative 
approach presented here (Smart-seq+5), PCR is performed using primers complimentary to both 
the adaptors introduced by the transposase, and to the 3’ and 5’ adaptors used for reverse 
transcription and pre-amplification. It is thus possible to bioinformatically assign reads to the 
terminal or internal regions of transcripts based on the presence or absence of these adaptor 
sequences at the start of the read. B) Comparison of metagene profiles over protein coding 
transcripts or ERCC spike-ins using either the classical Smart-seq2 protocol or the internal or 5’ 
fragments produced with the Smart-seq+5 protocol. C) Representative examples over one 
ERCC spike-in transcript and one endogenous gene. D) Differential expression analysis between 
the classical Smart-seq2 tagmentation protocol and the Smart-seq+5 tagmentation protocol, 
using either internal fragments only, or both 5’ and internal fragments. E) Exonic gene length 
comparison between Smart-seq+5 genes and all detected genes. F) Smart-seq+5 might result 
in additional sensitivity by permitting the capture of short transcripts that are typically cleaved by 


















Figure 2. Comparison between different single-cell RNA-seq protocols for sensitivity and 5’ 
specificity. 
A) Schematic representation of the different conditions employed for the reverse transcription 
reaction in each of the different protocols. B) cDNA yield obtained after pre-amplification in each 
of the different protocols. C) Number of genes detected at various estimated sequencing depths. 
D) Mappability profiles of each protocol, including proportion of rRNA reads. E) Proportion of 
reads in each protocol corresponding to terminal or internal fragments. F and G) Proportion of 5’ 
fragments mapped to true 5’ end of ERCC spike-in RNAs. H and I) Proportion of 5’ fragments 
mapped to promoter regions of annotated transcripts. J) Precision, sensitivity and F1 statistic of 
TSS identification using the three different protocols compared to TSS identification using 
transcript assembly of reads derived using the vanilla Smart-seq2 protocol. K) Comparison of 
true positive versus false positive rates at different sequencing depths. Shown are the three 
protocol variants in addition to TSS identification using transcript assembly of reads derived using 



























Figure 3. Comparison between Smart-seq2 and Smart-seq2+PA 
A) Schematic representation of the effect of the RNA polyadenylation reaction used in the Smart-
seq2+PA variant. B) Number of genes detected at various estimated sequencing depths. C) 
Mappability profiles of each protocol, including proportion of rRNA reads. D) Differential 
expression analysis between the vanilla Smart-seq2 protocol and the Smart-seq2+PA variant. 
Significantly differentially expressed genes are shown in red, and non-polyadenylated histone 





Fig 4. Comparison of transposable element expression dynamics during pre-implantation 
development across four mammalian species. 
Violin plots representing the expression dynamics of individual transposable element families 
annotated by RepeatMasker. Only 5’ fragments were used for this analysis. Multimapping reads 
were also considered if all reported alignments corresponded to different integrations of the same 
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SUV4-20 activity in the preimplantation
mouse embryo controls timely replication
André Eid,1 Diego Rodriguez-Terrones,2 Adam Burton,1,2 and Maria-Elena Torres-Padilla1,2
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Extensive chromatin remodeling after fertilization is thought to take place to allow a newdevelopmental program to
start. This includes dynamic changes in histone methylation and, in particular, the remodeling of constitutive
heterochromatic marks such as histone H4 Lys20 trimethylation (H4K20me3). While the essential function of
H4K20me1 in preimplantation mouse embryos is well established, the role of the additional H4K20 methylation
states through the action of the SUV4-20 methyltransferases has not been addressed. Here we show that Suv4-
20h1/h2 aremostly absent inmouse embryos before implantation, underscoring a rapid decrease of H4K20me3 from
the two-cell stage onward. We addressed the functional significance of this remodeling by introducing Suv4-20h1
and Suv4-20h2 in early embryos. Ectopic expression of Suv4-20h2 leads to sustained levels of H4K20me3, devel-
opmental arrest, and defects in S-phase progression. The developmental phenotype can be partially overcome
through inhibition of the ATR pathway, suggesting that the main function for the remodeling of H4K20me3 after
fertilization is to allow the timely and coordinated progression of replication. This is in contrast to the replication
program in somatic cells, where H4K20me3 has been shown to promote replication origin licensing, and anticipates
a different regulation of replication during this early developmental time window.
[Keywords: mouse embryo; Suv4-20; heterochromatin; replication stress]
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Fertilization of the oocyte by the sperm results in the
formation of a totipotent zygote that has the ability to gen-
erate all extraembryonic and embryonic tissues necessary
for development. The earliest stages of development prior
to implantation are of critical importance for setting
up the first embryonic lineages to generate an embryo
competent for implantation. Therefore, a central question
in biology is the defining role of the organization of the
chromatin and its architecture during the first cell divi-
sions and how they enable changes in cellular plasticity
and fate.
In mice, preimplantation development is characterized
by a distinctive atypical state of chromatin signatures,
with many histone post-translational modifications
(PTMs) reduced or absent after fertilization. In addition,
the paternal and maternal chromatin remain physically
segregated in two separate pronuclei that maintain dis-
tinctive chromatin marks, with the maternal chromatin
containing most constitutive heterochromatin PTMs,
while the paternal chromatin is enriched with PTMs
of facultative heterochromatin, thought to substitute
for the absence of constitutive heterochromatin therein
(for review, see Burton and Torres-Padilla 2014). The
histone H4 Lys20 dimethylation and trimethylation
(H4K20me2/3) are hallmarks of constitutive heterochro-
matin in somatic cells. H4K20me3 localizes primarily at
centromeres, pericentromeres, and telomeres that are en-
riched in repetitive sequences and are gene-poor (Schotta
et al. 2008).This is in contrast toH4K20monomethylation
(H4K20me1), which is one of the most abundant modifi-
cations on H4 and localizes to a wide variety of genomic
regions in a cell cycle-dependent manner across somatic
cells and in the early embryo (Barski et al. 2007; Jorgensen
et al. 2007; Houston et al. 2008; Oda et al. 2010). While, in
yeast, one single enzyme catalyzes the threeH4K20meth-
ylation states, in mammals, H4K20me1 is catalyzed by
PR-Set7, and H4K20me2 and H4K20me3 are both cata-
lyzed by the histone methyltransferases SUV4-20H1 and
SUV4-20H2 (Kmt5b and Kmt5c, respectively) (Nishioka
et al. 2002; Rice et al. 2002; Schotta et al. 2004, 2008). In
the zygote, immediately after fertilization, H4K20me3 is
detected exclusively on the maternal pronucleus, where
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it appears distributed mostly around ring-like structures
formed by the nucleoli precursors (nucleolar-like bodies
[NLBs]), which harbor the pericentromeric and centromer-
ic regions (Probst et al. 2007; Wongtawan et al. 2011). Im-
portantly, H4K20me3 is undetectable from the two-cell
stage onward and remains so until the peri-implantation
period (Wongtawan et al. 2011).
This transient loss ofH4K20me3 is perplexing and raises
two important questions. The only other cell types dis-
playing the absence of H4K20me3 seem to be cancer cells
with increased pluripotent capacity and proliferation ac-
tivity, resulting in poor prognosis for patients (Fraga et al.
2005; Van Den Broeck et al. 2008; Schneider et al. 2011;
Yokoyama et al. 2014). It is thus essential to understand
how fluctuations inH4K20me3 levels impact cell prolifer-
ation and cellular potency. In addition, the lack of conven-
tional constitutive heterochromatin in zygotes and two-
cell stage embryos has been linked to their characteristic
nuclear organization and high chromatin dynamics, be-
lieved to support a higher developmental plasticity. How-
ever, whether changes in this atypical heterochromatin
configuration play a functional role in developmental plas-
ticity beyond a mere correlation has not been addressed.
Because the absence of H4K20me3 correlates with the
highest developmental potency, we hypothesize that
lack of H4K20me3 is required for zygotic reprogramming
to take place. We thus set out to address whether enforc-
ing the maintenance of H4K20me3 during preimplanta-
tion restricts developmental capacity and investigate
how H4K20me3 relates to cellular proliferation in vivo.
For this, we first determined that Suv4-20h1 and Suv4-
20h2 are onlyweakly expressed after fertilization. Accord-
ingly, in order to achieve sustained maintenance of
H4K20me3 throughout preimplantation development,
we ectopically expressed Suv4-20h1 and Suv4-20h2. Our
results show that ectopic expression of Suv4-20h2 is suffi-
cient to enable global levels of H4K20me3. Suv4-20h2 dis-
played a markedly higher ability to restore H4K20me3
than Suv4-20h1, independently of changes in H3K9me3.
Embryos expressing Suv4-20h2—but not Suv4-20h1—do
not efficiently develop beyond the two-cell stage, indicat-
ing that the remodeling of H4K20me3 is required for
developmental progression. Suv4-20h2 expression led to
a proliferation defect accompanied by replication abnor-
malities. Importantly, the developmental phenotype was
partially rescued by inhibition of the ATR pathway, sug-
gesting that H4K20me3 induces replication stress and S-
phase arrest. Our results shed light on the functional
role of the absence of H4K20me3 during preimplantation
development and suggest that, in contrast to somatic
cells, H4K20me3 is incompatible with the timely progres-
sion of DNA replication of embryonic chromatin.
Results
Expression of H4K20 modifiers during preimplantation
development
SUV4-20H1 and SUV4-20H2 are the two mammalian
homologs of Drosophila Set8. In mammals, SUV4-20H2
has a slight preference for H4K20me3, but the combined
knockout of Suv4-20h1/h2 completely abolishes
H4K20me3 (Schotta et al. 2004, 2008), indicating that
they are the major H4K20me3 methyltransferases in
mammalian cells. We thus analyzed the expression of
both genes by RT-qPCR in all stages of preimplantation
development. The pattern of expression of both Suv4-
20h1 and Suv4-20h2 resembles that of maternally inherit-
ed transcripts, with higher levels in the zygote and a re-
duction at or after the two-cell stage (Supplemental Fig.
S1). However, both enzymes are expressed at very low lev-
els compared with the control housekeeping gene
(Actinb), with Suv4-20h1 exhibiting lower levels of ex-
pression than Suv4-20h2 (Supplemental Fig. S1). A third
enzyme, Smyd5, was reported to methylate H4K20 in vi-
tro (Stender et al. 2012), although the contribution of
SMYD5 to global H4K20me3 levels in vivo is unclear.
We found that, in contrast to the two Suv4-20 enzymes,
the expression of Smyd5 is strongly induced from the
two-cell stage onward and is expressed continuously
thereafter (Supplemental Fig. S1). Given the strong expres-
sion of SMYD5 during these developmental time periods,
when H4K20me3 is undetectable on embryonic chroma-
tin (Wongtawan et al. 2011), it is unlikely that SMYD5
contributes to the global remodeling of H4K20me3 after
fertilization. Note that there are no specific antibodies
available for SUV4-20H1, SUV4-20H2, or SMYD5 (our un-
published observations), and therefore our analysis for
these three enzymes focuses on mRNA exclusively. To
date, only one demethylase has been shown to be able to
act on H4K20me3 in vitro: PHF2, which can also deme-
thylate H3K9me1 (Wen et al. 2010; Stender et al. 2012).
RT-qPCR showed that the mRNA for Phf2 is abundant
in the zygote, in comparison with later stages, as Phf2
is practically absent from the eight-cell stage onward (Sup-
plemental Fig. S1), suggesting that Phf2mRNA is inherit-
ed maternally but degraded after fertilization.
Immunostaining revealed that PHF2 is present through-
out all stages of preimplantation development concomi-
tantly with the absence of H4K20me3 (data not shown).
While PHF2 may contribute toward keeping H4K20me3
practically absent from the embryonic chromatin, the re-
sults above suggest that lowH4K20me3 levels throughout
the cleavage stages is in part due to low expression of
SUV4-20 methyltransferases.
Expression of Suv4-20h2 results in accumulation
of H4K20me3
Given the above results, in order to maintain sustained
H4K20me3 during preimplantation development, we
chose to ectopically express Suv4-20h2 in zygotes, in par-
ticular because manipulating PHF2 levels may also
directly affect H3K9me1. Zygotes were microinjected
with mRNA for HA-tagged Suv4-20h2 in combination
withmRNA forGFP as an injection control (Fig. 1A). Con-
trol groups included embryos injected with mRNA for
GFP alone as well as noninjected embryos. Embryos
were cultured until the late zygote stage and analyzed
by immunofluorescence using an HA-antibody, which
Eid et al.
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Figure 1. Maintenance of H4K20me3 through Suv4-20h2 ectopic expression blocks embryonic development prior to the two-cell stage.
(A) A schematic representation of the experimental design is shown at the top. Zygotes between 17 and 19 h post-human chorionic go-
nadotropin (phCG) were microinjected with mRNA Suv4-20h2WT or Suv4-20h2mut in addition to GFP, cultured in KSOM (K-modified
simplex optimizedmedium), and then fixed in 4% formaldehyde (as indicated in theMaterial andMethods) at 27 h phCG. Representative
images showing single Z-projections of confocal sections of noninjected, Suv4-20h2WT-injected, and Suv4-20h2mut-injected zygotes
stained with DAPI, HA, and H4K20me3 antibodies. An inset of the maternal pronucleus is shown in the right panels.N numbers are in-
dicated at the right. (M)Maternal, (P) paternal. Bars: inset, 5 µm; all others, 10 µm. (B) Microinjections were performed as inA, except that
embryoswere fixed at 46 h phCG. Representative images showing singleZ-projections of confocal sections of noninjected, Suv4-20h2WT-
injected, and Suv4-20h2mut-injected two-cell stage embryos stained with DAPI, HA, and H4K20me3 antibodies. An inset of one of the
two nuclei is shown in the right panels. N numbers are indicated at the right. Bars: inset, 5 µm; all others, 10 µm. (C ) Zygotes were mi-
croinjected as in A and cultured until the blastocyst stage. The number of embryos reaching the morula stage (developed) was quantified
for noninjected, GFP alone-injected, Suv4-20h2mut-injected, and Suv4-20h2WT-injected embryos. Total numbers of embryos are indi-
cated next to the plot. Statistical testing was performed using the N−1 two-proportion test for comparing independent proportions.
(∗∗∗) P < 0.0001. (D) Pie chart showing the distribution of arrested Suv4-20h2WT-injected embryos by stage. (E,F ) Zygotes were microin-
jected as inA and analyzedwith anH3K9me3 (E) orH3K64me3 (F ) antibody at the two-cell stage. Representative images showing singleZ-
projections of confocal sections of noninjected, Suv4-20h2WT-injected, andGFP-injected or Suv4-20h2mut-injected embryos. An inset of
one of the two nuclei is shown in the right panels. N numbers are indicated. Bars: inset, 5 µm; all others, 10 µm. (PB) Polar body.
H4K20me3 and timely embryonic replication
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revealed that SUV4-20H2 was efficiently translated and
localized to both maternal and paternal pronuclei (Fig.
1A). In nonmanipulated embryos, H4K20me3 is detected
only around the NLBs and in the nuclear periphery at 4′-
6-diamidino-2-phenylindole (DAPI)-rich regions in the
maternal pronucleus and is undetectable in the paternal
chromatin (Fig. 1A, noninjected) (Kourmouli et al. 2004;
Wongtawan et al. 2011). Expression of Suv4-20h2 resulted
in a clear increase in H4K20me3 levels in the maternal
pronucleus but not in the paternal pronucleus (Fig. 1A).
This observation was surprising considering that SUV4-
20H2 was distributed equally between both pronuclei
and suggests that SUV4-20H2 is unable to modify the lev-
els of H4K20me3 on the paternal chromatin in zygotes,
perhaps due to the absence of H3K9me3 (Lange et al.
2013). At the two-cell stage, SUV4-20H2 as well as
H4K20me3were readilydetected in thenucleiofbothblas-
tomeresat levelscomparablewith those inzygotes (Fig. 1B;
Supplemental Fig. S1D). This was in contrast to nonin-
jected embryos, where there were no detectable levels of
H4K20me3, in agreement with earlier findings (Fig. 1B).
The distribution of H4K20me3 throughout two-cell stage
nucleus, as opposed to only half of the nucleus, indicates
that SUV4-20H2 can methylate both paternal and mater-
nal chromosomes at this stage, suggesting that methyla-
tion on the paternal chromatin is delayed in comparison
with the maternal one, which takes place in the zygote.
To test for the specific effects of the methyltransferase
activity of SUV4-20H2, we generated a mutant in the
SET domain. The SET domain is shared across several oth-
er histone methyltransferases, including SUV3-9H1, in
which amutation in the amino acid sequence (NHDC) ab-
rogates its catalytic activity (Rea et al. 2000; Lachner et al.
2001). We therefore generated a SUV4-20H2 construct in
which the corresponding NHDC motif was replaced by
AAAG. The resulting mutant protein is referred to here
as SUV4-20H2MUT, while the wild type is referred to
here as SUV4-20H2WT. We microinjected early zygotes
as above with mRNA for Suv4-20h2mut and GFP and an-
alyzed embryos at the late zygote stage. The AAAGmuta-
tion did not affect the localization of SUV4-20H2MUT
(which remained evenly distributed in both pronuclei)
but efficiently abolished the methyltransferase activity
of SUV4-20H2, since expression of SUV4-20H2MUT did
not lead to an increase in H4K20me3 levels in either the
maternal or paternal pronucleus (Fig. 1A). Likewise, levels
of H4K20me3 remained low in two-cell stage embryos ex-
pressing SUV4-20H2MUT, similar to control embryos
(Fig. 1B).
Our results show that SUV4-20H2WT efficiently in-
creases H4K20me3 levels in vivo, allowing us to sustain
H4K20me3 levels during preimplantation development.
H4K20me3 is incompatible with preimplantation
development
We next addressed whether embryos displaying sustained
H4K20me3 can develop normally. Embryosweremicroin-
jected with mRNA for Suv4-20h2WT as above and
cultured for 3 d until the blastocyst stage. As controls,
we used noninjected embryos, embryos microinjected
with GFP mRNA alone, and embryos expressing Suv4-
20h2MUT in combination with GFP. Control embryos
showed robust development, with 95.5%, 83.3%, and
82.5% developing to the morula stage for the noninjected
embryos (n = 68) or embryos expressing GFP (n = 96) and
SUV4-20H2mut (n = 40), respectively (Fig. 1C). These per-
centages reflect typical developmental rates obtained
in these assays (Santenard et al. 2010; Jachowicz et al.
2013). In contrast, embryos expressing SUV4-20H2WT
displayed a strikingly lower developmental rate (38%;
n = 71) (Fig. 1C). Since the SUV4-20H2MUTdid not exhib-
it a developmental delay, this indicates that the develop-
mental phenotype of the SUV4-20H2WT embryos is due
to its histone methyltransferase activity. Thus, we con-
clude that the embryonic arrest observed for SUV4-
20H2WT embryos is most likely due to the presence
of H4K20me3, suggesting that the removal of this
heterochromatic mark is a requisite for preimplantation
development.
Next, we asked whether the developmental phenotype
upon expression of SUV4-20H2WT at the zygote stage
is specific to that stage exclusively. For this, we asked
whether expression of SUV4-20H2WT at a different stage
results in a similar cellular arrest. We introduced mRNA
for Suv4-20h2WT in combination with GFP—or with
mRNA for GFP alone as a negative control—in a single
two-cell stage blastomere (Supplemental Fig. S2A). Expres-
sion of SUV4-20H2WT led to an increase in H4K20me3
levels in the injected cell in two-cell embryos (Supplemen-
tal Fig. S2B), which developed until the blastocyst stage.
However, a detailed analysis of thenumberof cells in these
embryos revealed a more limited cell progeny in SUV4-
20H2WT-expressing blastomeres compared with the neg-
ative control (GFP-only) (Supplemental Fig. S2C), indicat-
ing that expression of SUV4-20H2WT in two-cell embryos
leads to a cellular proliferation defect. Immunostaining of
these embryos showed that cell arrest was often accompa-
nied by nuclear fragmentation (Supplemental Fig. S2D). In
conclusion, SUV4-20H2-mediated H4K20me3 leads to
cell proliferation arrest in preimplantation embryos inde-
pendently of the developmental stage.
Sustained H4K20me3 results in developmental failure
prior to the two-cell stage
To understand the mechanism behind the developmental
arrest in Suv4-20h2WT-expressing embryos, we dissected
the developmental stages at which embryos arrest. Most
embryos arrested at the zygote and two-cell stages (45%
and 32%, respectively). The distribution of arrested em-
bryos across preimplantation development suggests that
H4K20me3 affects the earlier stages of development dur-
ing which epigenetic reprogramming takes place. Thus,
we first addressed whether maintenance of H4K20me3
perturbs other heterochromatic marks in zygotes and
two-cell stage embryos. Analysis of H3K9me3 revealed
no global differences between noninjected, GFP-express-
ing, or Suv4-20h2WT-expressing embryos (Fig. 1E; Supple-
mental Fig. S3A), in line with the suggested model for
Eid et al.
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heterochromatin establishment in which SUV39H1/
H2 acts upstream of SUV4-20H1/H2 (Schotta et al.
2004). Thus, increased H4K20me3 occurred without glob-
al changes in H3K9me3, allowing us to distinguish
between phenotypic effects of the typical “H3K9me3-di-
rected” heterochromatin and those effects specific to
changes in H4K20me3.
The distribution of H3K64me3, another PTM of con-
stitutive heterochromatin, strongly resembles that of
H4K20me3 (Daujat et al. 2009). H3K64me3 is present
in the maternal pronucleus but is undetectable from
the two-cell stage onward. In agreement with this,
H3K64me3 was undetectable in noninjected embryos at
the two-cell stage (Fig. 1F). In contrast, SUV4-20H2WT
embryos showed a marked increase in H3K64me3 in
two-cell stage nuclei, in contrast to SUV4-20H2MUT em-
bryos, where H3K64me3 was not detected (Fig. 1F; Sup-
plemental Fig. S3B). This observation is surprising
considering that double Suv4-20h1/Suv4-20h2 knockout
mouse embryonic fibroblasts (MEFs) retain H3K64me3,
which had led to the suggestion that H3K64me3 occurs
independently of SUV4-20 activity (Lange et al. 2013).
Thus, the interplay between H4K20me3 and H3K64me3
in the embryo may obey different regulatory mechanisms
than in somatic cells, or, alternatively, de novo acquisi-
tion of H4K20me3 may affect H3K64me3.
The developmental failure elicited by H4K20me3
is mediated by SUV4-20H2
Suv4-20h1 is the secondmammalian homolog of Set8 and
is expressed only weakly in the early embryo (Supplemen-
tal Fig. S1). To address whether the embryonic arrest ob-
served following H4K20me3 maintenance is specific to
the histone methyltransferase activity of SUV4-20H2,
we undertook the same experimental approach as above
with SUV4-20H1. When ectopically expressed, SUV4-
20H1 displayed a nuclear localization similar to that of
SUV4-20H2 at the zygote stage. However, SUV4-20H1
did not detectably increase levels of H4K20me3 at the zy-
gote stage (Fig. 2A), and H4K20me3 levels increased only
weakly at the two-cell stage (Fig. 2B), indicating that, in
vivo, in the embryo, the catalytic activity toward
H4K20me3 is higher for SUV4-20H2 than for SUV4-
20H1. This is in agreement with previous suggestions
from crystallography work (Southall et al. 2014). The
low histone methyltransferase activity of SUV4-20H1
was lost upon mutating the NHDC sequence of its SET
domain into AAAG, similar to SUV4-20H2 (Fig. 2B,
SUV4-20H1MUT). Next, we monitored development of
embryos expressing SUV4-20H1, similar to that of
SUV4-20H2 (Fig. 2C). We microinjected early zygotes
with either Suv4-20h1WT or Suv4-20h1MUT mRNA in
combination with mRNA for GFP or with mRNA for
GFP alone. Similarly, embryos expressing Suv4-20h1WT
did not show a significant change in developmental pro-
gression (n = 78) (Fig. 2C). Indeed, their development rate
to the blastocyst stage (66%) was not significantly differ-
ent from that of embryos expressing GFP alone (77%; P
= 0.16). These observations indicate that the increase in
H4K20me3 from the zygote to the two-cell stage is a pri-
mary cause of the embryonic arrest and is mediatedmain-
ly by SUV4-20H2 histone methyltransferase activity.
The effect of SUV4-20H2 on gene expression during
embryonic genome activation (EGA)
Deposition of H4K20me3 through SUV4-20H2 can cause
RNA polymerase II (Pol II) pausing. H4K20me3 has also
been shown to repress gene expression in transformed
cell lines by reducing H4K16 acetylation (H4K16ac) levels
(Kapoor-Vazirani et al. 2011). In mice, the first wave of
EGA takes place in the zygote, and the second wave,
with a higher transcriptional activity, takes place at the
two-cell stage (Flach et al. 1982; Bensaude et al. 1983;
Aoki et al. 1997). Given that most SUV4-20H2 embryos
arrested at the zygote and two-cell stages, we thus inves-
tigated whether the increase in H4K20me3 resulted in
suppression of EGA in these embryos, which could poten-
tially explain the developmental arrest. To evaluate global
levels of gene expression, we pulsed embryos with EU (5-
ethynyl uridine) at the late two-cell stage at a time point
corresponding to the late phase of transcription during
EGA (Fig. 3A). Noninjected and SUV4-20H2MUT embry-
os showed a similar distribution of EU pattern, indicating
that SUV4-20H2MUT does not compromise EGA, with
85% (n = 13) and 94% (n = 18) of embryos displaying active
transcription, respectively (Fig. 3A,B). A significant pro-
portion of two-cell stage embryos expressing SUV4-
20H2WT (61%, n = 18) also displayed active transcription
(Fig. 3B). Nevertheless, it seems that most embryos dis-
played lower transcriptional activity, since only 22% of
SUV4-20H2 embryos showed high levels of EU incorpora-
tion, in comparison with >50% for the noninjected and
SUV4-20H2MUT groups (Fig. 3B). This suggests that sus-
tainedH4K20me3 does not prevent EGAbut has some im-
pact on global levels of transcription at the two-cell stage,
which could partly explain the developmental block.
Thus, to address whether SUV4-20WT embryos display
specific changes in gene expression as opposed to a global
or delayed effect on EGA, we profiled gene expression in
individual embryos using a microfluidics Biomark ap-
proach, a robust and quantitative approach amenable to
gene expression analysis from low amounts of material
(Guo et al. 2010). We examined the expression of 45 genes
in individual embryos across the four experimental
groups: noninjected, SUV-420H1WT, SUV4-20H2WT,
and SUV4-20H2MUT (Supplemental Fig. S5). The 45
genes analyzed were selected on the basis of (1) their
known transcriptional activation at EGA, (2) their role
in developmental progression and signaling during early
development, and (3) their role in blastocyst formation
(Supplemental Table S1). Principal component analysis
(PCA) and unsupervised clustering analysis of these data
revealed that expression of SUV4-20H2 did not induce sig-
nificant changes in expression of the genes assessed, com-
pared with the three control groups (Fig. 3C;
Supplemental Fig. S5; Supplemental Table S2). Because
most SUV4-20H2WT embryos displayed transcriptional
activity, albeit at reduced rates, and the Biomark results
H4K20me3 and timely embryonic replication
GENES & DEVELOPMENT 5
 Cold Spring Harbor Laboratory Press on November 8, 2018 - Published by genesdev.cshlp.orgDownloaded from 
133
indicate that changes in specific gene expression were not
significant, our observations altogether could also suggest
a delay in the onset of transcriptional activation. Because
the timing of transcriptional activation in embryos is
closely related to that of replication, it therefore remains
possible that the reduced transcriptional activity in
SUV4-20H2WT embryos reflects a delay and/or a defect
in S-phase progression.
H4K20me3 perturbs developmental progression through
replication in zygotes and two-cell stage embryos
Previous reports have indicated that H4K20 methylation
levels may play a role in the control of replication timing
and origin licensing (Tardat et al. 2007, 2010; Oda et al.
2010; Vermeulen et al. 2010). Thus, we investigated
whether the developmental arrest observed upon expres-
sion of SUV4-20H2WT could be due to a misregulation
of S phase. For this, we subjected embryos to an EdU
(5-ethynyl-2′-deoxyuridine) pulse at the mid two-cell
stage, the time at which most embryos are known to be
in late S phase (Bolton et al. 1984). Because it is known
that replication does not proceed synchronously across
embryos, we further scored replication patterns as “late”
or “early” according to whether they reflect a late S phase
(with low levels of EdU detected at the NLBs or the nucle-
ar periphery) or an early–mid-S phase (where replication
foci are visible and evenly distributed in the nucleus), re-
spectively (Fig. 3D). As expected, most control embryos
displayed a late replication pattern at this time point (21
out of 25) (Fig. 3D,E). Similarly, albeit with some delay
presumably due to the microinjection procedure, most
SUV4-20H2MUT embryos also displayed a late replica-
tion pattern (12 out of 20) (Fig. 3D,E). SUV4-20H2WT em-
bryos instead mostly showed an early replication pattern,
with 85% of embryos displaying high levels of EdU incor-
poration (n = 13) (Fig. 3D,E). This observation points to-
ward a misregulation of S-phase progression in SUV4-
20H2WT embryos and prompted us to further investigate
the timing of S-phase initiation and completion.
Figure 2. Ectopic expression of Suv4-20h1 does not arrest embryonic development or increaseH4K20me3 levels in zygotes. (A) Schemat-
ic representation of the experimental design. Zygotes weremicroinjected withmRNA for Suv4-20h1WT or Suv4-20h1mut, cultured, and
fixed for immunostaining using HA or H4K20me3 antibodies at 27 h phCG. Representative images show single Z-projections of confocal
sections of noninjected, Suv4-20h1WT-injected, andGFP-injected zygotes. An inset of thematernal pronucleus is shown in the right pan-
els.N numbers are indicated. (M) Maternal; (P) paternal. Bars: inset, 5 µm; all others, 10 µm. (B) Zygotes were microinjected with mRNA
for Suv4-20h1WT or Suv4-20h1mut as inA, cultured, and analyzed at the two-cell stage. Representative images show singleZ-projections
of confocal sections of noninjected, Suv4-20h1WT-injected, and Suv4-20h1mut-injected embryos stainedwithDAPI, HA, andH4K20me3
antibodies. An inset of one of the two nuclei is shown in the right panels.N numbers are indicated. Bars: inset, 5 µm; all others, 10 µm. (C )
Zygotes were microinjected with mRNA for Suv4-20h1WT or Suv4-20h1mut in combination withGFP and cultured until the blastocyst
stage. The percentage of embryos that reached the blastocyst stage (developed) is plotted for noninjected, GFP-injected, Suv4-20h1mut-
injected, and Suv4-20h1WT-injected embryos. The total number of embryos analyzed is indicated. Statistical testingwas performed using
the N−1 two-proportion test for comparing independent proportions. (n.s.) Not significant.
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Weperformed EdU labeling at four different time points
that correspond to the onset and completion of S phase in
zygotes and two-cell stage embryos (early and late, respec-
tively). Because of the limited number of embryos avail-
able per experiment, in these experiments, we used only
noninjected embryos as negative controls. At the onset
of replication in zygotes, all control embryos had un-
dertaken replication and showed stable levels of EdU in-
corporation (Fig. 3F), with 80% of embryos having
finished replication by 29 h post-human chorionic gonad-
otropin (phCG) injection (Fig. 3G). In contrast, while most
SUV4-20H2WT embryos undertook replication in a time-
ly fashion (90%; n = 20), the majority of them (68%)
showed significantly higher levels of EdU incorporation
than noninjected embryos in both pronuclei (Fig. 3F),
and all embryos maintained robust levels of EdU incorpo-
ration at 29 h phCG (Fig. 3G). EdU levels in embryos ex-
pressing GFP alone at the late zygote stage were not
affected, compared with noninjected embryos (Supple-
mental Fig. S3C). These experiments suggest that while
SUV4-20H2WT embryos enter S phase at a time similar
to that of the controls, S-phase progression is delayed.
Figure 3. H4K20me3 affects replication progression. (A) Zygotes were microinjected with mRNA Suv4-20h2WT or Suv4-20h2mut, cul-
tured until the two-cell stage, and pulsed with EU for 1 h at 48 h phCG. Representative images show single Z-projections of confocal sec-
tions of noninjected, Suv4-20h2WT-injected, and Suv4-20h2mut-injected embryos stained with DAPI and EU visualized by Click-iT
reaction. An inset of one of the two nuclei is shown at the right. N numbers are indicated. Bars: inset, 5 µm; all others, 10 µm. (B). Dis-
tribution of EU patterns in late two-cell stage embryos. Embryoswere divided into three groups based on their EU pattern: (1) no transcrip-
tion (no EUdetected), (2) low levels of transcription (as exemplified inA, Suv4-20h2WT), and (3) high levels of transcription (as shown inA,
noninjected and Suv4-20h2mut). (C, right) Principal component (PC) projection of individual two-cell stage embryos based on the expres-
sion profiles of 45 genes detailed in Supplemental Table 1. Embryos are colored according to the experimental group. The first component
(PC1) is shown on theX-axis, and the second component (PC2) is shown on the Y-axis. (Left) Principal component projection of gene load-
ings showing the weight of each gene in the analysis. (D) Zygotes microinjected with mRNA Suv4-20h2WT or Suv4-20h2mut were cul-
tured until the two-cell stage, pulsedwith 5-ethynyl-2′-deoxyuridine (EdU) for 1 h at 38 h phCG, fixed, and analyzed for EdU incorporation.
Representative images showing single Z-projections of confocal sections of noninjected, Suv4-20h2WT-injected, and Suv4-20h2mut-in-
jected embryos. An inset of one of the two nuclei is shown at the right. White asterisks indicate EdU labeling in noninjected and Suv4-
20h2mut-injected embryos.N numbers are indicated. Bars: inset, 5 µm; all others, 10 µm. (E) Distribution of the replication patterns based
on EdU labeling at 38–39 h phCG as shown in D. (F,G) Normalized EdU levels measured in each pronucleus of noninjected and Suv4-
20h2WT-injected zygotes at 24–25 h phCG (F ) and 28–29 h phCG (G). (H,I ) Normalized EdU levels measured in each nucleus of nonin-
jected and Suv4-20h2WT-injected two-cell stage embryos at 34–35 h phCG (H) and 38–39 h phCG (I ).
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Likewise, at the two-cell stage, control and SUV4-
20H2WT embryos displayed similar levels of replication
foci at the start of S phase (35 h phCG) (Fig. 3H). However,
SUV4-20H2WT embryos showed persisting high levels of
EdU incorporation at 39 h phCG, while noninjected em-
bryos had mostly completed S phase at this time (Fig.
3I). These observations indicate a strong effect on S-phase
progression in embryos with sustained H4K20me3 levels
at the zygote and two-cell stages. Importantly, this pheno-
type correlates well with the timing and distribution of
the embryonic arrest elicited upon ectopic expression of
SUV4-20H2 (Fig. 1D).
Previous reports have shown that changes in the levels
of H4K20me1 and the expression of PR-Set7 lead to an in-
tra-S-phase checkpoint activation and cell cycle arrest
(Tardat et al. 2007; Houston et al. 2008; Oda et al. 2009).
Since H4K20 methylation is processive (Sims et al. 2006;
Congdon et al. 2010), it is possible that the increased
H4K20me3 levels upon ectopic expression of SUV4-
20H2WT have repercussions on the levels of H4K20me1,
and thus the developmental phenotype and themisregula-
tion of S phasemay be due to changes inH4K20me1 rather
than an increase in H4K20me3. To address this, we ana-
lyzed levels of H4K20me1 in control embryos as well as
embryos expressing SUV4-20H2WT or SUV4-20H2MUT
at the two-cell stage during G2 phase, when H4K20me1
levels are highest (Fig. 4A). Expression of SUV4-20H2WT
—but not of SUV4-20H2MUT—led to a reduction in
H4K20me1 levels, suggesting that H4K20me1 is indeed
used as a substrate for the higher methylation state (Fig.
4A; Supplemental Fig. S4A). To distinguish whether
changes in H4K20me1 levels are related to the develop-
mental phenotype elicited upon SUV4-20H2 expression,
we analyzed H4K20me1 in embryos expressing SUV4-
20H1, which do not display a developmental phenotype.
Surprisingly, expression of SUV4-20H1WT showed a
strong reduction of H4K20me1 (Fig. 4B) even though it
did not lead to an increase in H4K20me3 (Fig. 2B). This
suggests that SUV4-20H1WT converts H4K20me1 to
H4K20me2. Indeed, the reduction in H4K20me1 upon
expression of SUV4-20H1WTwas dependent on its meth-
yltransferase activity (Fig. 4B). However, in spite of multi-
ple attempts, we were unable to identify a specific
H4K20me2 antibody and therefore were unable to per-
form immunostaining for H4K20me2 (data not shown).
Importantly, even though SUV4-20H1WT embryos show
a reduction in H4K20me1 levels, they do not exhibit em-
bryonic lethality or cell cycle arrest (Fig. 2C), in contrast
to SUV4-20H2WT embryos, which show both reduction
of H4K20me1 and developmental arrest (Fig. 1C). This ob-
servation suggests that reductionofH4K20me1 levelsmay
not explain the developmental phenotype observed upon
expression of SUV4-20H2WT, leading us to conclude
that the developmental arrest in SUV4-20H2WT embryos
is mostly independent of changes in H4K20me1 levels. In-
deed, while PR-Set7 loss leads to a G2/M arrest (Oda et al.
2009; Tardat et al. 2010), we did not detect changes in
H3S10p in SUV4-20H2WT embryos compared with
noninjected or SUV4-20H2MUT controls (Fig. 4C; Sup-
plemental Fig. S4B). We aimed to address whether over-
expression of PHF2 would rescue the developmental
phenotype elicited by SUV4-20H2WT expression by re-
ducingH4K20me3.However, under the experimental con-
ditions tested, wewere unable to detect a change in global
H4K20me3 levels in spite of robust PHF2 expression (Sup-
plemental Fig. S3D–F).
SUV4-20H2-mediated embryonic arrest is partially
rescued by inhibiting ATR
All of our observations together suggest that the pheno-
typic arrest of embryos expressing SUV4-20H2WT is a re-
sult of a misregulation of DNA replication. H4K20
methylation can be a marker of DNA damage, and in-
creased levels of H4K20me2/3 have been linked to the ac-
tivation of the ATR pathway in cancer cells (Botuyan et al.
2006; Hajdu et al. 2011; Pei et al. 2011). We therefore hy-
pothesized that sustained H4K20me3 could trigger DNA
damage checkpoint activation during S phase in embryos.
We thus investigated the levels of γH2A.X, an indicator of
DNA damage and replication stress, in addition to CHK1
and phosphorylated CHK2 (CHK2p), downstream effec-
tors of the ATR/ATM pathway and S-phase checkpoint
activation (Mechali et al. 2013). Immunostaining of two-
cell stage embryos at late S phase using a γH2A.X antibody
revealed diffuse nuclear accumulation of γH2A.X with a
few foci in control noninjected embryos, in agreement
with previous observations (Fig. 4D; Ziegler-Birling et al.
2009). We did not detect changes in the global levels of
γH2A.X in embryos expressing either SUV4-20H2WT or
SUV4-20H2MUT (Fig. 4D; Supplemental Fig. S4C), sug-
gesting that sustained H4K20me3 levels do not cause
dsDNA damage globally. In contrast, SUV4-20H2WT em-
bryos showed higher levels of CHK1 in comparison with
noninjected and SUV4-20H2MUT embryos during S
phase (Fig. 4E; Supplemental Fig. S6A–D). In addition,
CHK2p was also strongly induced in both pronuclei of
SUV4-20H2WT embryos compared with noninjected
and SUV4-20H2MUT embryos, which showed barely
any signal for CHK2p (Fig. 4F; Supplemental Fig. S6E–
H). Note that we were unable to address levels of phos-
phorylated CHK1, since none of the commercially avail-
able CHK1p antibodies worked in immunostaining (data
not shown). The increase in CHK1 and CHK2p indicates
a potential signaling from DNA damage during S phase
upon expression of SUV4-20H2. Since H4K20me3 consti-
tutes a direct platform for origin replication complex
(ORC) loading (Beck et al. 2012), it is possible that in-
creased origins of replication may be used or available in
SUV4-20H2WT embryos. Indeed, this could explain the
increase in EdU levels in these embryos at the beginning
of S phase (Fig. 3F) as well as the CHK1 and CHK2p in-
crease through the generation of more ssDNA intermedi-
ates. The observation that CHK1 and CHK2p levels were
higher in SUV4-20H2WTembryos suggested a checkpoint
activation during S phase. We reasoned that if embryos
with sustained H4K20me3 levels upon expression of
SUV4-20H2 arrest because of an S-phase checkpoint acti-
vation, we should be able to release the developmental
arrest at least partially through inhibition of the ATR
Eid et al.
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Figure 4. Embryonic arrest is partially rescued by inhibition of ATR. (A) Representative images of two-cell stage embryos analyzed at 46
h phCGwithDAPI, HA, andH4K20me1 antibodies. SingleZ-projections of confocal sections are shown. An inset of one of the two nuclei
is shown at the right.N numbers are indicated. Bars: inset, 5 µm; all others, 10 µm. (PB) Polar gody. (B) Representative singleZ-projections
of confocal sections of Suv4-20h1WT-injected and Suv4-20h1mut-injected two-cell stage embryos stained at 46 h phCGwith DAPI, HA,
and H4K20me1 antibodies. An inset of one of the two nuclei is shown in the right panels.N numbers are indicated. Bars: inset, 5 µm; all
others, 10 µm. (PB) Polar body. (C ) Representative two-cell stage embryos acquired at 46 h phCG stained with DAPI and H3S10p antibod-
ies, showing confocal single Z-projections of noninjected, Suv4-20h2WT-injected, and Suv4-20h2mut-injected embryos. N numbers are
indicated. Bar, 10 µm. (PB) Polar body. (D) Representative confocal singleZ-projections of noninjected, Suv4-20h2WT-injected, and Suv4-
20h2mut-injected two-cell stage embryos stained at 46 h phCGwith DAPI and γH2A.X antibodies.N numbers are indicated. Bar, 10 µm.
(PB) Polar body. (E) Representative zygotes stained at 25 h phCG (early S phase) and 29 h phCG (late S phase) with DAPI and CHK1 an-
tibodies, showing single confocal Z-projections of noninjected, Suv4-20h2WT-injected, and Suv4-20h2mut-injected embryos. Bars: inset,
5 µm; all others, 10 µm. (M) Maternal; (P) paternal. (F ) Confocal single Z-projections of noninjected, Suv4-20h2WT-injected, and Suv4-
20h2mut-injected zygotes acquired at 29 h phCG with DAPI and CHK2p antibodies. An inset of the maternal pronucleus is shown in
the right panels. N numbers are indicated. Bars: inset, 5 µm; all others, 10 µm. (M) Maternal; (P) paternal. For E and F, SUV4-
20H2MUT and SUV4-20H2WT embryos were processed separately but in parallel with noninjected controls. (G) A schematic represen-
tation of the experimental design is shown at the top. Zygotes between 17 and 19 h phCG were microinjected with mRNA for Suv4-
20h2WT and GFP and cultured in the presence or absence of an ATR inhibitor (ATRi) until the eight-cell stage. A bar chart of the devel-
opmental progression until the four-cell stage is shown at the bottom. Statistical testingwas performed using theN−1 two-proportion test
for comparing independent proportions. (∗) P < 0.05.
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pathway. To address this, embryos were injected as above
with mRNA for Suv4-20h2WT and cultured in the pres-
ence of anATR inhibitor (ATRi) from the late zygote stage
(Fig. 4G). Since longer inhibition of ATR is known to
block developmental progression (Brown and Baltimore
2000; Nakatani et al. 2015), we focused specifically on as-
sessing the developmental block beyond the two-cell
stage, which accounts for the majority of the phenotype
(77% of SUV4-20H2 embryos arrest prior to the two-cell
stage), by scoring embryos that reached the four-to-
eight-cell stage transition. As shown in Figure 4G, all non-
injected embryos cultured in the presence of the ATRi
reached the four-cell stage at a rate similar to that of
noninjected embryos cultured without inhibitor. SUV4-
20H2WT embryos treated with ATRi developed at sig-
nificantly higher rates than SUV4-20H2WT embryos
cultured without the inhibitor (P < 0.05; n = 32) (Fig. 4G).
Although not all embryos overcame the two-cell stage
block upon inhibition of ATR, our results suggest that
the developmental defects elicited from sustaining
H4K20me3 levels are partially alleviated by inhibiting S-
phase checkpoint activation.We conclude that the prima-
ry function of H4K20me3 remodeling after fertilization is
to allow the timely progression of DNA replication
through S phase. This is in contrast to the replication pro-
gram in somatic cells, where replication occurs normally
in the presence of H4K20me3 through ORC binding and
anticipates a different regulation of replication during
this developmental time window.
Discussion
Embryonic development requires a unique reprogram-
ming mechanism to revert to a ground epigenetic state
for a new developmental program to initiate. However,
the repercussions of such remodeling at themolecular lev-
el are not understood. Zygotes and two-cell stage embryos
exhibit a particular nuclear structure with distinctive and
asymmetric chromatin signatures thought to be necessary
for epigenetic reprogramming. Heterochromatic marks
are unique identifiers of parental chromatin at fertiliza-
tion, which are rapidly remodeled thereafter. To address
the requirement for such a chromatin environment in
vivo, we aimed to sustain the levels of one such PTM,
H4K20me3, by expressing the correspondingmethyltrans-
ferases (Suv4-20h1 and Suv4-20h2). Indeed, expression of
such chromatin modifiers can be used to interrogate the
system to shed light on the regulatory mechanisms of
the early embryo by studying how they respond to such
perturbations. We found that expression of Suv4-20h2
modifies H4K20 methylation by reducing H4K20me1
and increasing H4K20me3 levels and leads to embryonic
arrestmostly before the two-cell stage. This embryonic ar-
rest is dependent on the histone methyltransferase activi-
ty of SUV4-20H2. In addition, the developmental failure
seems to derive from the specific activity of SUV4-20H2
and the sustained H4K20me3 levels, since expression of
SUV4-20H1 does not result in developmental arrest or af-
fect H4K20me3 levels markedly. While it is likely that
the developmental arrest observed is due mainly to the
H4K20me3 increase, we cannot rule out the possibility
that changes in H3K64me3 levels could also potentially
contribute to the developmental phenotype observed
upon Suv4-20h2WT expression.
It is interesting to note that, in spite of ectopic SUV4-
20H2 being detected in both pronuclei, H4K20me3 is
only readily detected in the maternal pronucleus prior to
the two-cell stage. It is possible that SUV4-20H2 is more
active on chromatin already methylated with H3K9me3,
which is in line with the reinforcement loop of constitu-
tive heterochromatin in somatic cells (Rea et al. 2000). In
addition, because H4K20 methylation is processive and
is among themodificationswith the slowest rate of forma-
tion (Zee et al. 2010), it may take longer for SUV4-20H1 to
reach full processivity in the absence of basal levels of
H4K20me3 and/or H3K9me3. It is noteworthy that
Suv4-20 enzymes canbe targeted to chromatin through in-
teraction with HP1, which mediates stable SUV4-20H2
binding synergistically (Schotta et al. 2004; Hahn et al.
2013). Because HP1β appears in the paternal chromatin
only after S phase (Santos et al. 2005; Santenard et al.
2010) and because SUV4-20H1/H2 are known to function
mostly inG1 (Zee et al. 2010), the lack ofHP1 on the pater-
nal pronucleus together with the processivity nature of
SUV4-20 enzymes would explain why H4K20me3 is de-
tected in the paternal chromatin only at the two-cell stage.
SUV4-20H1 seems to display lesser activity toward
H4K20me3 than SUV4-20H2 in the embryo. Although
their SETdomains are highly identical, SUV4-20H2 seems
to have higher histone methyltransferase activity than
SUV4-20H1 in vitro (Schotta et al. 2004). It is also possible
that the longer nature of SUV4-20H1, which has 406more
amino acids than SUV4-20H2, may modulate its proces-
sivity. Strong overexpression of Suv4-20h2 in embryonic
stem cells leads to increased chromatin compaction
around chomocenters and consequentmitotic segregation
defects (Hahn et al. 2013). However, we did not detect seg-
regation defects in SUV4-20H2-expressing embryos.
The expression of SUV4-20H2 also leads to amisregula-
tion of S phase with increased replication sites, concomi-
tant with activation of the ATR pathway (Fig. 5). We
postulate that the subsequent activation of the intra-S-
phase checkpoint is the cause of the cell cycle block. It
is known that activation of ATR leads to a block of repli-
cation forks that exhibit ssDNA, but, in order to compen-
sate for the delayed stalled forks undergoing repair, several
dormant origins initiate replication (Gilbert 2007), which
could explain the continuous EdU incorporation observed
in the late S phase in zygotes and two-cell stage embryos
expressing SUV4-20H2WT. Alternatively, increased load-
ing of ORC, favored by increased accessibility of its binder
target, may facilitate the activation of additional origins,
resulting in more extensive ssDNA and subsequent
checkpoint activation (Fig. 5). In line with the suggestion
of intra-S-phase checkpoint activation, chemical inhibi-
tion of ATR partially rescues the S-phase block and devel-
opmental capacity. The persistent embryonic arrest in a
proportion of embryos could result from misregulation
of gene expression independently of the cell cycle/S-phase
Eid et al.
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progression at the two-cell stage, whichmight not be over-
come by ATR inhibition. However, we could not formally
distinguish effects on gene expression caused by develop-
mental arrest.
Our results underscore the necessity for a chromatin
signature in zygotes and two-cell embryos that is devoid
of H4K20me3 and heterochromatin domains for the cor-
rect progression of replication. Indeed, it is possible that
the relatively open chromatin structure at these stages is
sufficient to enable regulated access to the replication
machinery (Boskovic et al. 2014; Wu et al. 2016). More
broadly, this anticipates a functional difference in the or-
ganization of the replication program between the early
embryos and somatic cells.
Materials and methods
Embryo collection, microinjection, and culture
Embryos were collected from 5- to 7-wk-old F1 (C57BL/6J × CBA/
H) superovulated females crossed with F1 males. Superovulation
was induced by intraperitoneal injection of 5 IU of pregnant mare
serum gonadotropin (PMSG, Intervet) and 7.5 IU of hCG (Inter-
vet) 46–48 h later. Zygotes were collected between 17 and 19 h
phCG injection. mRNAs were transcribed in vitro from the
pRN3P plasmid using the mMESSAGE mMACHINE kit
(Ambion). All cDNAs were subcloned to include identical 5′
caps and untranslated regions (UTRs; including Kozak) and a
poly-T 3′ UTR tail to ensure equivalent expression levels aftermi-
croinjection. Suv4-20h1 and Suv4-20h2 cDNA were obtained
through a generous gift from G. Schotta (Ludwig-Maximilians-
UniversitätMünchen,Munich), and Suv4-20h1mutwas obtained
through a generous gift from D. Beck (New York University,
New York). Suv4-20h2mut was prepared by site-directed muta-
genesis of Suv4-20h2 at asparagine 273 to cysteine 276 (NHDC)
into AAAG (wild-type sequence CAACCATGACTG to mutated
sequence CGCCGCTGCCGG) (Rea et al. 2000). Mouse Phf2
cDNA was obtained from H. Qi (University of Iowa) and subcl-
oned into the pRN3P plasmid. Zygotes were microinjected with
1–2 pL of the indicated mRNAs (700 ng/µL for Suv4-20h1/Suv4-
20h1mut/Suv4-20h2/Suv4-20h2mut/Phf2 or 250 ng/µL for Gfp)
and allocated to the experimental groups at random. Embryos
were cultured in KSOM (K-modified simplex optimizedmedium)
microdrops under oil at 37°C and 5% CO2 until they were fixed.
Microinjections at the two-cell stagewere performed in one of the
blastomeres at random after embryo collection at 41–43 h phCG.
Rescue experiments of the developmental blockwhere performed
by adding KSOM containing 10 µM ATRi (Millipore, catalog no.
5.04972.0001) after injection and renewing the medium daily for
2 d. Embryos were monitored and scored daily to determine
developmental progression. Data were derived from at least three
independent biological replicates. For statistical analysis of em-
bryonic development, theN−1 two-proportion test for comparing
independent proportions for small and large sample sizes was
used, which is based on the N−1 χ2 test originally proposed by
Pearson and recommended by Campbell. All experiments were
performed after approval of the Ethics Committee of the Univer-
sité de Strasbourg and according to French and European legisla-
tion on animal experimentation.
EU and EdU incorporation
Embryos were incubated with 50 µM EU for 1 h at 48 h phCG
treatment and then visualized by Click-iT chemistry (Life
Technologies) as described in the manufacturer’s instructions.
Quantifications were performed as described in “Quantification
of Fluorescence Intensity” (below). Embryos were incubated
with 50 µM EdU for 1 h at the times indicated in the figure
legends and figure schemes and then visualized by Click-iT
chemistry (Life Technologies) as described in the manufacturer’s
instructions.
Immunostaining and confocal microscopy
Fixation of freshly collected embryos from F1 superovulated, mi-
croinjected, and cultured embryos was performed as described
(Torres-Padilla et al. 2006). Briefly, the zona pellucida was re-
moved with Acid Tyrode solution followed by two washes in
PBS and fixation in 4% paraformaldehyde, 0.04% Triton, 0.3%
Tween20, and 0.2% sucrose at 37°C to ensure preservation of nu-
clear architecture. After permeabilization with 0.5% Triton in
PBS, embryos were washed three times in PBSt (0.1% Tween20
in PBS), quenched in 2.6 mg/mL freshly prepared ammonium
chloride, washed twice in PBSt, blocked for 3–4 h or overnight
at 4°C in blocking solution (BS: 3% BSA in PBSt), and incubated
with primary antibodies in BS. The antibodies used were as fol-
lows: anti-HA (Abcam, 16B12), anti-H3K9me3 (Millipore, 07-
442), anti-H4K20me3 (Millipore, 07-463), anti-H3K9me3 (Milli-
pore, 07-442), anti-H3K64me3 (generous gift from S. Daujat Insti-
tut de Génétique et de Biologie Moléculaire et Cellulaire,
Illkirch), anti-H4K20me1 (Abcam, ab9051), anti-H3S10p (Abcam,
ab5176), anti-γH2A.X (Millipore, 05-636), anti-CHK1 (Cell Sig-
naling, 2G1D5), and anti-CHK2p (Cell Signaling, T68 2661S). Af-
ter overnight incubation at 4°C, embryos were washed three
Figure 5. Working model for Suv4-20h2 and H4K20me3 effects
on cell cycle progression in embryos. Expression of Suv4-20h2 es-
tablishes higher levels of H4K20me3, which is a known target of
ORCA. In turn, ORCA can recruit ORC during early S phase to
replication origins. The increased levels of H4K20me3 lead to in-
creased ORC loading, which would result in higher levels of
ssDNA, as measured by EdU labeling. The increase in ssDNA
can activate the ATR pathway, which promotes CHK2 phosphor-
ylation, leading to the activation of the intra-S-phase checkpoint,
causing a delay in cell cycle progression and developmental
arrest.
H4K20me3 and timely embryonic replication
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times in PBSt, blocked for 20 min in BS, and incubated for 3 h at
room temperature in BS containing secondary antibodies labeled
withAlexa fluorophores (Invitrogen). Afterwashing twice in PBSt
and once in PBS, embryos were mounted in VectaShield (Vector
Laboratories) containing DAPI to visualize DNA. Confocal mi-
croscopy was performed on a 63× oil objective in a TCS SP5 in-
verted confocal microscope (Leica). Z-sections were taken every
0.5–1 μm. Image analysis was performed using the LAS-AF (Leica)
and Imaris (Bitplane) software.
Quantification of fluorescence intensity
Confocal z-series stacks were reconstructed in three dimensions
using Imaris software (Bitplane), and the pronuclei (zygote) or nu-
clei (two-cell stage) were segmented based on the DAPI channel.
The average fluorescence intensity for the channel of interest
within the segmented region was calculated after uniform back-
ground subtraction with a 95% confidence. The fluorescence in-
tensity for each embryo was normalized to the average of the
noninjected control group. The data were tested for normality us-
ing the Kolmogorov-Smirnov test. If the datawere found to not be
normally distributed, the Mann-Whitney U-test, a nonparamet-
ric test, was used.
Gene expression analysis
Control noninjected, Suv4-20h1WT-injected, Suv4-20h2WT-in-
jected, and Suv4-20h2mut-injected two-cell stage embryos were
washed in PBS and flash-frozen in liquid nitrogen in 5 µL of 2× re-
action buffer (CellsDirect One-Step qRT–PCR kit, Invitrogen) at
44 h phCG. TaqMan gene expression assays (20×; Applied Biosys-
tems), previously tested using embryonic stem cell cDNA for
amplification efficiency, were pooled to a final concentration of
0.2× for each of the 48 assays. To each of the single-cell samples
in 2× reaction buffer, 2.5 µL of 0.2× assay pool, 0.5 µL of RT/
Taq enzyme (CellsDirect qRT–PCR kit, Invitrogen), and 2.3 µL
ofwater were added. Cell lysis and sequence-specific reverse tran-
scription were performed for 20 min at 50°C. The reverse
transcriptase was inactivated by heating for 2 min to 95°C. Se-
quence-specific preamplification was performed by denaturing
for 15 sec at 95°C and then annealing and amplification for 4
min at 60°C for 18 cycles. The resulting cDNA was diluted five-
fold before analysis with Universal PCRmaster mix and TaqMan
gene expression assays (Applied Biosystems) in 48:48 Dynamic
Arrays on a Biomark system (Fluidigm).Ct valueswere calculated
from the system’s software (Biomark real-time PCR analysis, Flu-
idigm). All raw Ct values were normalized to the assumed detec-
tion Ct level of 28 following the recommendation from Fluidigm
technical support as in Guo et al. (2010) and Burton et al. (2013).
Ct values >28 and those with curve qualities <0.65 were deemed
unreliable measurements and were substituted with values of 28.
Whenever Ct values or quality scores were judged unreliable in
one replicate but not the other, those of the successful replicate
were kept. Additionally, all samples lacking expression of refer-
ence genesActin-b andGapdhwere removed from further analy-
sis. The remaining Ct values were subtracted from 28 in order to
achieve a scale in which zero corresponded to the lack of expres-
sion, and an increase of 1 U indicated a doubling of the expression
level (Guo et al. 2010; Burton et al. 2013). Violin plots of the re-
sulting data set were generated using the ggplot2 R package. Stat-
istical analysis was performed using the Mann-Whitney U-test.
The PCA was performed using the pcaMethods R package, and
variables were scaled to unit variance. All plotting was done in
R using the ggplot2 package. The dendrogram clustering was gen-
erated in R using Euclidean distance.
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Supplemental Figure Legends 
Figure S1. Expression levels of H4K20me3 dimethyl- and trimethyl-
transferases during pre-implantation development. 
Relative expression level of Suv4-20h1 (A), Suv4-20h2 (A), Smyd-5 (B) and Phf-
2 (C) at all stages of pre-implantation development normalized to Actinb. Shown 
are means ± s.d. of two independent experiments performed in technical 
replicates. Blue and red dots correspond to individual biological replicates. 
(D) Relative expression levels of SUV4-20H2WT in zygotes and 2-cell stage 
embryos upon mRNA injection as in Figure 1A. Quantification was done using 
HA staining, and was normalized to DAPI. Shown are means ± s.e.m. of 13 
zygotes and 21 2-cell stage embryos. 
 
Figure S2. Expression of SUV4-20H2 at the 2-cell stage results in cell 
proliferation arrest. 
A. Experimental design: a random blastomere of a 2-cell stage embryo (37h 
phCG) was micro-injected with mRNA for Suv4-20h2WT and GFP. 
B. Representative confocal single Z-projections of Non injected, Suv4-20h2WT- 
and GFP-injected 2-cell stage embryos stained at 48h phCG with DAPI, GFP; HA 
and H4K20me3 antibodies. An inset of one H4K20me3 of the two nuclei is shown 
in the right panels. Scale bar corresponds to 10µm, except in the inset where it 
corresponds to 5µm. PB, Polar Body. 
C. Bar chart distribution of the number of GFP negative and positive blastomeres 
at the blastocyst stage in GFP- or Suv4-20h2WT- injected 2-cell stage embryos. 
The number of blastocysts analyzed is indicated at the bottom of the chart. 
D-E. Representative full Z-projections of confocal sections of blastocysts injected 
with Suv4-20h2WT- and GFP acquired with DAPI, GFP, and phalloidin. A 
merged channel of the three signals is shown at the bottom. Scale bar 
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Figure S3. Suv4-20h2 ectopic expression affects the levels of H3K64me3. 
Quantification of H3K9me3 (A), H3K64me3 (B) in late 2-cell-stage embryos at 
46h phCG. The fluorescence intensity per nucleus was normalized to the mean 
intensity of non injected embryos following background subtraction (detailed in 
the material and methods) and the number of nuclei analyzed is shown below the 
graphs. The mean averages of these values are shown (± SEM). The Mann-
Whitney U test was applied and only significant differences are indicated. 
C. Normalized EdU levels measured in each pronucleus of non injected and 
GFP-injected zygotes at late S-phase. 
D-F. PHF2 does not lead to changes in global H4K20me3 levels upon Suv4-20h2 
expression. (D) Experimental design: zygotes were microinjected with mRNA for 
Suv4-20h2 as in Figure 1 except that RFP mRNA was used as positive control 
for injection. Embryos were left to develop until the mid 2-cell stage at which time 
one of the 2 blastomeres was injected with mRNA for HA-PHF2 together with 
membraneGFP in order to identify the injected blastomere. (E) Embryos were 
then fixed 24h later and analyzed with an HA antibody to reveal PHF2 and with 
an H4K20me3 antibody as indicated. Note that because of the delay induced by 
SUV4-20H2, the embryo shown is still at the 2-cell stage. In (F), H4K20me3 
levels were quantified and normalized against the negative blastomere for HA-
PHF2. Note that under the experimental conditions used, PHF2 does not appear 
to regulate H4K20me3 globally. 
 
Figure S4. Suv4-20h2 ectopic expression reduces the levels of H4K20me1 
but does not affect H3S10p or γH2A.X. 
Quantification of H4K20me1 (A), H3S10p (B) and γH2A.X (C) in late 2-cell-stage 
embryos at 46h phCG. The fluorescence intensity per nucleus was normalized to 
the mean intensity of non injected embryos following background subtraction 
(detailed in the material and methods) and the number of nuclei analyzed is 
shown below the graphs. The mean averages of these values are shown (± 
SEM). The Mann-Whitney U test was applied and only significant differences are 
indicated. 
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Figure S5. Gene expression analysis does not show a different expression 
profile in Suv4-20h2WT- expressing embryos. 
A. Cluster dendrogram of single 2-cell stage embryos at 44h phCG (during mid-
EGA) based on 45 genes’ expression levels. Embryos are identified by their 
experimental group (Non injected, Suv4-20h1, Suv4-20h2 and Suv4-20h2AAAG) 
followed by an identification number. 
B. Violin plots of 43 genes analyzed in single 2-cell stage embryos at 44h phCG 
and averaged to Actinb and Gapdh. Average expression levels is indicated with a 
black dot. 
 
Figure S6. Activation of the S-phase checkpoint. 
Quantification of CHK1 (A-D) and CHK2p (E-F) in early (25h phCG) and late 
(29h phCG) S-phase at the zygote stage in the maternal and paternal pronuclei 
in embryos expressing Suv4-20h2WT and Suv4-20h2MUT as indicated, 
compared to Non injected controls. The fluorescence intensity per pronucleus 
was normalized to the mean intensity in Non injected embryos following 
background subtraction and the number of embryos analyzed is shown to the left 
of the graphs. The mean averages of these values are shown (± SEM). The 
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Gene Taqman probe Function
beta-catenin Mm00483039_m1 Signalling, polarity, axis specification, proliferation
hoxb1 Mm00515118_g1 Homeobox b1, transcription factor
hoxb4 Mm00657964_m1 Homeobox b4, transcription factor
hoxb9 Mm01700220_m1 Homeobox b9, transcription factor
yap1 Mm01143263_m1 Centromere proximal location, chr 9
lats2 Mm00497217_m1 Large tumor suppressor 2 kinase, cell division, Hippo pathway
brg1 Mm01151948_m1 ATPase subunit, remodelling complex, required for zygotic genome activation
rock1 Mm00485745_m1 Signalling kinase, Centromere proximal location, chr 18
rb Mm00485586_m1 Cell cycle, cell proliferation
cyclin D1 Mm00432359_m1 Cell cycle
gapdh Mm99999915_g1 Housekeeping, internal control
Actin-B Mm00478923_m1 Housekeeping, internal control
Smc1a Mm00490624_m1 Cohesion, can bind to Suv4-20h2
Nap1l4 Mm01131802_m1 nucleosome assembly, maternally expressed
Gnas Mm01242435_m1 G-protein alpha subunit (Gs-α), imprinted
Dhcr7 Mm00514571_m1 production of cholesterol from NADPH, imprinted
Rpl19 Mm02601633_g1 60S ribosomal protein
Btg4 Mm00517103_m1 B-cell translocation gene 4, G1 arrest
Trim28 Mm00495594_m1 TF interacts with HP1a and controls gene expression
Hmgb1 Mm00849805_gH Chromatin remodeler, affects transcricptional expression
Hspa8 Mm01731394_gH Protein folding
Polr2d Mm00770943_m1 One the RNA pol 2 subunits
Zscan4f Mm01234988_g1 Exclusive expression at 2-cell stage
Tif1a/Trim24 Mm00446831_m1 TF binds to (AF2) region of several nuclear receptors
EZH2 Mm00468464_m1 Enhancer of Zest homolog 2, Polycomb Repressive Complex 2
Ring1b Rnf2 Mm00803321_m1 Histone H2A ubiquitylation, Polycome Repressive Complex 1
Suv4-20H1 Mm00523065_m1 Di- and tri- methyl transferase
Suv4-20h2 Mm00525366_m1 Di- and tri- methyl transferase
Suv39H1 Mm00468952_m1 Centromere proximal location, chr X
Dnmt1 Mm00599763_m1 Maintenance DNA methyltransferase
Dnmt3a Mm00432881_m1 De novo DNA methyltransferase
Dnmt3b Mm01240113_m1 De novo DNA methyltransferase
Dnmt3l Mm00457635_m1 De novo DNA methylation, cofactor
Pou5f1 Mm03053917_g1 Oct4, transcription factors
Nanog Mm02019550_s1 Transcription factor, zygotically expressed, pluripotency
Sox2 Mm03053810_s1 Transcription factor, ICM maintenance, essential for early development
Gata4 Mm00484689_m1 Transcription factor, specification of primitive endoderm
Fgf4 Mm00438917_m1 Signalling molecule
Cdx2 Mm01212280_m1 Transcription factor, trophectoderm differenciation
Gata6 Mm00802636_m1 Transcription factor, centromere proximal location, chr 18
Bmp4 Mm00432087_m1 TGF signalling, lineage specification
Fgfr2 Mm01269930_m1 Proliferation and differentiation, signalling
Dppa1 Mm00626454_m1 Developmental pluripotency associated 1, zygotically expressed
Tead4 Mm01189836_m1 Hippo pathway (transcription enhancer factor)
Klf4 Mm00516104_m1 Transcription factor, pluripotency
Pard3 Mm00473929_m1 Partitioning defective 3, cell polarity
Apkcλ Mm00435769_m1 Atypical PKC, cell polarity




*Fold changes calculated based on the median of gene expression values per experimental group compared to 
  Suv420h2MUT controls, and the corresponding P-values are indicated.
** Significant P-values between Suv420h2WT and Suv420h2MUT controls are highlighted in beige. Note that when
significant changes were observed for the Suv420h2WT experimental group, values were also significant for the other two 
groups, suggesting that effects are not-specific to Suv420h2WT expression.
























ActinB 1.04 0.99 0.99 0.97 0.97 0.74
Ezh2 0.65 0.66 1.04 0.31 0.35 0.68
Beta-catenin 1.23 1.04 0.96 0.15 0.76 0.91
Tead4 7.26 49.16 0.74 0.15 0.01 0.43
Rpl19 0.93 1.03 0.68 0.60 0.76 0.09
Gapdh 0.96 1.01 1.01 0.97 0.97 0.74
Hoxb1 31.94 0.25 3.55 0.22 0.34 0.67
Fgfr2 0.71 1.07 0.90 0.08 0.51 1.00
Pou5f1 0.60 0.76 0.72 0.01 0.04 0.03
Btg4 0.60 0.74 0.82 0.002 0.08 0.12
CyclinD1 0.65 0.90 0.68 0.25 0.81 0.80
Suv39h1 1.03 0.84 0.38 0.92 0.76 0.09
Hoxb4 2.72 3.26 4.46 0.73 0.64 0.50
Gata4 0.91 1.21 0.84 0.51 0.39 0.39
Nanog 0.40 1.32 0.74 0.06 0.35 0.68
Trim28 1.02 1.27 0.86 0.60 0.39 0.39
Gata6 2029.69 10.07 0.86 0.04 0.45 0.87
Dnmt1 107.29 69.59 3.39 0.21 0.50 0.85
Hoxb9 0.37 414.04 17.33 0.42 0.03 0.53
Fgf4 48.68 256.76 8.58 0.10 0.01 0.60
Sox2 0.71 1.66 1.50 0.31 0.22 0.25
Hmgb1 0.66 0.81 0.84 0.003 0.17 0.17
Dppa1 0.51 0.66 0.82 0.01 0.13 0.25
Dnmt3a 0.52 0.67 0.87 0.00 0.08 0.12
Smc1a 0.96 0.91 0.94 0.60 0.47 0.31
Cdx2 0.32 18.82 3.91 0.42 0.61 0.84
Hspa8 0.95 0.95 0.65 0.81 0.76 0.06
Rock1 0.79 0.97 0.85 0.13 0.76 0.19
Dnmt3b 0.68 0.90 1.05 0.08 0.60 0.74
Nap1l4 0.71 0.85 0.91 0.17 0.47 0.68
Bmp4 9.88 10.67 1.91 0.27 0.86 0.46
Pard3 0.54 0.76 0.63 0.002 0.04 0.01
Polr2d 1.15 1.30 0.84 0.92 0.20 0.39
Rb1 0.73 0.93 0.94 0.04 0.35 0.44
Dnmt3l 0.61 0.87 0.81 0.00 0.28 0.25
Gnas 0.50 0.53 0.76 0.00 0.02 0.08
Klf4 1.14 1.62 1.19 0.70 0.11 0.63
Yap1 0.67 0.83 0.86 0.01 0.15 0.22
Zscan4f 0.31 0.64 0.95 0.00 0.05 0.91
Apkc 0.73 0.98 0.93 0.06 0.86 0.31
Caf1 0.76 0.94 0.89 0.03 0.70 0.31
Dhcr7 1.43 1.76 0.79 0.31 0.10 0.39
Lats2 0.33 0.33 0.21 0.37 0.30 0.42
Rnf2 0.64 0.90 0.86 0.05 0.35 0.31

















































Part 1 – The molecular basis of totipotent-like cells in 
culture 
In the work presented in this thesis, we have addressed several open questions regarding the 
molecular and developmental identities of the 2-cell-like subpopulation that arises in mouse 
embryonic stem cell cultures. As described above, approximately 0.5% of a mouse ESC culture 
spontaneously transitions to a state reminiscent of the totipotent 2-cell stage embryo, and 
recapitulates several of its molecular features such as downregulation of OCT4 and expression 
of the MERV-L family of endogenous retroviruses (Macfarlan et al., 2012). However, before this 
work, it remained an open question how exactly this subpopulation arose from the rest of the 
pluripotent stem cell culture, and whether these cells recapitulated any other major features of 
the totipotent embryo such as its unique metabolism. 
 
By employing several single cell approaches, our work has clarified the series of molecular events 
that occur during this transition and places into context their developmental identity. In addition 
to the 2-cell-like subpopulation, an altogether different heterogeneity of mouse ESCs 
recapitulating some features of the 2-cell stage embryo had been previously reported (Falco et 
al., 2007; Zalzman et al., 2010), although the relationship between these two states had never 
been established. The Zscan4+ fraction of mouse ESCs corresponds to ~5% of the culture at 
any given time, and its main defining feature consists in the expression of the 2-cell stage specific 
genes Zscan4a-f. By employing a combination of time-lapse microscopy, fluorescent reporters 
and a highly-precise single cell expression profiling assay on a set of differentially expressed 
genes between the three subpopulations, we were able to identify an ordered series of molecular 
events occurring during the transition from the ES cell to the 2-cell-like state (Rodriguez-Terrones 
et al., 2018).  
 
The ESC to Zscan4+ cell transition 
First, through an as yet unknown molecular mechanism, a small percentage of preferentially naïve 
pluripotent stem cells activates transcription of the Zscan4 gene cluster. Shortly after this event, 
and again through an as yet undetermined molecular mechanism, key pluripotency-associated 
transcription factors such as OCT4 and SOX2 – but not NANOG – are downregulated at the 
protein level. Considering that barely any Zscan4+ cell is positive for OCT4 when assayed through 
immunofluorescence, this downregulation must be quick and might involve an active degradation 
mechanism. Once in this Zscan4+ positive state and with pluripotency-associated transcription 
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factors downregulated, at least two major things happen. First, Zscan4+ cells appear to 
reorganize their pericentromeric heterochromatin into a ‘blob’-like structure within their nuclei, as 
described in (Akiyama et al., 2015); and second, Zscan4+ cells appear to initiate a shift in their 
central carbon metabolism, and exhibit significantly higher glucose consumption in spite of lower 
oxygen consumption (Rodriguez-Terrones et al., unpublished). Both in our targeted 
transcriptomic data and in the genome-wide RNA-seq data that we reanalyzed, a considerable 
fraction – but not the entirety of the 2-cell-like transcriptome – is upregulated once in this Zscan4+ 
state. Despite these transcriptional changes – including some involving 2-cell stage specific 
genes – no upregulation of MERV-L transcripts or reporters is observed, and the chromatin over 
their LTRs remains inaccessible.  
 
Interestingly, a number of genomic sites across the genome already exhibit a sharp drop in 
chromatin accessibility in the Zscan4+ state, mostly reflecting the loss of binding pluripotency-
associated transcription factors (Figure 4, unpublished observation). Indeed, this observation is 
particularly surprising, given that the forced downregulation of OCT4 outside of a differentiation 
context results in cell death, both in our experiments (Rodriguez-Terrones et al., 2018) and in 
other reports (Chen et al., 2012). Given that our Rex1-reporter experiments also suggest that 
entry into the Zscan4+ state is independent of differentiation, this suggests that this transition 
involves an altogether different pathway out of pluripotency. Although the precise in vivo 
developmental analogue of the Zscan4+ subpopulation remains to be established, our Rex1-
reporter work suggests that – if it exists – it must be a cellular state developmentally closer to the 
Figure 4. Heatmaps representing ATAC-seq and ChIP-seq signals over the differentially 




pre-implantation epiblast (i.e. naïve pluripotency) 
rather than to the post-implantation epiblast (i.e. 
primed pluripotency). Indeed, in the mouse 
embryo, Zscan4 expression occurs in parallel to 
MERV-L expression (Figure 5, unpublished 
observation), raising the questions as to whether 
a developmental equivalent of this Zscan4+ yet 
MERV-L- state exists at all. 
 
The Zscan4+ to 2-cell-like cell transition 
Mouse embryonic stem cells have been widely 
reported to be able to transition in and out of the 
Zscan4+ state over the course of several cell 
cycles. Indeed, this state is essential for the self-
renewal of the pluripotent culture, as it permits 
telomere elongation and the preservation of 
genomic stability. Indeed, our time-lapse 
microscopy experiments permitted us to confirm 
this observation, and in addition provided conclusive proof that a small subpopulation of Zscan4+ 
cells – around 1 in every 10 – would activate MERV-L expression rather than revert back to the 
ESC state. It is unclear, however, what occurs to this double positive Zscan4+ and MERV-L+ state 
– to which throughout this thesis I have referred to as the 2-cell-like state – and whether there 
are any distinct molecular states beyond MERV-L activation. 
 
As previously mentioned, the LTRs of the MERV-L family of retrotransposons serve as promoters 
(Franke et al., 2017; Peaston et al., 2004) for many of the genes activated at the time of zygotic 
genome activation in the 2-cell stage embryo, following the opening of their chromatin at the early 
2-cell stage (Wu et al., 2016). By reanalyzing previously published ATAC-seq data across these 
three subpopulations (Eckersley-Maslin et al., 2016), we were able to determine that opening of 
the chromatin at the MERV-L LTRs occurs in the 2-cell-like subpopulation but not in the Zscan4+ 
one, in agreement with the pattern of transcriptional activation. Recent reports (Hendrickson et 
al., 2017; De Iaco et al., 2017; Whiddon et al., 2017) have identified the transcription factor DUX 
as one of the main regulators of zygotic genome activation in mouse and human, acting in part 
through its binding to MERV-L LTRs. Indeed, the reanalysis and modelling of previously published 
Figure 5. Violin plots representing Zscan4 and 
MERV-L LTR expression levels over the 
course of early mouse development. 
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single-cell RNA-seq data in these three subpopulations suggests that Dux expression precedes 
MERV-L transcription, and that transcriptional activation of this transcription factor only occurs 
in a fraction of the highest-expressing Zscan4+ cells (Figure 6, unpublished observation). Thus, 
the joint analysis and modeling of these various datasets suggests that a small fraction of Zscan4+ 
cells expressing the highest Zscan4 transcript levels activates expression of the DUX transcription 
factor, which subsequently binds to the MERV-L LTRs and leads to their transcriptional activation 
and chromatin opening. 
 
 
Figure 6. Violin plots representing Zscan4, Dux and MERV-L LTR expression levels over the course of 
the transition to the 2-cell-like state. Data reanalyzed from Eckersley-Maslin et al., 2016.  
 
2-cell-like cells enable the identification of novel molecular features of totipotent cells 
Indeed, as previously mentioned, the 2-cell-like subpopulation recapitulates several features of 
the 2-cell stage embryo, and this work permitted us to identify some novel ones. Before this 
work, the main defining features of this population included the downregulation of OCT4 and the 
transcriptional activation of MERV-L and other 2-cell stage specific genes and transcripts. After 
noticing that an overall reorganization of pericentromeric heterochromatin – i.e. major satellites – 
was evident in the DAPI stainings of 2-cell-like cells, Ishiuchi et al. identified another parallel to 
the 2-cell stage embryo and further determined that these genomic regions were being 
transcribed in a manner analogous to the situation seen in the zygote and the 2-cell stage embryo 
(Ishiuchi et al., 2015). Following up on these careful observations, it was determined that this 
reorganization of pericentromeric regions was reminiscent of that seen upon downregulation of 
replication-dependent chromatin assembly, and thus downregulation of the CAF-1 complex was 
identified as a powerful inducer of the 2-cell-like state. Following the publication of one of the first 
high-quality and comprehensive single-cell transcriptomes in the mouse early embryo (Deng et 
al., 2014), my contribution to the aforementioned work resided in identifying a significant 
enrichment in the 2-cell-like cell transcriptome of genes expressed exclusively in the 2-cell stage 
embryo, but not of those of any other developmental stage. As previously mentioned, the LTRs 
of the MERV-L family of retrotransposons serve as promoters for some of the genes activated at 
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the time of zygotic genome activation in the 2-cell stage embryo (Franke et al., 2017; Peaston et 
al., 2004), and these LTRs were determined in this study to be enriched in the vicinity of genes 
upregulated in the 2-cell-like state.  
 
Having determined the sequence of molecular events leading to the activation of the MERV-L 
family of retrotransposons, we also undertook a loss-of-function screen – carried out mainly by 
Xavier Gaume – to identify negative regulators of this transition. At least five major molecular 
complexes were identified through these experiments: the spliceosome complex, the PRC1.6 
complex, the CAF-1 complex and other DNA replication factors, the Ep400/Tip60 complex and 
the SUMO complex. While the effect of the downregulation of the spliceosome complex was not 
studied further, the mechanism of action of three of the four other complexes was to a certain 
extent determined. The Ep400/Tip60 complex proved to be particularly elusive to characterize in 
this context, and so far, our only functional insight is that it binds 2-cell-like upregulated genes in 
a mutually exclusive fashion to the PRC1.6 complex. Given the lack of gene expression changes 
seen in Ep400 and Tip60 catalytically inactive mutants (Acharya et al., 2017), it’s likely that their 
mechanism of action is independent of their direct activity on chromatin, and might have a rather 
structural basis. 
 
The PRC1.6 complex is a non-canonical variant of the Polycomb Repressive Complex 1, which 
represses target genes through the deposition of H2AK119 mono-ubiquitination. Indeed, the 
bioinformatic analyses that I undertook as part of that paper identified an enrichment of PRC1.6 
bound genes in the set of upregulated genes in the 2-cell-like state, suggesting that this complex 
acts to repress at least part of the 2-cell stage transcriptional program. In addition, while we were 
not able to identify binding of either the PRC1.6 complexes or the Ep400/Tip60 complex to 
MERV-L elements, these analyses did identify the transcription factor DUX as one of its targets, 
providing a molecular explanation for the activation of these retrotransposons and the entry of 
these cells into the 2-cell-like state. Upon PRC1.6 knockdown, Dux might become de-repressed 
and go on to activate MERV-L transcription. Subsequently, further work from our lab and from 
Anne Dejean’s lab identified a critical role for SUMO proteins in facilitating the recruitment of 
PRC1.6 to the Dux array (Cossec et al., 2018), indicating that both of these complexes act – at 
least partially – through the same pathway.  
 
Finally, perhaps the most interesting of all these negative regulators of the 2-cell-like state is the 
CAF-1 complex, which is involved in the deposition of H3.1 and H3.2 histone variants at the time 
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of DNA-replication. Indeed, through its association with the DNA-replication machinery, this 
complex partially mediates the inheritance of the epigenetic state of the cell and thus of its precise 
cellular identity. The fact that the downregulation of this complex results in a considerable 
upregulation of the 2-cell-like transcriptome, raises the possibility that the clearance of the cell’s 
epigenetic state might underlie the totipotent capacity seen at the beginning of development. 
Indeed, in this work (Ishiuchi et al., 2015), 2-cell stage embryos at an early phase of DNA-
replication – that is, when gene-rich regions are replicated (Rhind and Gilbert, 2013) – were 
shown to be replicating in the absence of CAF-1. Thus, to a certain extent, the erasure of 
epigenetic memory might underlie the totipotent capacity of early-embryonic cells. 
 
 
Part 2 – The molecular basis of mammalian totipotency in vivo 
In this work, I have presented some preliminary work on a systematic comparison of pre-
implantation development transcriptomes across mammals. Because of the low RNA inputs 
inherent to the pre-implantation embryo and the extraordinary scarcity of the embryos from some 
of the mammalian species we are assaying, I have adapted an existing single-cell RNA-
sequencing protocol into providing both improved sensitivity and 5’ information. Having verified 
the effectiveness of this approach, we have set out to benchmark a range of reaction conditions 
and identified an optimal protocol in terms of sensitivity and precision of the 5’ end profiling for 
use in our transcriptomic comparison. The result is a highly sensitive transcriptional profiling 
approach that can also pinpoint transcription start sites and promoter architectures.   
 
As a proof of concept, in this thesis I have used this transcriptional data to compare the 
transcriptional dynamics of a set of ancient – yet abundant – transposable element families 
between four mammalian species. Indeed, despite the divergent developmental timings guiding 
the pre-implantation development process across the mammalian species assayed, these 
ancient transposable elements appear to exhibit a mostly consistent expression pattern across 
species. In this context, equivalent developmental stages in terms of cell number are not 
necessarily equivalent in terms of the biological processes underlying them, and thus the 
conservation of the transcriptional dynamics appears to occur relative to the timing of the zygotic 




While the well-defined transcriptional profiles observed for L2, L3, MIR, L1M4 or the various DNA 
transposons discussed is undoubtedly not necessarily indicative of a functional role of these 
elements for the host organisms, it might rather be suggestive of a functional relevance of these 
stages and their regulatory context for the once active transposable elements. Some 
transposable elements such as ERV-L or HERV-H appear to achieve stage-specificity by relying 
on the binding of sequence specific transcription factors such as DUX (Hendrickson et al., 2017; 
De Iaco et al., 2017; Whiddon et al., 2017) or OCT4 (Lu et al., 2014) to activate their transcription. 
It remains an open question to which extent are transposable elements reliant on transcription 
factor binding to activate their expression, and whether they can achieve stage-specific 
expression during pre-implantation development through other mechanisms. Thus, the 
conserved transcriptional pattern observed for the analyzed elements might potentially reflect an 
ancestral co-option of a conserved stage-specific host factor by the once active transposable 
element. 
 
Another possibility however, is that the global chromatin remodeling process that occurs during 
pre-implantation development is what permits transposable elements to exhibit stage-specific 
expression patterns. As Eid et al. show here, the absence of certain heterochromatic marks is 
essential for developmental progression in the early embryo, and it remains to be addressed 
whether any of the pathways involved in the chromatin remodeling process lead to the activation 
of transposable elements at this time. Instead, some evidence of the converse situation where 
transposable elements modulate the chromatin landscape does exist. Indeed, the transcriptional 
activation of L1 elements has been shown to affect chromatin accessibility, and their timely 
transcriptional activation has been determined to be essential for pre-implantation development 
(Jachowicz et al., 2017). In general, it remains to be addressed how does chromatin mediate the 
transcriptional activation of transposable elements during pre-implantation development.  
 
Concluding remarks 
Overall, the work carried out during my PhD has aimed to characterize the molecular features of 
mammalian totipotency in terms of its transcriptional profiles, its chromatin state and its metabolic 
properties. Further work to systematically determine which properties of totipotent cells are 
reproduced in totipotent-like cells in vitro will be needed before totipotency can be ultimately 
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Nimble and Ready to Mingle: Transposon
Outbursts of Early Development
Diego Rodriguez-Terrones1 and Maria-Elena Torres-Padilla1,*
Transposable elements are the largest individual constituent of mammalian
genomes. These elements are highly diverse, a consequence of the multiplicity
of genomic habitats that they inhabit and of the complex evolutionary histories that
they have developed therein. Intriguingly, a surge of transposable element tran-
scription occurs during mammalian preimplantation development, contributing to
the establishment of totipotency and pluripotency and to the activation of the
embryonic genome. However, it remains an open question how such an evolution-
arily divergent set can mediate such conserved developmental processes. Here,
we review transposable element diversity across mammals and their evolutionary
significance. We also discuss the implications that their high evolutionary diver-
gence has for the regulation of preimplantation development across mammals.
The Diversity of Mammalian Transposons
Despite their classical rendition as selfish, parasitic genetic elements [1,2], transposable
elements are major drivers of genome evolution and fundamental coordinators of regulatory
function. Long suspected to harbor regulatory roles [3–5], transposable elements have recently
surfaced as conspicuous actors behind the transcriptional and epigenomic remodeling pro-
cesses underlying development and disease. These elements are a nimble bunch, using a
compact set of molecular mechanisms in their replication yet quickly diverging in their abun-
dance, even among closely related species (Box 1). Broadly, transposable elements can be
classified into two classes (Figure 1), according to the molecular intermediate involved in their
transposition [6]: class I elements or retrotransposons, which transpose through an RNA
intermediate; and class II elements or DNA transposons, which directly excerpt, as DNA
molecules, from a donor site in the genome before reintegrating elsewhere at a target site.
Highlights
Transposable elements are extensively
transcribed during early development
in a stage-specific manner in both mice
and humans.
Stage-specific transcriptional activity
of transposable elements reflects a
complex interplay between their co-
option by host regulatory programs
and their own selective pressure to
replicate within the germline.
Despite their limited conservation
across mammals, transposable ele-
ments have been co-opted into regu-
latory functions during early
development.
The ERV-L family of endogenous retro-
viruses can function as alternative pro-
moters during embryonic genome
activation in both mice and humans,
and despite its lack of sequence con-
servation, an orthologous transcription
factor binds their long terminal repeat
(LTR) in both species.
The timely transcription of some trans-
posable elements, such as L1 in mice,
is necessary for developmental
progression.
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Box 1. Transposable Elements Exhibit Limited Conservation across Mammals
The transposable element content of mammalian genomes is exceedingly variable between species (see Figure 2 in the
main text). Even without considering the diversity of individual families, mammalian genomes exhibit marked differences
in the abundance and activity of the different classes, orders, and superfamilies of transposable elements. For instance,
while DNA transposons have long been extinct in most mammals, they appear to have recently flourished in some
lineages of bats. In contrast to other vertebrate genomes, LTR retrotransposons are also extinct across mammals, but
have proliferated primarily as endogenous retroviruses. Given their viral origin, endogenous retrovirus content differs on
a species-by-species basis and reflects the history of exposure of the lineage of the host to different exogenous
retroviruses. Nevertheless, even purely vertically transmitted elements, such as the mammalian-wide ERV-L family,
exhibit variability in their transposition activities, even among closely related lineages, such as mice and rats. LINE
elements are also mainly vertically transmitted, yet have evolved distinct lineage-specific forms and molecular features,
as can be observed when comparing human and mouse L1 elements. Despite being by far the most abundant
transposable element in humans and mice, L1 appear to have died out in some lineages of rodents and bats and to be
undergoing a gradual displacement by the RTE clade in ruminants. Finally, numerous SINEs have emerged de novo over
the course of mammalian evolution and, therefore, are typically restricted to the lineage in which they appear. Thus,
mammalian species exhibit limited conservation in their transposable element content and it remains an open question
to what extent their functional co-options are conserved.
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In mice and humans [7,8], transposable elements exhibit a surge in transcriptional activity
during preimplantation development, which is thought to contribute to cellular plasticity [9,10]
and to the activation of the embryonic genome [11–13]. However, given their limited conser-
vation, it remains an open question how such an evolutionarily divergent set can mediate such
conserved developmental processes. Here, we first summarize the diversity, abundance, and
activity of the two transposon classes across mammals before proceeding to discuss their
evolutionary significance and the implications that their high evolutionary divergence has for the
regulation of preimplantation development across mammals.
DNA Transposons Are Ancient, Predominantly Extinct Inhabitants of
Mammalian Genomes
DNA transposons can be classified into two subclasses depending on the number of DNA
strands cut during transposition [14]. Whenever both strands are cleaved, elements are
classified into Subclass I, which currently comprises 21 superfamilies [15]. These elements
replicate via the classical ‘cut-and-paste’ mechanism, whereby a transposon-encoded protein,
typically a transposase, catalyzes the excerption of the transposon from the host genome and
its subsequent reintegration at a different genomic site. Given their perilous ‘cut-and-paste’
nature, Subclass I elements rely on the timely action of their transposases for their proliferation.
As shown in maize [16], some of these elements increase their copy number by excerpting from
the replicated genome during DNA replication and reintegrating ahead of the replication fork. In
an alternative manner, P elements in Drosophila melanogaster also make use of the S-phase
cellular machinery to increase their copy number [17]. After excising from the genome to
undertake transposition, these elements rely on homologous recombination to repair the
double-stranded break left behind by their excision, consequently restoring the donor copy.
Thus, Subclass I elements make prompt use of the cellular replication and repair machineries to
increase their copy number [18].
At least five different superfamilies of Subclass I DNA transposons occur within the human
genome, which they comprise almost 3% of [19]. Specifically, Tc1/mariner and hAT are the
dominant superfamilies and account for approximately 97% of the 380 000 individual elements
[20]. The last detected waves of Subclass I DNA transposon activity within the human genome
appear to have occurred between 85 and 40 million years ago (Mya), during the early
evolution of the primate lineage [20] (Figure 2). This period saw a tremendous amount of
Subclass I activity, with up to one-third of the 125 DNA transposon families found in the human
genome being active, but subsequently going extinct. Intriguingly, the same trend appears to
apply to all other mammalian lineages studied so far [19,21,22], in which DNA transposon
activity appears to have concurrently ceased 40–50 Mya [18]. The Vespertilionidae family of
bats, which ranks among the most diverse and species-rich mammalian families, is a particu-
larly striking exception to this trend and is the only mammalian lineage wherein recent activity of
Subclass I DNA transposons has been detected [23–25].
Conversely, whenever a DNA transposon requires only a single DNA strand to be cleaved for its
transposition, it is termed a Subclass II element [14]. Two distinct orders of Subclass II elements
exist: Mavericks and Helitrons, both of which replicate through a ‘copy-paste’ mechanism that
does not involve full exaction of both DNA strands from the host genome. Intriguingly, Subclass
II elements do not appear to have been particularly successful in expanding throughout the
mammalian lineage. Whereas Helitron-related sequences are detectable but generally found in
very low abundance [26,27], Mavericks have not been detected within mammalian genomes
[26,28,29]. Remarkably, the single known occurrence of Subclass II activity within mammals is
once again found in the Vespertilionidae [30] (Figure 2). Approximately 6% of the genome of the
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little brown bat (Myotis lucifugus) comprises Helitron elements, some of which replicated as
recently as 1.8 Mya [31]. These transposition events have occurred with deep evolutionary
significance, often capturing functional genomic elements, including promoters, 50-untrans-
lated regions (UTRs), and first exons, and introducing them at different genomic sites [31].
Class I
Retrotransposons




Long interspersed nuclear elements (LINEs)
L1 / L2 / CR1























Subclass I – cut-and-paste elements 
Subclass II – copy-paste elements 





Figure 1. Schematic Representations of the Different Transposable Element Groups Found in Mammalian
Genomes. Colored boxes demarcate coding regions and the protein domains encoded within.
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Therefore, although DNA transposons of both subclasses are generally extinct and represent a
minority within the mammalian repertoire of transposable elements (Figure 1), they have
contributed significantly to the evolution of mammalian genomic landscapes. Overall, DNA
transposons have remained largely unexplored in the context of early mammalian develop-
ment. While it is well established that specific retrotransposon families are actively transcribed
during specific windows of preimplantation development [8], DNA transposons have not yet
been characterized in this context.
Retrotransposons Dominate the Transposable Element Repertoire of
Mammalian Genomes
In contrast to most DNA transposons, retrotransposons typically encode several protein
domains harboring a wide array of biochemical activities, including the RNA-dependent
DNA polymerase activity catalyzed by their idiosyncratic reverse transcriptase (RT). This RT
is responsible for converting the RNA intermediate into the DNA molecule that will be integrated
into the host genome. Thus, because of their dependency on transcription, elements within this
class are of a strict ‘copy-paste’ nature. Retrotransposons can be classified into five orders
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Figure 2. The Diversity of Transposable Element Landscapes in Mammals. The diameter of each dot is proportional to the absolute abundance in base pairs of
the respective transposable element order or superfamily, as determined by RepeatMasker. The largest dot corresponds to the species with the highest genomic
content of a particular transposable element group. The abundance of each transposon group was calculated by RepeatMasker v4.07 using Repbase library
20170127. The phylogenetic relationships shown in the dendogram are based on [104]. Branch lengths are not representative of evolutionary distance. Abbreviations:
ERV, endogenous retrovirus; LINE, long interspersed nuclear element; LTR, long terminal repeat; SINE, short interspersed nuclear element; TIR, terminal inverted
repeat.
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[14]: (i) long terminal repeat (LTR) elements; (ii) Dictyostelium intermediate repeat sequences
(DIRSs); (iii) Penelope-like elements (PLEs); (iv) long interspersed nuclear elements (LINEs); and
(v) short interspersed nuclear elements (SINEs). However, given that only ancestral activity of
DIRSs and PLEs has been detected within mammalian genomes [27], these will not be
discussed further here.
LTR Elements
As their name conveys, LTR elements are characterized by the presence of initially identical,
equally oriented 300–1000 base-pair (bp) sequences on both ends of the retrotransposon [32].
These pairs of sequences, which are termed LTRs themselves, provide a promoter at the 50
end, and transcriptional termination and polyadenylation signals at the 30 end of the retro-
transposon. Although the particularities of their sequential arrangement and their disposition
into distinct open reading frames (ORFs) differ depending on the family, LTR elements typically
encode a gag ORF with structural and nucleic acid-binding functions, and a pol ORF with
protease, RT, RNase-H, and integrase protein domains [33]. Based on the divergence of their
RT and the organization of their functional domains, at least four superfamilies exist within the
LTR order: (i) Copia/Ty1; (ii) Gypsy/Ty3; (iii) Bel/Pao; and (iv) endogenous retroviruses (ERV)
[14,33].
Copia/Ty1, Gypsy/Ty3, and Bel/Pao represent three distinct lineages based on their RT
phylogeny [34]. Despite the wide distribution of these three superfamilies across eukaryotes,
only Gypsy/Ty3 elements are detected within mammalian genomes, albeit in very low numbers
[26,35]. By contrast, ERVs are among the most abundant transposable elements found in the
human genome, of which they comprise 8% [19]. Endogenous and exogenous vertebrate
retroviruses share a startling resemblance to LTR retrotransposons and are presumed to have
arisen from a Gypsy/Ty3 element that acquired an envelope gene [36,37]. This envelope gene,
typically termed env, encodes the transmembrane domain that enables these retroviruses to
undergo an extracellular infectious phase and determines the tropism of the virus [38]. Although
this tropism is typically limited to somatic cells, an exogenous retrovirus might occasionally
infect the germline and be vertically transmitted to the offspring. Over evolutionary timescales,
numerous exogenous retroviruses have invaded mammalian genomes and have settled within
them, establishing novel ERV families.
Vertebrate ERV families can be further classified based on their RT phylogeny into four distinct
classes, commonly referred to as Class I, Class II, Class III, and the recently described reptile-
specific Class IV [38,39]. Each of these classes relates to a specific group of exogenous
retrovirus genera, in addition to their endogenous counterparts (Box 2). Unfortunately, while this
four-class system adequately represents the phylogenetic relationships between RT sequen-
ces, it provides few insights into the phylogenetic relationships of full-length elements. A recent
attempt [40] to systematically classify human ERVs led to the realization that mosaic forms
between classes are common, and often form as a result of secondary integrations and
recombination events between elements of distinct families and even distinct classes. Thus,
while ERVs are commonly discussed in the context of this four-class system, the phylogenetic
relationships between ERV families frequently involve recombination events and, therefore,
their constituent sequences often have diverse origins.
Given their co-option as alternative promoters during embryonic genome activation [41] and as
regulatory elements within gene regulatory networks in embryonic stem cells (ESCs) [42], LTR
elements have emerged as potential leading regulators of early mammalian development,
which we discuss further below.
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LINEs and SINEs
LINEs comprise an additional order within retrotransposons, and greatly differ from LTR
elements in structure and transposition mechanism. Full-length elements reminisce an
integrated mRNA and harbor an internal promoter on their 50 end, a variable number of ORFs,
and a polyA tail on their 30 end. LINE elements can be monocistronic or polycistronic, and
exhibit differing arrangements of their RT, endonuclease, and accessory domains depending
on the clade in question. LINE-encoded proteins exhibit a certain degree of cis-preference [43]
and catalyze the preferential transposition of their transcript of origin [44]. In the absence of an
integrase domain, LINE elements can replicate by reverse transcribing directly into the host
genome, using the DNA of the host as a primer. However, the LINE replication machinery can
also act in trans and often catalyzes the transposition of host transcripts and additional
nonautonomous elements. Despite their extraordinary diversity, most eutherian mammals
display a remarkably consistent LINE landscape dominated by the L1 clade (Box 3). A typical
eutherian genome harbors a L1 content of 10–30% in addition to a L2 contribution hovering in
the low single digits.
SINEs are an additional order of nonautonomous retrotransposons that rely on the replication
machinery of LINEs for their transposition. SINEs have composite structures and incorporate a
50 sequence (head) of variable origin, a central sequence (body) with diverse origins, and a 30
sequence (tail) often related to the 30 end of a LINE. Depending on the origin of their 50
sequence, SINEs can be classified into five superfamilies [15]: (i) SINE1 display a head derived
from the 7SL RNA; (ii) SINE2 have a tRNA-derived head; (iii) SINE3 exhibit a head derived from
the 5S rRNA; (iv) the recently described SINEU carry a snRNA-derived head [45]; and (v) the
recently proposed SINE28 are derived from 28S rRNA [46]. However, despite originating from a
common set of sequences, SINE families have repeatedly arisen independently during
Box 2. Endogenous Retroviruses of Mice and Humans
Mouse and human genomes represent contrasting scenarios of ERV activity (see Figure 2 in the main text). While
Classes I, II, and III have active members in mice, no naturally occurring ERV has been demonstrably shown to be
replication competent in humans. In addition, the relative abundance of the first two classes has evolved radically
differently in the two species. Thus, while Class I sequences are sevenfold more abundant in humans than in mice, Class
II sequences are tenfold more abundant in mice than in humans [19,21]. In humans, the Class I repertoire is dominated
by HERV-H, which by itself encompasses around one-third of all ERVs in the human genome and is the most abundant
human ERV family [85]. This family integrated in several waves during primate evolution and is now extinct. By contrast,
Class II elements are highly abundant in mice and all integrated following the mouse–human speciation event [86].
Notable examples of this class are HERV-K (HML2) in humans, and IAP and MusD/ETn elements in mice. HERV-K is a
superfamily of elements that have invaded the human genome in various waves at different time points, with HERV-K
(HML2) being the most recent and potentially still active [87]. In mice, the MusD/ETn families and the IAP superfamily of
elements are both active representatives of Class II and share a common feature in that both groups lack an env gene.
Likewise, ETn elements are an exacerbated example of this trend and, because of their complete lack of coding
potential, they rely on MusD elements for their retrotransposition [88].
Class III elements comprise the ERV-L family of elements and their internally deleted nonautonomous counterparts
MaLR, which rely on the machinery of the former for replication. Class III elements have been detected in all eutherian
mammals [89], but not in monotremes [35] or metatherians [89–91], and were probably present in their last common
ancestor [89]. Despite their ancient origins, ERV-L elements have remained active throughout eutherian evolution and
have undergone several independent waves of expansion in both primates and rodents [89,92,93]. Similarly, MaLR
elements have also been active throughout mammalian evolution, having reached up to 3.6% and 4.8% of the mouse
and human genomes, respectively, and becoming some of the most successful retrotransposon families therein.
Lastly, in striking contrast to the situation observed in mice, humans, and all other mammalian species analyzed, ERVs
are almost nonexistent in the platypus genome, where they amount to only 0.1% of its genome [35] (see Figure 2 in the
main text). Thus, the specific abundance of the different endogenous retrovirus families differs on a species-by-species
basis and reflects the history of exposure of the host to different exogenous retrovirus families, the proficiency of these
families to replicate within the germline, and the selective forces acting over these integrations.
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mammalian evolution and are often lineage specific [47]. Having arisen only once in an ancestor
of rodents and primates (Figure 2), SINE1 elements constitute 10% of the human genome in the
form of the primate Alu family, and 2.7% of the mouse genome in the form of the rodent B1
family [48]. Among the numerous lineage-specific SINE2 families found in mammalian
genomes, the MIR family stands out for its wide distribution among mammals. Amounting
to more than 2% of the human and mouse genomes, this family is still active in monotremes [35]
but became extinct in metatherians and eutherians following the demise of L2 (Box 3) [19].
While most eutherian SINEs rely on L1 for their transposition, RTE-dependent SINEs (e.g.,
AfroSINEs [49]) are also present in the genomes where the RTE clade is active. Finally, SINE3
elements have only been described in megabats [50] (Figure 2) and springhare [51], suggesting
their emergence is a rare event. Thus, eutherian SINEs are a diverse group of sequences that
have repeatedly emerged de novo over mammalian evolution and, therefore, are generally
restricted to a particular set of taxa.
While, to the best of our knowledge, no functional roles have been ascribed to SINEs during
early mammalian development, timely activation of L1 transcription was recently reported to be
essential for mouse development [10]. Below, we discuss the implications that LINE transcrip-
tion poses for the regulation of mammalian preimplantation development.
Co-option of Transposable Elements by Host Regulatory Programs
Transposable elements are thought to have been co-opted into numerous regulatory roles in
mouse and human cells. Much of our current understanding of how transposable elements
regulate gene expression builds upon early concepts of gene regulation [3,5], which have only
recently been tackled thanks to the growth of massively parallel DNA-sequencing techniques,
which enable a full overview of the genome and the functional features within transposable
elements themselves. Faulker and Carninci note that an important distinction must be made
when referring to transposed elements versus transposable elements [52], given that most
transposable elements are truncated and unable to transpose. Examples of how transposable
Box 3. LINE Diversity across Mammals
Based on reverse transcriptase phylogenies, currently known LINE elements can be classified into 32 clades [15]. In
mammals, four of these clades constitute the bulk of the LINE repertoire, with the more basal lineages harboring
increased LINE diversity (see Figure 2 in the main text). In the platypus genome, to our knowledge, the only monotreme
genome to be systematically analyzed, L2 is the dominant LINE clade, although small amounts of the RTE and CR1
clades are also present [35]. L2 and the L2-dependent SINE MIR have both proliferated to great lengths within this
genome and each comprise around 20% of its sequence. Intriguingly, while L1 is almost nonexistent in the platypus and
echidna genomes [35,94], this clade has become the dominant LINE clade in metatherians [95]. In the metatherian
opossum and wallaby genomes, L1 contributes 15–20% of the genomic sequence, while the monotreme-dominant L2
is limited to a mere 5–7%. A relatively large number of CR1 and RTE elements is also present in these genomes,
constituting 2–3% of their respective sequences. Together with Ruminantia and Afrotheria [96], Metatheria is one of the
few mammalian lineages harboring a substantial amount of RTE LINEs and also harbors RTE-dependent SINEs [95].
Thus, metatherian genomes are exceptional among mammals because of the diversity of LINE clades that they harbor,
and stand in stark contrast to monotreme genomes, which are solely populated by the L2 clade.
Despite their extraordinary diversity, most eutherian mammals display a remarkably consistent LINE landscape
dominated by the L1 clade. A typical eutherian genome harbors a L1 content of 10–30% in addition to a L2 contribution
hovering in the low single digits. While the monotreme-dominant L2 clade is now extinct in eutherian genomes [97], the
L1 clade is generally still active and has evolved numerous lineage-specific attributes, such as a recently described novel
ORF in primates [98]. Ruminant and Afrotherian genomes [96], such as those of cows and sheep and those of elephants
and tenrecs, represent the only known exceptions to L1 hegemony in eutherians, because up to half of their LINE
content corresponds to the RTE clade [99]. Another anomalous situation has been reported in bats of the suborder
Megachiroptera [100], and rodents of the taxa Sigmodontinae [101] and Spermophilus [102], where L1 transposition
appears to have ceased, along with that of its associated SINEs. Overall, eutherian genomes are characterized by a
LINE landscape comprising a single, nonbranching lineage of successively dominant L1 families [103], although some
taxa contain additional clades and some others have lost LINE activity altogether.
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element-derived sequences impact gene expression are multiple, and operate at the following
levels: (i) by creating new or alternative promoters [53]; (ii) by providing or disrupting binding
sites for regulatory factors [54–56]; (iii) by facilitating silencing of nearby genes [57]; (iv) through
the action of noncoding RNAs [58]; (v) by generation of antisense transcripts, typically down-
stream of gene promoters [53]; (vi) by generating dsRNA, a mechanism recently described in
mouse [59] and Drosophila oocytes [60]; (vii) by regulating chromatin accessibility [10]; and
(viii) by contributing RNA regulatory sequences within introns and UTRs [53,61].
Whenever they are co-opted into providing functional promoters, transposable elements
typically confer tissue-specific regulation as opposed to housekeeping activity. In agreement
with their role as tissue-specific regulators, transposable elements initiate transcription from
sharp promoters [53] (i.e., from a single, well-defined site), which is a typical feature of single-
copy gene promoters that display a high degree of tissue specificity [62]. Depending on the cell
type analyzed, between 6% and 30% of transcripts initiate within repetitive elements [53].
Notably, tissues from embryonic origin and transformed tissues tend to contain the highest
proportion of transposable element-derived sequences in their transcriptomes. In the placenta,
specific ERVs of the RLTR13D5 family have been suggested to act as species-specific
enhancers in mouse and rat [63]. In addition, pioneering work by Knowles and colleagues
[41] demonstrated that 12% of mouse oocyte transcripts contain transposable element-
derived sequences, in particular MaLR LTRs of the MT family, and that MERV-L LTRs often
function as alternative promoters of genes activated during embryonic genome activation
(EGA).
However, host factors can also be exploited by transposable elements and, therefore,
co-option is a two-sided process. Indeed, transposable elements themselves are also subject
to selective pressures, among which the most important is probably the ability to transpose
within the germline. Transposable elements have been found to carry DNA-binding motifs for
numerous transcription factors [11–13,42,54,56], and it is possible that some transcription
factors exert a positive effect on the replicative fitness of transposable elements. When bound
by a host transcription factor, transposable elements might achieve higher levels of expression
and, consequently, increase their chances for transposition. The recent description of the DUX
transcription factor binding to, and driving the expression of, ERV-L elements [11–13] is an
excellent example of this phenomenon, although a link to actual retrotransposition has not yet
been established. All in all, the integration of transposable elements into host regulatory
programs probably reflects a complex interplay between the co-option of transposon-derived
sequences (e.g., as binding sites) by host factors and the selective pressure over transposable
elements themselves to promote their own replication through the acquisition of DNA-binding
motifs.
Transposable Element Expression Coincides with Highest Cellular Plasticity
Regardless of the evolutionary forces that have enabled transposable elements to acquire
regulatory functions, transposable elements must be able to efficiently replicate within the
germline for co-option and transposon expansion within a host genome. In mammals, the
germline emerges soon after implantation, upon specification of the primordial germ cells
(PGCs). PGC specification is accompanied by their segregation from the epiblast and, in the
mouse, this process occurs 7.5 days after fertilization. Therefore, the developmental period
before PGC specification provides an ideal setting for transposons to replicate. Indeed, in both
mouse [7,41] and human [8] preimplantation embryos, transposable elements have been
shown to exhibit high levels of transcriptional activity. Preimplantation development provides
an excellent window of opportunity for the transcriptional activation of transposable elements
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for several reasons. In mice, the remodeling of heterochromatic marks [64], the relaxed
chromatin structure [65,66], and the temporary uncoupling of chromatin assembly and
DNA synthesis after fertilization [67] are now well established, and may promote the robust
transcriptional activation of transposable elements that occurs after fertilization, for example by
favoring an open chromatin environment [7]. Transcriptional activation of transposable ele-
ments is observed as early as the zygote in the mouse and persists throughout preimplantation
development (Figure 3, Key Figure). Slightly different kinetics have been documented for other
species [8], yet transcriptional activation of transposons is a common theme. During this period
of development, the zygote undergoes a series of cleavages, which lead to the first cell fate
decision upon emergence of the blastocyst, which segregates the pluripotent inner cell mass
and the trophectoderm. The latter is an epithelium of restricted plasticity, which will form the
placenta, while the former will give rise to the embryo proper. While there are only a few cell
divisions during this period, the chromatin and epigenomic landscape are heavily remodeled
[64,68]. This remodeling is thought to mediate, at least in part, the transition from the totipotent
blastomeres to the pluripotent cells of the inner cell mass.
LINE Control of Chromatin Accessibility in Early Development
It is unknown whether the unique chromatin features observed in preimplantation embryos are
a consequence of the transcriptional activation of transposable elements, the other way
around, or a combination. For example, young L1 elements are transcribed as early as the
one-cell zygote in the mouse (Figure 3). Using a DNA-sequence-targeting strategy to manipu-
late L1 expression in vivo, recent work [10] showed that preventing L1 silencing after the 2-cell
stage or, conversely, enforcing premature silencing of L1 at the zygote stage, significantly
decreased developmental progression. L1 elements appear to regulate global chromatin
accessibility during preimplantation development, suggesting that transposable elements also
contribute to shaping chromatin architecture during these stages. This is likely to be the result of
a general effect of L1, since the authors found no evidence for the regulation of nearby genes
after transcriptional manipulation of L1 in preimplantation embryos [10]. In fact, genes that are
activated early during EGA in the mouse are generally depleted of L1 [69]. Given the abundance
of L1 elements, one could envision that they have a general role in maintaining chromatin
structure, in line with previous reports indicating that repetitive, Cot-1 RNA associates with
chromatin and can affect compaction and chromatin organization in cells in culture [70]. In
agreement, a role for SINEs in the regulation of chromatin organization has been previously
documented, whereby various SINE families have driven the spread of CTCF-binding sites
across the mouse, dog, and opossum genomes [55]. While in-depth analyses of transposable
element distribution in the context of chromatin conformation capture data sets have not yet
been documented during preimplantation development, we anticipate that transposable
elements may play a key role in the organization of higher order chromosomal structures
during the initial establishment of nuclear architecture in the early embryo.
As we previously discussed (Box 3), L1 is no longer active in some rodents and bats and has been
gradually supersededby other LINE clades in species such as cows (Figure 2). The extent to which
the co-option of L1 elements observed in mice is conserved, particularly in species with highly
divergent LINE content or activity, and whether the other three LINE clades observed in mammals
have been co-opted into similar roles, are both outstanding questions. In porcine embryos [71], L1
elements are also actively transcribed and their transcription peaks at the eight-cell stage,
coincident with EGA (Figure 3). Interestingly, antisense transcription of L1 at this stage prevents
retrotransposition, providing a mechanism whereby, despite the robust upregulation of L1 during
this developmental window, the retrotransposition events are rare. Thus, while there is evidence
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Key Figure
The High Potency Habitats of Transposable Elements
Mouse:
·Young L1 families 
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peak levels during 
the two-cell stage








·L1 expression peaks during the four- 
and eight-cell stages
Human:
·HERV-9 transcripon occurs throughout preimplantaon development, between the oocyte and morula stages
Human:
·HERV-K14 elements peak in expression in 
zygotes and two-cell stage embryos
Mouse:
·MaLR elements of the ORR 








      wave
  Major
           wave
Human:
·HERV-H LTRs have a high degree 
of stage specificity. LTR7B is expressed 
in eight-cell and morula stage embryos,
LTR7Y is expressed in all blastocyst cells 
and LTR7 is specifically expressed in 
pluripotent cells of the blastocyst
Human:
·HERV-K (HML-2) peaks in expression 
during the eight-cell and morula stages
but does not contribute to chimeric 
transcripts
Mouse:
·MERV-L LTRs(MT2_Mm) funcon as 
alternave promoters during mouse 
EGA at the zygote and two-cell stages
Mouse:
·MaLR elements of the MT 
family are highly enriched 
in oocyte transcriptomes
Human:
·Human MaLR elements are also
transcribed during EGA, because the
THE1A family has been reported 
to peak at the eight-cell stage
Mouse:
·B1 and B2 SINEs are transcribed from 
the two-cell stage on, and peak at the 
morula and blastocyst stages
Human:
·HERV-L LTRs (MLT2A1/2) also serve as
alternave promoters during human 
EGA at the four- to eight-cell stage
Figure 3. Known windows of transposable element expression for mice, humans, and pigs are shown. Abbreviations: EGA, embryonic genome activation; ERV,
endogenous retrovirus; LINE, long interspersed nuclear element; SINE, short interspersed nuclear element.
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that L1 elements in species with similar LINE content to mouse have similar expression dynamics,
other species with more divergent LINE landscapes remain unexplored.
In addition, LINE elements might also be shaping the regulatory landscape of early develop-
ment through indirect mechanisms. In humans, L1 has been shown to be responsible for the
retrotransposition of host transcripts and the formation of more than 8000 processed, intron-
less retrogenes [72]. Several retrogenes are transcribed during preimplantation development,
including those encoding some important regulatory factors, such as the DUX transcription
factor [73], which is in turn believed to regulate transcription of murine ERV-L. We speculate that
L1-dependent retrogene formation has shaped the regulatory landscape of early development
and perhaps contributed to some of the uncoupling of splicing from transcription that is
observed at the earliest stages of genome activation [74].
Gene Transcription Initiates within LTRs during EGA in Primates and
Rodents
In mice, another interesting example is the MERV-L family of transposable elements and their
MT2 LTRs, which are actively transcribed in two-cell embryos [41]. During EGA, these LTRs
serve as powerful promoters enabling the transcription of neighboring genes, resulting in
‘chimeric’ LTR-host transcripts. In fact, a significant proportion of genes activated during
mouse EGA are located in proximity to an MT2 LTR, which contains a binding motif for the
pioneer transcription factor DUX [11–13]. Ectopic expression of Dux in mouse ESCs results in
the transcriptional activation of MERV-L LTRs, as well as of a substantial proportion of the
murine EGA transcriptional program. Indeed, it appears that Dux is expressed at the early
stages of EGA in the mouse, similarly to its human ortholog DUX4 [11,12]. In analogy to its
mouse ortholog, ectopic expression of DUX4 in human induced pluripotent stem cells (iPSCs)
activates a subset of the human EGA transcriptional program, as well as HERV-L. Nonetheless,
human DUX4 fails to activate murine MERV-L LTRs when overexpressed in mouse cells,
reflecting the partial divergence of the DNA-binding motif of the two DUX proteins. This is an
extraordinary example of strong functional conservation in the absence of sequence conser-
vation, because both transcription factor orthologs bind the homologous transposon families
despite their limited sequence conservation. In addition, it is a nice illustration of LTRs
containing species-specific transcription factor-binding sites. DUX is probably not the excep-
tion, and we anticipate that additional factors that can drive developmental programs with the
help of transposable elements may exist.
Indeed, Class III ERVs, such as ERV-L and MaLR, appear to significantly contribute to both
oocyte and embryo transcriptomes in both mice and humans [41]. In the mouse zygote,
downregulation of MERV-L through RNA interference can result in developmental arrest at the
two-cell stage [75]. However, it is unclear whether this phenotype is a consequence of the
downregulation of the transcript itself, of the protein products, or of the chimeric transcripts that
initiate within MERV-L LTRs. Determining whether MERV-L itself is required for totipotency has
yet to be addressed. In addition, a systematic characterization of ERV-L co-option beyond mice
and humans is lacking and it remains unclear whether ERV-L elements have undergone similar
co-options in other eutherian lineages.
Expression of transposable elements appears to be a widespread feature of mammalian early
development (Figure 3) [8]. Human preimplantation development is characterized by sequential
waves of transcriptional changes, each of them with distinctive signatures of transposable
element transcription [8]. Namely, HERV-K (HML-2), one of the youngest LTR insertions in the
human genome, undergoes DNA hypomethylation, becomes activated during human EGA,
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and remains expressed at least until the blastocyst stage [76]. In this case, however, there is no
evidence of chimeric transcripts arising from LTR5HS and instead retroviral ORFs were
observed to regulate host mRNA translation and/or stability of host mRNAs in the cytoplasm.
In addition to the increasing evidence documenting roles of transposable elements during
development in vivo, they also have a clear role in promoting cellular plasticity or differentiation
of stem cells in vitro. Approximately 231 HERV-H LTRs are expressed in human ESCs, where
they function as enhancers and affect the expression of long noncoding (lncRNAs) and
neighboring protein-coding genes [9]. Depletion of HERV-H not only reduced the efficiency
of iPSC reprogramming, but also induced early differentiation markers, suggesting that they are
important for maintaining cellular potency. In contrast to the work on L1 in mice discussed
above, where no evidence of regulation of expression of neighboring genes was observed in
embryos, HERV-H may regulate stem cell identity through different mechanisms. Approxi-
mately one-third of HERV-H LTRs affect nearby lncRNAs, while the remaining two-thirds affect
protein-coding genes. In addition, HERV-H transcripts themselves may directly interact with
chromatin modifiers to potentially recruit them to enhancers. Thus, transposable elements can
regulate cellular plasticity through a variety of mechanisms.
Chromatin Regulation of Transposable Elements during Early Mammalian
Development
Despite the wealth of data on transposable element transcription during human and mouse
preimplantation development, relatively little is known about the epigenetic and/or chromatin-
mediated regulation of these elements during this period. There have been many important
contributions to our understanding of the chromatin regulation of transposons in ESCs, but
in vivo studies in embryos have only recently started to emerge. While transposable elements
are typically repressed in somatic cells by H3K9me3 and/or DNA methylation, preimplantation
mouse embryos appear to resort to alternative mechanisms to regulate transposon expression.
In mouse and humans, the parental genomes undergo major DNA demethylation following
fertilization [77]. Different families of LTR elements exhibit different levels of DNA methylation
during preimplantation development. While ERV-L and MaLR elements are mostly hypome-
thylated after fertilization in both species, ERV2 elements generally maintain high levels of DNA
methylation [78]. By contrast, ERV1 elements are mostly hypomethylated in humans, but
exhibit intermediate levels of methylation in mouse embryos. LINEs are highly methylated in
human sperm but become demethylated following fertilization, particularly in the case of young
L1 families [77]. Finally, while SINEs exhibit intermediate levels of DNA methylation in human
sperm and also become hypomethylated upon fertilization [77], their DNA-methylation dynam-
ics are mostly comparable to intergenic sequences.
Using ChIP-qPCR, one of the first characterizations of histone modifications over transposable
elements in preimplantation embryos [69] revealed little changes in the levels of H3K9me3 on
L1 and IAP between the two-cell and eight-cell stages. Instead, a stark decrease in the levels of
H3K4me3 during the same developmental period was observed. Thus, it was suggested that
downregulation of L1 after the four-cell stage is associated with the reduction of H3K4me3,
rather than with the acquisition of heterochromatic marks. In agreement, maternal depletion of
Lsd1 resulted in increased L1 transcription [79]. More recently, ChIP-sequencing approaches
largely confirmed these observations and significantly expanded our knowledge of the distri-
bution of H3K27me3 [80,81], H3K4me3 [80,82], and H3K9me3 [83] across transposons in the
early embryo. For example, they revealed that the number of LTR loci marked by H3K9me3
gradually increases between the zygote and blastocyst stages. Notably, at least some MERV-L
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elements lack H3K9me3 in oocytes and zygotes [83], but acquire H3K9me3 at the four-cell
stage concomitant with their transcriptional repression. In addition, some LTR families appear
to gain H3K9me3 concomitant with their loss of DNA methylation after fertilization, in what has
been proposed to be an epigenetic switch of transposon control for a reduced group of LTR
families [83].
However, globally, the dynamics of transcriptional activation and repression of transposons
during preimplantation development cannot be solely explained by their DNA methylation levels
or H3K9me3 enrichment. Indeed, a specific class of LTRs (IAPz) are regulated by the arginine
methyltransferase PRMT5 in the embryo [84]. Overall, little is known about the molecular
players that regulate transposable element expression during preimplantation development,
and much work remains to be done to dissect the molecular mechanisms underlying their
regulation by specific chromatin pathways.
Concluding Remarks: Towards a Systematic Understanding of Transposable
Element Activity in Early Development Across Mammals
Given the broad co-option of transposable elements into regulatory functions in mice and
humans, we can expect that similar and/or additional functional roles are widespread across
mammals. While the human and mouse models have proven exceedingly useful in character-
izing the contribution of transposable elements to the regulation of early development, it is
important to note the many parallels in repetitive element content that both species have and
that might inadvertently paint a false picture of conservation. Indeed, characterization of
additional mammalian species with more divergent repetitive landscapes is necessary to fully
appreciate the repertoire of regulatory roles and the evolutionary impact of transposable
elements (See Outstanding Questions). For example, while DNA transposons have long been
extinct in both primates and rodents, they have dramatically expanded in bats in the form of
numerous families across at least two distinct transposon orders. It will be interesting to
address whether DNA transposons are active during early development in this lineage and
whether they have been co-opted for similar purposes as their retrotransposon counterparts in
mice and humans. Given the limited conservation of transposable element content across
species, we anticipate that further characterization of early embryonic transcriptomes across
mammals will uncover conserved regulatory mechanisms driven by divergent repetitive land-
scapes. Transcriptomic analyses capable of distinguishing transposable element-driven tran-
scription from read-through transcription during early development are particularly lacking,
regardless of the species, and will certainly contribute to elucidating the evolutionary and
regulatory roles of transposable elements during preimplantation development.
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